Digital PCR detector, digital PCR quantitative detection method, quantitative analysis method for digital PCR with different volumes, digital PCR detection method, nucleic acid detection microspheres, nucleic acid detection microsphere manufacturing method, nucleic acid detection microsphere reagent kit and high throughput nucleic acid detection method
The digital PCR detector addresses inefficiencies in conventional methods by integrating devices for real-time monitoring and automated processing of microdroplets, enhancing detection efficiency and accuracy for multiple target sequences.
Patent Information
- Application Number
- JP2023042563
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-11-21
- Filing Date
- 2023-03-17
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2039-01-24
AI Technical Summary
Conventional digital PCR methods face limitations such as a narrow dynamic range, low working efficiency, and the need for sequential detection of multiple target sequences, leading to increased workloads and inefficiencies.
A digital PCR detector integrating a microdroplet generation device, temperature control device, fluorescence signal detection device, and quantitative analysis device, enabling real-time monitoring and automated processing of microdroplets for enhanced detection efficiency and accuracy.
The integrated system allows for high-throughput, accurate, and efficient detection of multiple target sequences with improved dynamic range and reduced detection time, minimizing false positives and negatives.
Smart Images

Figure 0007576864000033 
Figure 0007576864000034 
Figure 0007576864000035
Abstract
Description
[Technical field]
[0001] This application claims priority to the following Chinese patent applications: No. 201810070377.2, filed on January 24, 2018, entitled "DIGITAL PCR QUANTITATIVE DETECTION METHOD", No. 201810932950.6, filed on August 16, 2018, entitled "DIGITAL PCR DETECTION METHOD", and No. 201811392278.2, filed on November 21, 2018, entitled "Nucleic acid detection microspheres, manufacturing method, reagent kit and high-throughput nucleic acid detection method", all of which are incorporated herein by reference.
[0002] The present application relates to the field of nucleic acid detection analysis, in particular to a digital PCR detector, a digital PCR quantitative detection method, a method for quantitative analysis of different volume digital PCR, a digital PCR detection method, nucleic acid detection microspheres, a method for manufacturing nucleic acid detection microspheres, a nucleic acid detection microsphere reagent kit and a high-throughput nucleic acid detection method. [Background technology]
[0003] Digital PCR (dPCR) is a technique for absolute quantification of nucleic acid molecules. Compared to qPCR, dPCR directly counts the number of DNA molecules, so it is absolute quantification relative to the copy number of the initial sample. Quantitative PCR detects the amount of nucleic acid according to a standard curve or reference gene. Summary of the Invention [Problem to be solved by the invention]
[0004] At present, digital PCR includes droplet PCR detection methods and chip detection methods. In the chip detection method, a single chip contains only a few thousand effective reaction chambers, which is much less than the droplet method. Therefore, the dynamic range of the chip digital PCR is narrower than that of the droplet method. In the droplet PCR detection method, the sample is dispersed into the reaction cells of "water in oil", and then each reaction cell is analyzed in real time or analyzed by fluorescence at the end point. However, since the effective reaction chambers in the conventional digital PCR device are few in number, the dynamic range of the current digital PCR is relatively narrow and the efficiency of the work is low. The end point detection method of the conventional droplet digital PCR has limitations and low detection accuracy. In the process of digital PCR detection and analysis, if a matrix of tens of millions of nanoliter microdroplets is used to simultaneously detect multiple types of target sequences using the conventional digital PCR detection method, it is necessary to design multiple types of primers and detect them sequentially. If multiple detections are continuously repeated, the amount of work becomes huge, time-consuming, and the work efficiency is low. Moreover, conventional PCR detection techniques can only detect limited target sequences, and when attempting to detect tens, tens, or hundreds of target sequences by PCR detection, multiple detections must be repeated, resulting in a huge amount of work, consuming a large amount of sample, and low work efficiency per hour. [Means for solving the problem]
[0005] In view of this, the present application provides a digital PCR detector including a microdroplet generating device, a temperature control device, a fluorescent signal detection device, and a quantitative analysis device. The microdroplet generating device is used to microdropletize a nucleic acid amplification reaction liquid to form a plurality of microdroplets. The temperature control device is connected to the microdroplet generating device via a rail, and is used to transfer the plurality of microdroplets to the temperature control device and realize nucleic acid amplification by temperature cycling. The fluorescent signal detection device is disposed opposite the temperature control device and is used to photograph and detect the plurality of microdroplets that have undergone nucleic acid amplification. The fluorescent signal detection device can perform imaging of the microdroplets with a plurality of fluorescent channels and imaging in bright field and dark field. Among them, imaging with a plurality of fluorescent channels is used to detect reaction signals of the microdroplets, and imaging with bright field and dark field is used to detect size information of the microdroplets formed and monitor the state of the droplets in the reaction process. As for the quantitative analysis device, the quantitative analysis device is connected to the fluorescent signal detection device via a data line, and is used to realize transmission of fluorescent information of the plurality of microdroplets and quantitative analysis. Regarding the controller, the controller is connected to the microdroplet generating device, the temperature control device, the fluorescent signal detection device and the quantitative analysis device, respectively, and is used to control the microdroplet generating device, the temperature control device, the fluorescent signal detection device and the quantitative analysis device. The digital PCR detector integrates the microdroplet generating device, the temperature control device, the fluorescent signal detection device and the quantitative analysis device, so that the integrated digital PCR detection device can realize the automated operation of the operator, and can improve the work efficiency of the digital PCR detector.
[0006] In view of this, the present application provides a digital PCR quantitative detection method, which includes the steps of: acquiring multiple real-time fluorescence images for all microdroplets; acquiring a real-time fluorescence curve of the microdroplets to be amplified based on the multiple real-time fluorescence images; acquiring all Ct values of the microdroplets to be amplified based on the real-time fluorescence curve; acquiring all initial nucleic acid copy numbers of the microdroplets to be amplified based on the relationship between the Ct values and the initial nucleic acid copy numbers of the microdroplets to be amplified; acquiring a frequency distribution of the initial nucleic acid copy numbers based on all initial nucleic acid copy numbers of the microdroplets to be amplified; and calculating a parameter λ of a Poisson distribution based on the frequency distribution of the initial nucleic acid copy numbers. The digital PCR quantitative detection method can realize dynamic tracking of the multiple microdroplets, and can find the specific position of each microdroplet in the process of performing temperature cycling on the multiple microdroplets, thereby realizing monitoring throughout the entire process of performing nucleic acid amplification.
[0007] The digital PCR quantitative detection method not only avoids the reliance on a standard curve, but also solves the problem that quantitative results are not definite due to the standard curve, and also solves the limitations of the end-point detection method in droplet digital PCR, and overcomes the constraint of estimating parameters for the entire sample to be detected using only one p(χ=0) data. At the same time, the accuracy of quantitative detection in digital PCR is improved by processing the fluorescence curves of the multiple microdroplets and performing statistics and corrections without the assumption of uniformity.
[0008] In view of this, the present application provides a quantitative analysis method for different volumes of digital PCR. According to the quantitative analysis method for different volumes of digital PCR, the standard deviation σ and confidence interval corresponding to ln(c) can be obtained. The standard deviation σ and confidence interval corresponding to ln(c) can be used to obtain the nucleic acid concentration c of the nucleic acid amplification reaction solution to be detected, so that the number of DNA initial copies contained in the nucleic acid amplification reaction solution to be detected can be known. The quantitative analysis method for different volumes of digital PCR can achieve a dynamic detection range of five orders of magnitude with less than 200 microdroplets, improving the dynamic detection range of the digital PCR detector. Moreover, its performance is as good as that of a single-volume digital PCR with 12,000 microdroplets, and the cost of the equipment and the cost of consumables are also reduced.
[0009] In view of this, the digital PCR detection method provided by the present application includes step S10 of preparing a nucleic acid amplification reaction solution to be detected, step S20 of microdropletizing the nucleic acid amplification reaction solution to be detected to form a microdroplet matrix, step S30 of subjecting the microdroplet matrix to a polymerase chain reaction to obtain a fluorescence curve and a dissolution curve of each microdroplet in the microdroplet matrix, and step S40 of analyzing the microdroplet matrix based on the fluorescence curve and the dissolution curve of each microdroplet in the microdroplet matrix to obtain information on the nucleic acid to be detected.
[0010] The digital PCR detection method provided by the present application can realize genotyping, mutation scanning, methylation research, etc., by using only one dye when preparing the nucleic acid amplification reaction solution to be detected, and has high resolution and sensitivity, and reduces the cost of detection. Moreover, according to the digital PCR detection method, the microdroplet matrix can be subjected to a polymerase chain reaction in the same highly integrated digital PCR detector, and the microdroplet matrix can be amplified by PCR, and then the dissolution curve of the PCR product can be analyzed. At the same time, the digital PCR detection method can seamlessly realize both real-time monitoring of the PCR amplification throughout the entire process and analysis of the dissolution curve of the PCR product by obtaining a fluorescence curve and a dissolution curve for the microdroplet matrix. And, based on the fluorescence curve and dissolution curve of the microdroplet matrix, genotyping and classification according to dissolution curves of different shapes can be realized, and qualitative and quantitative analysis of the microdroplet matrix can be realized, so that the digital PCR detection can be completed more comprehensively, simply, and efficiently.
[0011] In view of this, the present application provides nucleic acid detection microspheres, a manufacturing method, a reagent kit, and a high-throughput nucleic acid detection method. The coating layer covers the nucleoli to form the nucleic acid detection microspheres. The substrate is a hydrophilic polymer gel formed in a hydrophobic oil, which has no fluidity and is not easily changed in shape or volume. The hydrophilic polymer gel is in a gel state at room temperature and dissolves at a temperature higher than room temperature, and does not affect the diffusion and activity of enzymes, reaction solutions, etc. At the same time, the primers dispersed in the substrate can qualitatively analyze and identify the target detection nucleic acid. The nucleoli are made of a material that can withstand high temperatures and have a special marking function, and each nucleolus is uniquely associated with one of the primers, so that the nucleic acid detection microspheres can be marked by the nucleoli so as to be tracked and detected. When PCR detection is performed, a nucleic acid detection solution can be obtained by mixing multiple and various types of the nucleic acid detection microspheres with a nucleic acid amplification reaction solution to be detected. When the nucleic acid detection solution is made into droplets, multiple microdroplets can be formed, and the multiple microdroplets can be made to undergo a PCR reaction. In the PCR reaction process, the double-stranded DNA is denatured at 90°C to 95°C, and then rapidly cooled to 50°C to 60°C. After the primers anneal and bind to the target sequence, the temperature is rapidly raised to 70°C to 75°C. The primer strands are extended along the template by the action of Taq DNA polymerase, and the nucleic acid is amplified in an appropriate temperature range. In the process of controlling the PCR temperature for a plurality of microdroplets, the coating layer is dissolved and decomposed. Then, the primers attached to the coating layer are released into the corresponding microdroplets to react with the target nucleic acid molecules contained in the microdroplets. Finally, the nucleoli are located, tracked and identified, and the target nucleic acid molecules are identified by the corresponding primers of the nucleoli, thereby realizing PCR detection with high throughput.
[0012] In practical application, various kinds of the nucleic acid detection microspheres can be produced in batch processing, and various kinds of the nucleic acid detection microspheres can be mixed in a certain ratio according to the needs of the nucleic acid actually targeted for detection, and then mixed with the nucleic acid amplification reaction solution to be detected to obtain the nucleic acid detection solution to detect the target nucleic acid, and various kinds of target nucleic acid molecules can be detected in one go, eliminating the need for repeated detection, thus reducing the workload, shortening the detection time, and increasing the sensitivity. [Brief description of the drawings]
[0013] In order to more clearly describe the embodiments of the present application or the technical means in the prior art, the drawings necessary for describing the embodiments or the prior art are briefly described below. The drawings in the following description are merely the embodiments of the present application, and it is obvious to those skilled in the art that other drawings can be obtained based on the drawings provided without creative labor.
[0014] [Figure 1] FIG. 1 is a schematic diagram of the overall structure of the digital PCR detector provided by the present application. [Diagram 2] FIG. 1 illustrates a microdroplet generating device for a digital PCR detector provided by the present application. [Diagram 3] 1 is a schematic diagram of a droplet subjected to a force when the outlet end of a liquid ejection pipette tip provided by one embodiment of the present application moves; [Figure 4] FIG. 2 is a schematic diagram of the velocity change at the outlet end of a liquid ejection pipette tip provided by one embodiment of the present application. [Diagram 5] FIG. 2 is a schematic diagram of the process of generating microdroplets when the outlet end of a liquid ejection pipette tip provided by one embodiment of the present application moves; [Figure 6] 1 is a schematic diagram of the structure of a fluorescent signal detection device according to the present application. [Figure 7] FIG. 1 is a schematic diagram of the structure of a temperature control device according to the present application. [Figure 8] 1 is a schematic diagram of a cross-sectional structure of a temperature control device according to the present application; [Figure 9]2 is a schematic diagram of an electrode connection structure in a semiconductor thermocouple of the temperature control device according to the present application. FIG. [Figure 10] FIG. 2 is a schematic diagram of an instantaneous performance test by the temperature control device according to the present application. [Figure 11] FIG. 2 is a schematic diagram of a steady-state performance test using a temperature control device according to the present application. [Figure 12] 1 is a flowchart of an analysis method of a digital PCR detector according to the present application. [Figure 13] 1 is a flowchart of a method for laying out microdroplets according to the present application. [Figure 14] FIG. 2 is a schematic diagram of micro-droplets being stacked on the bottom plate of a micro-droplet container according to the present application. [Figure 15] 1 is a flow chart of the complete sampling digital PCR quantitative detection method according to the present application. [Figure 16] 1 is a flowchart of a partial sampling digital PCR quantitative detection method according to the present application. [Figure 17] This is a comparison graph of the standard deviation of CPD of the partial sampling digital PCR quantitative detection method and other methods. [Figure 18] 1 is a flowchart of a method for quantitative analysis of different volume digital PCR. [Figure 19] 1 is a flow chart of the overall steps of the digital PCR detection method provided by the present application. [Figure 20] FIG. 1 is a schematic diagram of a matrix of microdroplets obtained by the digital PCR detection method provided by the present application. [Figure 21] FIG. 2 is a schematic diagram of a fluorescent image of a matrix of microdroplets obtained by the digital PCR detection method provided by the present application. [Figure 22] FIG. 1 is a schematic diagram of real-time fluorescence curves obtained by the digital PCR detection method provided by the present application. [Figure 23] This is a comparison diagram comparing the standard deviation of CPD of a partial sampling obtained by the digital PCR detection method provided by the present application with that of other methods. [Figure 24]FIG. 1 is a schematic diagram of a melting curve obtained by the digital PCR detection method provided by the present application. [Diagram 25] FIG. 1 is a schematic diagram of the structure of a nucleic acid detection microsphere provided by the present application. [Figure 26] FIG. 2 is a schematic diagram of the structure of the coating layer provided by the present application. [Figure 27] FIG. 1 is a schematic diagram of the structure of a nucleolus provided by the present application. [Figure 28] FIG. 2 is a schematic diagram of the structure of a coating layer in one embodiment provided by the present application. [Figure 29] FIG. 1 is a schematic diagram of the structure of a nucleic acid detection microsphere according to an embodiment of the present application. [Diagram 30] FIG. 1 is a schematic diagram of the structure of a microdroplet generating device provided by the present application. [Diagram 31] 1A-1D are schematic diagrams of the structures of different kinds of microfluidic control chips provided by the present application. [Diagram 32] FIG. 1 is a schematic diagram of a first effective microdroplet structure provided by the present application. [Diagram 33] FIG. 1 is a schematic diagram of the structure of a microdroplet generating device provided by the present application. [Diagram 34] 1A-1D are schematic diagrams of the structures of different kinds of microfluidic control chips provided by the present application. [Diagram 35] FIG. 2 is a schematic diagram of a second effective microdroplet structure provided by the present application. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0015] The following clearly and completely describes the technical solutions of the embodiments of the present application with reference to the accompanying drawings of the embodiments of the present application. Of course, the embodiments described herein are only a part, not all, of the embodiments of the present application. All other embodiments obtained based on the embodiments of the present application without creative work for those skilled in the art should be included in the protection scope of the present application.
[0016] In order to make the purpose, technical means and advantages of the present application clearer, the present application will be described in more detail below with reference to the examples and drawings. It should be understood that the specific examples described herein are used to interpret the present application, and are not intended to limit the present application.
[0017] To provide a digital PCR detector for solving the problems of conventional digital PCR devices, such as a small number of effective reaction cells, high cost as consumables, a relatively narrow dynamic range, low operation efficiency, and a low degree of integration.
[0018] Referring to FIG. 1, the present application provides a digital PCR detector 1 including a microdroplet generating device 10, a temperature control device 20, a fluorescent signal detecting device 30, a quantitative analyzing device 40, and a controller 50. The microdroplet generating device 10 is used to microdropletize a nucleic acid amplification reaction solution to form a plurality of microdroplets. The temperature control device 20 is connected to the microdroplet generating device 10 via a rail and is used to transfer the plurality of microdroplets to the temperature control device 20 and realize nucleic acid amplification by temperature cycling. The fluorescent signal detecting device 30 is disposed opposite the temperature control device 20 and is used to photograph and detect the plurality of microdroplets that have undergone nucleic acid amplification. The quantitative analyzing device 40 is connected to the fluorescent signal detecting device 30 via a data line and is used to transmit fluorescent information of the plurality of microdroplets to perform quantitative analysis. The controller 50 is connected to the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30, and the quantitative analysis device 40, and is used to control the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30, and the quantitative analysis device 40.
[0019] The digital PCR detector 1 integrates the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detecting device 30, and the quantitative analyzing device 40, so that the operator can automatically operate the detector. The digital PCR detector 1 has a relatively high operating efficiency.
[0020] When the digital PCR detector 1 is in operation, the microdroplet generating device 10 can microdropletize the nucleic acid amplification reaction liquid to be detected and form a plurality of microdroplets. The temperature control device 20 amplifies the nucleic acid in the plurality of microdroplets. The fluorescent signal detecting device 30 captures an image of the changing fluorescence in the plurality of microdroplets in real time. Based on the image of the changing fluorescence related to the plurality of microdroplets, a changing fluorescence curve can be obtained for the plurality of microdroplets. Based on the changing fluorescence curve, the Ct value of the plurality of microdroplets can be obtained, and the concentration of the initial DNA can be quantitatively analyzed based on the relationship between the Ct value and the initial copy number. Here, the Ct value is the number of cycles that have elapsed until the fluorescent signal of each microdroplet reaches a predetermined threshold value.
[0021] The temperature control device 20 causes the microdroplets to undergo a nucleic acid amplification reaction, and the fluorescent signal detection device 30 collects signals (e.g., signals of fluorescence, ultraviolet absorption, turbidity, etc.) of the products of the microdroplets that have undergone the nucleic acid amplification reaction. Based on the difference in the structure between the amplified and unamplified microdroplets, the number of droplets from which target sequence amplification has been obtained can be analyzed, and quantitative analysis of nucleic acid molecules can finally be realized. By monitoring the changing fluorescent images of the microdroplets in real time, the detection results are direct, and the problem of false positives and false negatives in the microdroplets can be solved.
[0022] The digital PCR detector 1 integrates the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detecting device 30, and the quantitative analysis device 40, so that it not only enables the operator to perform the operation automatically, but also has the advantages of improved work efficiency, rapid reaction, good reusability, high sensitivity, strong specificity, and clear results.
[0023] In one embodiment, a method and apparatus for generating micro-droplets is provided in which the micro-droplets are generated rapidly and with high uniformity in volume.
[0024] 2, in one embodiment, the micro-droplet generating device 10 includes a liquid ejection pipette tip 110, a fluid driving mechanism 120, a motion control mechanism 130, and a first controller 170. The liquid ejection pipette tip 110 has an outlet end and an inlet end, and is used to store a first liquid. The micro-droplet generating device 10 is used in cooperation with a micro-droplet container in which a second liquid is stored, and the outlet end of the liquid ejection pipette tip 110 is inserted below the surface of the second liquid.
[0025] The first liquid and the second liquid are mutually immiscible or have an interface reaction. The first liquid and the second liquid may be any two liquids that are mutually immiscible or have an interface reaction. In one embodiment of the present application, the first liquid is an aqueous solution, and the second liquid is an oily liquid that is mutually immiscible with water, such as mineral oil (including tetradecane, etc.), vegetable oil, silicone oil, perfluoroalkane oil, etc., and the generated droplets are aqueous droplets. Alternatively, the first liquid is an organic phase such as mineral oil, for example, tetradecane and n-hexane, and the second liquid is a perfluoroalkane oil that is mutually immiscible with mineral oil. The first liquid and the second liquid may be aqueous phases that are mutually immiscible with each other. In another embodiment of the present application, the first liquid is an aqueous solution and the second liquid is an aqueous liquid that is immiscible with water, for example, the first liquid is a dextran solution and the second liquid is an aqueous polyethylene glycol (PEG) solution, and the generated droplets are droplets of the dextran solution.
[0026] The first liquid and the second liquid may be two liquids having an interface reaction. In one embodiment of the present application, the first liquid is a sodium alginate aqueous solution, and the second liquid is, for example, a calcium oxide aqueous solution having a mass concentration of 1% calcium oxide, and the two liquids have an interface reaction, and the droplets generated become microspheres of calcium alginate gel. In the present application, the components of the first liquid flowing from the liquid ejection pipette tip or the liquid ejection pipette tip may be replaced to sequentially form droplets of multiple different components and volumes in the open container. And, since it can realize high-throughput screening in a microvolume by batch processing, and can realize ultra-microreaction and detection in biochemistry by multiple steps, it has a wide range of application prospects.
[0027] The fluid drive mechanism 120 is connected to the inlet end of the liquid ejection pipette tip 110 and is used to discharge the first liquid stored inside the liquid ejection pipette tip 110 from the outlet end of the liquid ejection pipette tip 110. The motion control mechanism 130 is used to control the outlet end of the liquid ejection pipette tip 110 to move in opposition to the second liquid according to a predetermined trajectory, a predetermined speed, or a predetermined acceleration, so that the first liquid discharged from the outlet end of the liquid ejection pipette tip 110 overcomes the surface tension and the adhesive force received from the liquid ejection pipette tip 110 to form microdroplets. The first controller 170 is connected to the fluid drive mechanism 120 and the motion control mechanism 130, respectively, and is used to control the fluid drive mechanism 120 and the motion control mechanism 130 to operate in coordination with each other.
[0028] In one embodiment, a method for generating microdroplets is provided, in which the process for generating microdroplets is stable.
[0029] 3, in one embodiment of the present application, the motion control mechanism 130 can be operated to move the outlet end 112 of the liquid dispensing pipette tip 110 below the surface of the second liquid, including an instantaneous accelerated motion, where the acceleration is a1. The first liquid is discharged from the outlet end 112 of the liquid dispensing pipette tip 110, and then forms a droplet 195 that is attached to the outlet end 112 of the liquid dispensing pipette tip 110. The droplet 195 is detached from the outlet end 112 of the liquid dispensing pipette tip 110 at the moment when the outlet end 112 of the liquid dispensing pipette tip 110 undergoes an instantaneous accelerated motion, forming a microdroplet. The forces acting on the microdroplet until it is detached from the outlet end 112 of the liquid-ejecting pipette tip 110 are gravity G, the buoyant force f1 of the second liquid, the viscous resistance f2 of the second liquid, and the maximum adhesive force f3 between the outlet end 112 of the liquid-ejecting pipette tip 110 and the droplet 195. If the mass of the microdroplet until it is detached from the outlet end 112 of the liquid-ejecting pipette tip 110 is m and the acceleration is a2, then according to Newton's second law of motion,
number
[0030] The maximum value f3 of the adhesive force between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195 is related to the surface free energy of the liquid ejection pipette tip 110, the surface tension of the droplet 195, and the geometric dimensions of the liquid ejection pipette tip 110. When the outlet end 112 of the liquid ejection pipette tip 110 undergoes an instantaneous accelerated motion, the direction of the adhesive force of the outlet end 112 of the liquid ejection pipette tip 110 to the droplet 195 and the direction of the acceleration are the same. The droplet 195 attached to the outlet end 112 of the liquid ejection pipette tip 110 is simplified as a sphere. According to Stokes' law, the viscous resistance of the droplet 195 experienced when moving in the second liquid is f2=6πηrv, where η is the viscosity coefficient of the second liquid, r is the radius of the droplet 195, and v is the moving speed of the droplet 195. Since the velocity of the droplet 195 is zero until the outlet end 112 of the liquid-ejecting pipette tip 110 undergoes instantaneous accelerated motion, the viscous resistance f2 of the droplet 195 received by the second liquid at the moment the outlet end 112 of the liquid-ejecting pipette tip 110 undergoes instantaneous accelerated motion is zero or extremely small. In the process of generating microdroplets, the diameter range of the droplet 195 is generally on the order of picoliters to microliters, and since the gravity G of the droplet 195 and the buoyancy f1 of the second liquid are in the opposite directions, the vector sum of the gravity G of the droplet 195 and the buoyancy f1 of the second liquid is approximately zero. Since the viscous resistance f2 is zero or extremely small, and the vector sum of the gravity G and the buoyancy f1 is approximately zero,
number
[0031] The motion control mechanism 130 can accurately control the magnitude of the acceleration at which the outlet end 112 of the liquid-ejecting pipette tip 110 undergoes instantaneous accelerated motion. Therefore, if the value of the acceleration at which the outlet end 112 of the liquid-ejecting pipette tip 110 undergoes instantaneous accelerated motion is controlled to be relatively large, the instantaneous accelerated motion of the outlet end 112 of the liquid-ejecting pipette tip 110 can effectively generate droplets 195.
[0032] Based on this, the present application further provides a method for generating microdroplets, comprising: Step S201: providing a liquid ejection pipette tip 110 having an outlet end 112 and storing a first liquid; providing a micro-droplet container having an opening and storing a second liquid, the first liquid and the second liquid being any two liquids that are incompatible with each other or have an interface reaction; Step S202: inserting the outlet end 112 of the liquid ejection pipette tip 110 below the surface of the second liquid through the opening of the micro-droplet container; The method includes a step S203 of discharging a first liquid from the outlet end 112 of the liquid-discharging pipette tip 110 while the outlet end 112 of the liquid-discharging pipette tip 110 is moving below the surface of the second liquid, including with instantaneous accelerated motion, forming a droplet 195 attached to the outlet end 112 of the liquid-discharging pipette tip 110 using the first liquid discharged from the outlet end 112 of the liquid-discharging pipette tip 110, and detaching the droplet 195 from the outlet end 112 of the liquid-discharging pipette tip 110 during the instantaneous accelerated motion of the outlet end 112 of the liquid-discharging pipette tip 110 to form a microdroplet below the surface of the second liquid.
[0033] In one embodiment of the present application, in step S203, the outlet end 112 of the liquid ejection pipette tip 110 periodically moves under the surface of the second liquid, including an instantaneous acceleration motion. The periodic movement of the outlet end 112 of the liquid ejection pipette tip 110 under the surface of the second liquid means that the displacement, speed or acceleration of the outlet end 112 of the liquid ejection pipette tip 110 all change periodically. The outlet end 112 of the liquid ejection pipette tip 110 periodically moves under the surface of the second liquid, including an instantaneous acceleration motion, and cooperates to eject the first liquid at a constant flow rate through the outlet end 112 of the liquid ejection pipette tip 110, thereby realizing the generation of microdroplets at equal time intervals. Alternatively, although the flow rate of the outlet end 112 of the first liquid ejection pipette tip 110 changes, the volume of the outlet end 112 of the first liquid ejection pipette tip 110 is kept the same in one motion cycle of the outlet end 112 of the liquid ejection pipette tip 110. Then, to generate microdroplets of consistent volume, the volume of the droplets 195 is ensured to be the same before each instantaneous accelerated movement of the outlet end 112 of the liquid dispensing pipette tip 110.
[0034] When the liquid ejection pipette tip 110 or the first liquid is not replaced, the surface free energy of the liquid ejection pipette tip 110, the geometrical dimensions of the liquid ejection pipette tip 110, and the surface tension of the droplet 195 do not change as two factors that affect the maximum adhesion force f3 between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195. Therefore, when the liquid ejection pipette tip 110 or the first liquid is not replaced, the maximum value f3 of the adhesion force between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195 does not change. Due to the interlocking of the fluid drive mechanism 120, the first liquid is continuously discharged from the outlet end 112 of the liquid ejection pipette tip 110 at a uniform flow rate. The motion control mechanism 130 can accurately control the timing when the outlet end 112 of the liquid ejection pipette tip 110 accelerates according to the instantaneous acceleration a1, and the magnitude of the instantaneous acceleration a1. The cooperation of the fluid drive mechanism 120 and the motion control mechanism 130 makes it easy to realize that at the moment when the volume of the droplet 195 becomes a constant value, the outlet end 112 of the liquid ejection pipette tip 110 is driven to generate an instantaneous accelerated motion with an acceleration of a1, thereby forming microdroplets of the same volume. If the fluid drive mechanism 120 can be controlled to uniformly and continuously discharge the first liquid from the outlet end 112 of the liquid ejection pipette tip 110, the motion control mechanism 130 can simply drive the outlet end 112 of the liquid ejection pipette tip 110 to perform an instantaneous accelerated motion at the same time, thereby generating microdroplets of the same volume.
[0035] When multiple liquid ejection pipette tips 110 are used to generate microdroplets simultaneously or sequentially, the surface free energy of the liquid ejection pipette tip 110 and the geometric dimensions of the liquid ejection pipette tip 110 change as two factors that affect the maximum adhesive force f3 between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195. However, by processing in batch processing, the surface free energy of the liquid ejection pipette tip 110 and the geometric dimensions of the liquid ejection pipette tip 110 can be controlled to change in a certain range. The surface tension of the droplet 195 changes only in a very small range as another factor that affects the maximum adhesive force f3 between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195. Therefore, the maximum value f3 of the adhesive force between the outlet end 112 of the liquid ejection pipette tip 110 and the droplet 195 also undulates only in a very small space. The fluid drive mechanism 120 can drive the first liquid so that it is discharged from the outlet end 112 of the liquid discharge pipette tip 110 continuously at a uniform flow rate. The motion control mechanism 130 can accurately control the timing at which the outlet end 112 of the liquid discharge pipette tip 110 accelerates according to the instantaneous acceleration a1 and the magnitude of the instantaneous acceleration a1. When the fluid drive mechanism 120 and the motion control mechanism 130 cooperate with each other, it is possible to easily realize that at the moment when the volume of the droplet 195 becomes a constant value, the outlet end 112 of the driven liquid discharge pipette tip 110 performs instantaneous accelerated motion at an acceleration of a1, thereby generating microdroplets with the same volume. If the fluid drive mechanism 120 can control the first liquid to be discharged uniformly and continuously from the outlet end 112 of the liquid discharge pipette tip 110, the motion control mechanism 130 can simply drive the outlet end 112 of the liquid discharge pipette tip 110 to perform instantaneous accelerated motion at equal time intervals, thereby generating microdroplets with the same volume.
[0036] The fluid driving mechanism 120 cooperates with the motion control mechanism 130 to perform instantaneous accelerated motion according to a relatively large acceleration at the moment when the volume of the droplet 195 reaches a predetermined value while discharging the first liquid from the outlet end 112 of the liquid discharging pipette tip 110 at a uniform speed. The microdroplet generating method provided by the present application can generate droplets 195 with a uniform volume by only one liquid discharging pipette tip 110, and can ensure that the volumes of the microdroplets generated simultaneously or sequentially by multiple liquid discharging pipette tips 110 are also uniform. The microdroplet generating method provided by the present embodiment can ensure the uniformity of the volume of the microdroplets, and can simultaneously generate microdroplets by multiple liquid discharging pipette tips 110, thereby improving the generation efficiency of the microdroplets.
[0037] Furthermore, under the control of the motion control mechanism 130, the outlet end 112 of the liquid discharging pipette tip 110 includes a plurality of instantaneous acceleration motions in one periodic motion, and the magnitude of acceleration of the plurality of instantaneous acceleration motions is the same, and one motion cycle of the outlet end 112 of the liquid discharging pipette tip 110 is evenly divided through the timing of the plurality of instantaneous acceleration motions. The outlet end 112 of the liquid discharging pipette tip 110 includes a plurality of instantaneous acceleration motions in one periodic motion, which helps the outlet end 112 of the liquid discharging pipette tip 110 to generate a plurality of microdroplets within one motion cycle. Preferably, in step S203, the motion trajectory of the outlet end 112 of the liquid discharging pipette tip 110 below the liquid surface of the second liquid includes one or a combination of various kinds of trajectories, such as a straight line segment, a circular arc segment, and a polygonal shape. In one possible embodiment, when the outlet end 112 of the liquid dispensing pipette tip 110 includes two instantaneous accelerated motions in one periodic motion, the motion trajectory of the liquid dispensing pipette tip 110 is a straight line or a circular arc. When the outlet end 112 of the liquid dispensing pipette tip 110 includes two or more instantaneous accelerated motions in one periodic motion, the trajectory of the outlet end 112 of the liquid dispensing pipette tip 110 in the second liquid is a regular polygonal shape, including an equilateral triangle, a square, a regular pentagon, a regular hexagon, etc.
[0038] In one possible embodiment, in step S203, in the process of periodically moving the outlet end 112 of the liquid dispensing pipette tip 110 below the surface of the second liquid, the speed of the outlet end 112 of the liquid dispensing pipette tip 110 changes in a square wave shape. The fact that the speed of the outlet end 112 of the liquid dispensing pipette tip 110 changes in a square wave shape and transitions to a uniform speed stage immediately after the acceleration stage is completed helps the motion control mechanism 130 to accurately control the motion state of the outlet end 112 of the liquid dispensing pipette tip 110. Preferably, the high level timing and low level timing of the square wave shape indicating the change in the motion speed of the outlet end 112 of the liquid dispensing pipette tip 110 may be equal or different. Furthermore, in step S203, in the process of periodically moving the outlet end 112 of the liquid dispensing pipette tip 110 below the surface of the second liquid, the speed of the outlet end 112 of the liquid dispensing pipette tip 110 changes in a square wave shape. The high level timing and the low level timing of the square wave shape showing the change in the moving speed of the outlet end 112 of the liquid ejection pipette tip 110 are equal. When the square wave shape showing the change in the moving speed of the outlet end 112 of the liquid ejection pipette tip 110 is at the low level, the speed of the outlet end 112 of the liquid ejection pipette tip 110 is zero or has a speed in the opposite direction to the direction when it is at the high level. Furthermore, as shown in FIG. 4, in the first half and the second half of the period in which the outlet end 112 of the liquid ejection pipette tip 110 periodically moves, the speeds of the outlet end 112 of the liquid ejection pipette tip 110 are equal in magnitude and opposite in direction. One moving period of the outlet end 112 of the liquid ejection pipette tip 110 includes instantaneous acceleration movements in two opposite directions.
[0039] In this embodiment, the motion trajectory of the outlet end 112 of the liquid-ejecting pipette tip 110 below the surface of the second liquid is a straight line segment, and the outlet end 112 of the liquid-ejecting pipette tip 110 starts to perform an instantaneous accelerated motion from one end point of the straight line segment, and performs an instantaneous accelerated motion in the opposite direction from the other end point of the straight line segment. The acceleration of the two instantaneous accelerated motions is both a1. In another embodiment, the motion trajectory of the outlet end 112 of the liquid-ejecting pipette tip 110 below the surface of the second liquid is a circular arc segment or a polygonal shape. Furthermore, in step S203, the frequency of the outlet end 112 of the liquid-ejecting pipette tip 110 periodically moving below the surface of the second liquid is between 0.1 Hz and 200 Hz. This makes it easy to realize in the project.
[0040] As shown in Figures 4 and 5, in one specific embodiment of the present application, the fluid driving mechanism 120 controls the first liquid to be discharged from the outlet end 112 of the liquid discharging pipette tip 110 at a constant flow rate. The motion control mechanism 130 controls the output end of the liquid discharging pipette tip 110 to periodically move at a speed that changes like a square wave along a linear motion trajectory. When the speed direction of the outlet end 112 of the liquid discharging pipette tip 110 changes, the acceleration of the instantaneous accelerated motion of the outlet end 112 of the liquid discharging pipette tip 110 becomes a maximum value. The droplet 195 attached to the outlet end 112 of the liquid discharging pipette tip 110 also detaches from the outlet end 112 of the liquid discharging pipette tip 110 to form a microdroplet 199 when the acceleration of the instantaneous accelerated motion of the outlet end 112 of the liquid discharging pipette tip 110 becomes a maximum value. As the first liquid is discharged from the outlet end 112 of the liquid dispensing pipette tip 110 at a constant flow rate, a new droplet 195 transitions to a generation state as the droplet 195 falls off the outlet end 112 of the liquid dispensing pipette tip 110. When the outlet end 112 of the liquid dispensing pipette tip 110 again undergoes an accelerated motion in the opposite direction, the newly generated droplet 195 also falls from the outlet end 112 of the liquid dispensing pipette tip 110 to form a new microdroplet 199.
[0041] In this embodiment, the outlet end 112 of the liquid ejection pipette tip 110 can generate two microdroplets 199 in one motion cycle, and a square wave shape is easily realized by projecting. In another embodiment, the outlet end 112 of the liquid ejection pipette tip 110 generates one microdroplet 199 in one motion cycle. Preferably, in the embodiment, the outlet end 112 of the liquid ejection pipette tip 110 performs a motion in the second liquid 699 in an arbitrary direction, with a straight trajectory and a square wave-like speed change. This motion includes, for example, a motion in which the speed changes in a square wave-like manner in a straight trajectory in a plane perpendicular to the extension direction of the liquid ejection pipette tip 110, a motion in which the speed changes in a square wave-like manner in a straight trajectory in a plane at an arbitrary angle to the extension direction of the liquid ejection pipette tip 110, and a motion in which the speed changes in a square wave-like manner in a straight trajectory in a plane at an arbitrary angle to the extension direction of the liquid ejection pipette tip 110, and the like. In other embodiments of the present application, when the motion trajectory of the outlet end 112 of the liquid discharging pipette tip 110 is in the shape of an arc segment or a polygon, the motion of the outlet end 112 of the liquid discharging pipette tip 110 in an arbitrary direction in the second liquid 699, in which the speed changes in a square wave shape along a trajectory in the shape of an arc segment or a polygon, includes motion in which the speed changes in a square wave shape along a trajectory in the shape of an arc segment or a polygon on a plane perpendicular to the extension direction of the liquid discharging pipette tip 110, motion in which the speed changes in a square wave shape along a trajectory in the shape of an arc segment or a polygon on a plane at an arbitrary angle to the extension direction of the liquid discharging pipette tip 110, and motion in which the speed changes in a square wave shape along a trajectory that is a straight line in the extension direction of the liquid discharging pipette tip 110.
[0042] In one embodiment, the microdroplets 199 are nucleic acid amplification reaction liquid to be detected, and the microdroplet generating device 10 converts the nucleic acid amplification reaction liquid to be detected into multiple microdroplets, which are then used for detection by the digital PCR detector 1. The nucleic acid amplification reaction liquid to be detected is converted into multiple microdroplets 199 through a process of microdroplet generation by the microdroplet generating device 10 of the integrated digital PCR detector 1, and the fragments to be detected in the sample to be detected are separated from the large and complex background, and placed in the microdroplet container 60 to wait for detection. The microdroplet generating device 10 can generate multiple microdroplets 199 with uniform size. Each of the microdroplets 199 has a size on the order of microns, and each of the microdroplets 199 is treated as an independent reactor, which can correspond to a test tube commonly used in biochemical reactions. For convenience of observation, the multiple microdroplets 199 are placed in the microdroplet container 60. At the same time, the microdroplet generating device 10 can generate microdroplets with different volumes, so that it can be applied to medical clinical detection. The multiple microdroplets 199 have small volumes and are numerous, which is an advantage that many ordinary test tubes do not have. The microdroplet generating device 10 can generate a large amount of microdroplets 199, so that the digital PCR detector 1 has the advantages of high throughput, low cost as consumables, and low background noise, and has good prospects for industrialization.
[0043] In one embodiment, a temperature control device is provided that has a fast heating and cooling speed and a long service life.
[0044] 7 and 8, the present application further provides a temperature control device 20, which includes a flexible circuit board 220, a heating substrate 240 spaced apart from the flexible circuit board 220, and a plurality of semiconductor thermocouples 230. The heating substrate 240 includes a first surface 241 and a second surface 242 opposed to each other. The plurality of semiconductor thermocouples 230 are disposed between the flexible circuit board 220 and the first surface 241. The plurality of semiconductor thermocouples 230 are connected in series, in parallel, or in a series-array.
[0045] The temperature control device 20 is generally applied in a high and low temperature circulating environment, and the temperature needs to be raised and lowered quickly, so the requirements for the temperature control device 20 are very high. In order to meet the application needs of the temperature control device 20, the flexible circuit board 220 is used in the temperature control device 20. The flexible circuit board 220 has the advantages of high wiring density, light weight, thin thickness, and good bendability. The flexible circuit board 220 can eliminate thermal stress by its own deformation during the temperature raising and lowering process. The flexible circuit board 220 can reduce the thermal stress existing in the temperature raising and lowering process, so that the service life of the temperature control device 20 can be extended. At the same time, the flexible circuit board 220 can solve the problem of uneven temperature distribution. When amplifying nucleic acid in different temperature ranges in the multiple microdroplets, the flexible circuit board 220, the heating board 240, and the multiple semiconductor thermocouples 230 can quickly realize switching in just a few seconds. Furthermore, the temperature control device 20 can instantly raise and lower the temperature, shortening the temperature raising and lowering process and realizing high and low temperature circulation, thereby shortening the detection time of the digital PCR detector 1 and improving detection efficiency.
[0046] The flexible printed circuit board 220 (Flexible Printed Circuit, FPC) may be a printed circuit board formed of polyimide or polyester film and having high reliability and particularly excellent flexibility. The flexible printed circuit board has advantages of high wiring density, light weight, thin thickness, and good bendability. The flexible printed circuit board is light weight and thin thickness, and can effectively reduce the volume of the product. Among them, the thermoelectric cooler (Thermo Electric Cooler, TEC) is manufactured by the Peltier effect using semiconductor materials. The so-called Peltier effect is a phenomenon in which when a direct current flows through a thermocouple made of two semiconductor materials, one end of the thermocouple absorbs heat and the other end releases heat. The flexible printed circuit board 220 can replace one substrate of a conventional thermoelectric cooler and improve the thermal conduction performance of the thermoelectric cooler.
[0047] When the temperature changes, an object cannot expand or contract freely due to external restrictions and mutual restrictions between internal parts, and stress occurs. Thermal stress is also called stress due to temperature change. A high degree of balance between thermal stress and zero external load is a stress that is balanced by the thermal deformation, and compression occurs at high temperatures and elongation occurs at low temperatures. Under certain conditions, stress can be controlled to achieve a reasonable distribution, which can extend the mechanical performance and service life of parts and turn harmful things into beneficial things.
[0048] In one embodiment, the heating substrate 240 may be an aluminum superconducting substrate circuit.
[0049] The aluminum substrate is a metal substrate copper-clad plate with good heat dissipation performance, and generally, a single-sided board has a structure consisting of three layers: a circuit layer (copper foil), an insulating layer, and a metal base layer. The aluminum superconducting substrate circuit is made of an aluminum alloy wiring circuit board material, and has fast heat conduction. The aluminum substrate has the lowest thermal resistance, extremely excellent heat conduction performance, and its mechanical performance is also extremely excellent compared to ceramic circuits with thick films.
[0050] As shown in FIG. 9, in one embodiment, the semiconductor thermocouple 230 includes one P-type thermoelectric element 231 and one N-type thermoelectric element 232 spaced apart from the P-type thermoelectric element 231 .
[0051] The P-type thermoelectric element 231 and the N-type thermoelectric element 232 are welded between the flexible circuit board 220 and the substrate 240. The semiconductor thermocouple 230 includes a pair of thermocouples formed by a plurality of the P-type thermoelectric elements 231 and the N-type thermoelectric elements 232, and electrodes are connected between the plurality of pairs of the semiconductor thermocouples 230, and are interposed between the flexible circuit board 220 and the first surface 241. When a current flows, a "hot" side and a "cold" side are generated. The direction and magnitude of the current determine whether to cool or heat, and the speed of cooling or heating. Since the thermoelectric effect generated by the pair of semiconductor thermocouples 230 is very small, in practice, hundreds of pairs of the semiconductor thermocouples 230 are often connected in series to increase the generated thermoelectric effect.
[0052] In one embodiment, the first surface 241 includes a plurality of spaced apart first electrode pieces 243, each of the first electrode pieces 243 corresponding to one of the semiconductor thermocouples 230, and the P-type thermoelectric element 231 and the N-type thermoelectric element 232 in the semiconductor thermocouple 230 are connected in series via the first electrode pieces 243.
[0053] In one embodiment, the flexible circuit board 220 includes a plurality of second electrode pieces 221 spaced apart and connected in series with each other, and two adjacent semiconductor thermocouples 230 are connected in series with one of the second electrode pieces 221.
[0054] When a current flows through the semiconductor thermocouple 230 to which the P-type thermoelectric element 231 and the N-type thermoelectric element 232 are coupled, heat is transferred between both ends, and a cooling / heating end is formed due to a temperature difference caused by the heat being transferred from one end to the other end. However, when a current flows through the P-type thermoelectric element 231 and the N-type thermoelectric element 232 due to the electrical resistance present in the P-type thermoelectric element 231 and the N-type thermoelectric element 232, heat is generated, which affects the heat conduction. Furthermore, the heat between the flexible circuit board 220 and the heating board 240 may be conducted in the opposite direction through the air and the material of the P-type thermoelectric element 231 and the N-type thermoelectric element 232. When the cooling / heating end has a certain temperature difference and the two heat conductions are equal, the forward and reverse heat conductions cancel each other out at one balance point. At this time, the temperature of the cooling / heating end does not change any more. In order to obtain a lower temperature, the temperature of the heat generating end may be lowered by a method such as heat radiation.
[0055] In one embodiment, the temperature control device 20 further includes a thermal conduction enhancement layer 250 disposed on the second surface 242 .
[0056] The thermal conduction enhancing layer 250 has particularly good strength, flexibility, electrical conduction, thermal conduction and optical properties. The thermal conduction enhancing layer 250 directly contacts the micro-droplet container 60, thereby realizing the amplification of nucleic acid by controlling the temperature so as to uniformly conduct heat to the multiple micro-droplets. The thermal conduction enhancing layer 250 may be a graphite thermal conductive layer or a silicone grease thermal conductive layer. In this way, the thermal conduction is fast, the temperature uniformity is improved on the second surface 242 of the heating substrate 240, and the surface close to the micro-droplet container 60 can be ensured to have a uniform temperature, and the thermal conduction to the multiple micro-droplets can be uniform. In addition, the amplification of nucleic acid is completed, the detection efficiency is improved, and the time is shortened.
[0057] In one embodiment, the material of the thermal conduction enhancing layer 250 includes graphene, which is a planar thin film and has particularly good thermal conduction properties, and can conduct heat uniformly in the lateral direction.
[0058] In one embodiment, the temperature control device 20 further includes a second controller 210 electrically connected to the flexible circuit board 220 for controlling the current.
[0059] In one embodiment, the temperature control device 20 further includes a temperature sensor 260 disposed on the second surface 242 and electrically connected to the second controller 210 for detecting and transmitting the temperature of the second surface 242 to the second controller 210.
[0060] The temperature sensor 260 is disposed on the second surface 242 of the thermal conduction enhancing layer 250, detects the real-time temperature of the second surface 242, and feeds back the temperature information to the second controller 210 to control the heating temperature of the microdroplets. The temperature sensor 260 measures the temperature of the microdroplet container 60 by detecting the change in the electrical resistance of metal, and also detects the temperature change in real time during the process of amplifying nucleic acid in the microdroplets, and feeds back the temperature information to the second controller 210, so that the control circuit can adjust the temperature, thereby realizing temperature control and aiming for better amplification of nucleic acid.
[0061] In one embodiment, the second controller 210 includes a temperature control means 212 and a control circuit 214. The temperature control means 212 is connected to the temperature sensor 260 and is used for detecting the temperature of the second surface 242 in real time. The control circuit 214 is connected to the flexible circuit board 220 and is used for adjusting and controlling the change of the temperature of the plurality of semiconductor thermocouples 230.
[0062] The temperature control means 212 and the control circuit 214 are disposed on one circuit board. The relationship between the temperature control means 212 and the control circuit 214 is a relationship of logical operation of an internal algorithm, and a closed loop control algorithm of Packet Identifier called a PID closed loop control algorithm may be adopted. The temperature detected by the temperature control means 212 is the input of the internal algorithm, which is the temperature feedback of the nucleic acid amplification, and the result calculated by the control circuit 214 is the output of the internal algorithm, thereby forming a closed loop relationship. The temperature feedback of the circuit part is actually a sampling circuit. The collected signal is an electrical signal by a platinum resistor, which is converted into a temperature value and then transmitted to the input end of the control circuit. The temperature sensor 260 is connected to the temperature control means 212 by a platinum resistor three-wire system standardized.
[0063] In one embodiment, the flexible circuit board 220 is disposed with a first electrode 222 and a second electrode 223. The second electrode pieces 221 are connected in series and then connected in series to the first electrode 222 and the second electrode 223. The first electrode 222 and the second electrode 223 are respectively connected to the control circuit.
[0064] The control circuit 214 and the flexible circuit board 220 are connected to the first electrode 222 and the second electrode 223 via two wires, respectively.
[0065] In an embodiment, the temperature control device 20 further includes a heat dissipation device 270, which includes a substrate 271 and a heat dissipation fin 272 connected to the substrate 271. The flexible circuit board 220 is disposed on the surface of the substrate 271.
[0066] Since the heat dissipation fins 272 are disposed on the surface of the substrate 271, the area of the substrate 271 is not reduced, but the area of heat exchange is increased. This not only extends the time that cool air acts on the surface of the substrate 271, but also forms multiple heat dissipation ducts, which helps to speed up heat exchange, but also allows more heat to escape from the surface of the substrate 271, thereby achieving a more ideal heat dissipation effect.
[0067] In one embodiment, the temperature control device includes a fan 273 disposed to surround the heat dissipation fins 273 .
[0068] The fan 273 may assist the heat dissipation by the heat dissipation device 270. A plurality of fans 273 may be arranged around the heat dissipation fins 273. This can achieve a better heat dissipation effect and can increase or decrease the temperature of the temperature control device 20 more quickly.
[0069] In one embodiment, when AC power is applied to the temperature control device 20, the second controller 210 adjusts the magnitude of the current to control whether the temperature control device 20 is cooled or heated, and the rate of cooling or heating. At the same time, the temperature sensor 260 detects the heating temperature of the microdroplet container 60 in real time, and feeds back the temperature information to the temperature control means 212. The temperature control means 212 feeds back the temperature change to the control circuit 214, and controls the temperature of the multiple microdroplets. The temperature control device 20 can amplify nucleic acids in the multiple microdroplets. Based on the three-step principle, three temperature points, denaturation, annealing, and extension, are arranged in PCR. By using the three temperature point method for the standard reaction, the double-stranded DNA is denatured at 90-95°C, then rapidly cooled to 40-60°C again to anneal the primers and bind to the target sequence, and then rapidly heated to 70-75°C, and the primer strands are extended along the template by the action of Taq DNA polymerase to amplify the nucleic acid in a suitable temperature range. At the same time, in the process of amplifying the nucleic acid, the bottom of the micro-droplet container 60 is tightly attached to the temperature control device 20, and there is no gap between them, which improves the accuracy of the digital PCR detector 1.
[0070] Referring to FIG. 10, in general, the temperature control device 20 detects the temperature rise and fall changes of the temperature control device 20 in an instantaneous state and a stable state, respectively, as two main indicators for testing the performance of temperature control. By monitoring the heating process of the microdroplets, when the temperature control device 20 raises and lowers the temperature of the microdroplets, the temperature rise and fall speed is a maximum of 13.34448°C / s, and the control accuracy is 0.02722°C. Moreover, the measured speed until the temperature rise of the temperature control device 20 reaches a stable state can be as fast as 18.953894°C / s. Therefore, the temperature control device 20 has a good instantaneous response, and the temperature control device 20 can realize instantaneous temperature rise and fall, shortening the time and improving the detection efficiency.
[0071] 11 shows the case where the temperature controller 20 is in a stable state, that is, the temperature fluctuates after it is stabilized. When the temperature controller 20 is in a stable state, the temperature change is relatively stable and the temperature fluctuates relatively small. Therefore, the temperature controller 20 can realize a cycle by rapid temperature rise and fall, and the temperature fluctuates relatively small after it is stabilized, so that the time required for detecting a solution sample by digital PCR is saved, and the work efficiency is improved. Such a temperature rise and fall speed saves the time required for completing the amplification of nucleic acid, and the efficiency of nucleic acid amplification is improved, and the accuracy of the detection system by digital PCR is improved.
[0072] Referring to FIG. 6, in one embodiment, the fluorescent signal detection device 30 includes an excitation light source 340, a fluorescent detection assembly 330, and a third controller 310. The excitation light source 340 is disposed above the detection area of the micro-droplet container 60, and irradiates the detection area of the micro-droplet container 60 at an oblique angle to form an oblique irradiation light path. The fluorescent detection assembly 330 is disposed directly above the detection area of the micro-droplet container 60, and is used to collect fluorescent images of the multiple micro-droplets. The third controller 310 is connected to the excitation light source 340 and the fluorescent detection assembly 330, respectively, and is used to control the excitation light source 340 and the fluorescent detection assembly 330. The fluorescent signal detection device can perform imaging of the micro-droplets with multiple fluorescent channels and imaging in bright field and dark field. Among them, imaging with multiple fluorescent channels is for detecting reaction signals of the micro-droplets, and imaging with bright field and dark field is for detecting size information of the micro-droplets and monitoring the droplet state in the reaction process.
[0073] In one embodiment, the third controller 310 controls the movement of the excitation light source 340, but at this time, the fluorescence detection assembly 330 and the micro-droplet container 60 do not move. In other words, at this time, the fluorescence detection of the multiple micro-droplets is performed by moving the excitation light source 340. Alternatively, the third controller 310 controls the movement of the fluorescence detection assembly 330, but at this time, the fluorescence detection of the multiple micro-droplets is performed while the micro-droplet container 60 and the excitation light source 340 do not move. Alternatively, the third controller 310 controls the movement of the micro-droplet container 60, but the fluorescence detection of the multiple micro-droplets is performed while the fluorescence detection assembly 330 and the excitation light source 340 do not move. The third controller 310 adjusts the positional movements of the excitation light source 340, the fluorescence detection assembly 330, and the micro-droplet container 60, and when the opposing motion occurs, the micro-droplet container 60 and the fluorescence detection assembly 330 in the detection area are aligned, and the entire process of detecting fluorescence by photography is completed.
[0074] The light path emitted by the excitation light source 340 is obliquely irradiated onto the plurality of microdroplets, thereby causing the microdroplets containing the fluorescent substance in the microdroplet container 60 to fluoresce. The fluorescence detection assembly 330 collects fluorescence information from the microdroplets containing the fluorescent substance, and transmits the fluorescence information of the microdroplets containing the fluorescent substance in the form of a fluorescence image to the quantitative analysis device 40 for quantitative analysis.
[0075] The micro-droplet container 60 is illuminated at an oblique angle from above the micro-droplet container 60. The fluorescent signal detection device 30 periodically performs two-dimensional scanning on the micro-droplets and captures images in real time. The oblique illumination optical path can effectively reduce the background scattering of the excitation light and increase the sensitivity of the fluorescence detection. The fluorescence inside the micro-droplets in the micro-droplet container 60 is excited, and the fluorescent detection assembly 330 collects fluorescent images of the micro-droplets.
[0076] The excitation light source 340 provides the energy required for the evaporation, atomization and excitation of the microdroplets, and has the advantages of narrow spectral bandwidth, high frequency spectrum purity, good wavelength stability, high efficiency, long service life, good reliability, good light beam quality, etc., so that the detection results can be ensured to be accurate and stable.
[0077] In one embodiment, the excitation light source 340 includes a plurality of LED light sources 341 of different colors, a dichroic mirror 344, a compound lens 345, and a condenser lens 346. Each of the LED light sources 341 is sequentially provided at its tip with a collimator mirror 342 and a first optical filter 343. The dichroic mirror 344 is inclinedly disposed at the tip of the first optical filter 343 and is used to refract the light emitted by each of the LED light sources 341 into one optical path. The compound lens 345 is used to increase the uniformity of the refracted optical path. The condenser lens 346 is disposed at the tip of the compound lens 345 and is used to condense light for imaging.
[0078] The LED light sources 341 of different colors can generate fluorescence of different colors as an excitation light source 340, increase the detection channel, and detect different kinds of microdroplets. The collimator mirror 342 and the first optical filter 343 are sequentially provided at the tip of each LED light source 341. The collimator mirror 342 is used in a system where the light beam is guided, and is used to maintain the collimation of the light beam between the laser resonating chamber and the focusing optical element. Moreover, the LED light source 341 can separate light of a required frequency band as excitation light by the first optical filter 343. Using optical mirrors such as the dichroic mirror 344, the compound lens 345, and the focusing lens 346, the excitation light is converted into a parallel or focused light beam, which is irradiated onto an area containing multiple droplets in the chip to form an excitation area, and the excitation light is excited into the multiple microdroplets in the microdroplet container 60.
[0079] In one embodiment, the excitation light source 340 and the fluorescence detection assembly 330 may be integrally formed or may be separately formed.
[0080] When the fluorescent signal detection device 30 irradiates the micro-droplet container 60 at an oblique angle, the fluorescent signal detection device 30 can periodically perform two-dimensional scanning on the multiple micro-droplets and capture images in real time. By irradiating the micro-droplet container 60 with the fluorescent signal detection device 30 at an oblique angle, the background scattering of the excitation light can be effectively reduced and the sensitivity of the fluorescence detection can be improved. When the internal fluorescence of the multiple micro-droplets in the micro-droplet container 60 is excited, it passes through the second optical filter 333 and is collected by the objective lens 332 above, and then enters the camera 331, and the camera 331 collects the fluorescent images of the multiple micro-droplets.
[0081] The first optical filter 343 is used to select the optical components of the required radiation frequency band. The first optical filter 343 is made by adding a special kind of dye to a piece of plastic or glass, and the red optical filter only passes red light. In this way, it is inferred. The transmittance of the glass piece is almost the same as that of air, and it is transparent because it cannot pass all colors. However, after being colored by dye, the molecular structure changes and the refractive index also changes. The passing of a certain kind of light also changes. For example, when a white light passes through a blue optical filter, the emitted light is blue light, and there is very little green or red light contained, and most of the light is absorbed by the optical filter. The dichroic mirror 344 is arranged at an angle at the tip of the first optical filter 343, and refracts the light emitted by each of the LED light sources 341 into one optical path. The compound lens 345 is used to increase the uniformity of the refracted optical path. The condenser lens 346 is disposed at the tip of the compound lens 345 and is used for condensing and imaging. The condenser lens 346 corresponds to a gradient index lens, has the characteristics of condensing and imaging at the end face, and has the apparent characteristic of being cylindrical, so that it can be applied to many different types of micro optical systems.
[0082] The third controller 310 can control switching between the multiple different color LED light sources 341 to form different fluorescence detection channels. The multiple different color LED light sources 341 can work in turn, and no separate replacement ring is required.
[0083] The collimator mirror 342 can be divided into a reflective collimator mirror and a transmissive collimator mirror. The reflective collimator mirror and the transmissive collimator mirror are used in the light beam guiding system to maintain the collimation of the light beam between the laser resonator chamber and the focusing optical element. The reflective collimator mirror generally uses a copper total reflection mirror, while the transmissive collimator mirror uses a zinc selenide lens.
[0084] In one embodiment, the fluorescence detection assembly 330 includes an objective lens 332 , a camera 331 , and a second optical filter 333 , with the objective lens 332 disposed between the camera 331 and the second optical filter 333 .
[0085] The second optical filter 333 is a multi-bandpass filter. The multi-bandpass filter can simultaneously pass light of multiple frequency bands corresponding to a certain type of dye. In a biomedicine fluorescence inspection and analysis system, the frequency band spectrum characteristic of the excitation light or emitted fluorescence of a substance is separated and selected. The molecule absorbs the excitation spectrum in the absorption band, and then emits a long-wave radiation spectrum in the emission band, that is, a fluorescence spectrum is formed.
[0086] The camera 331 mainly generates a fluorescent image of the microdroplets. The camera 331 can convert an optical image into a digital signal. A large number of aligned capacitors are arranged in the camera 331, so that the camera 331 can excite light and convert the image into a digital signal. Each small capacitor can transfer its charge to other adjacent capacitors under the control of an external circuit. The camera 331 collects the fluorescent light from the microdroplets, providing an intuitively visible fluorescent image, improving the speed of fluorescence detection, and making the detection result more accurate.
[0087] The fluorescent signal detection device 30 images the multiple microdroplets using fluorescence, taking a fluorescent image of a fixed number of the multiple microdroplets only once, and based on image processing technology, automatically identifying the fluorescence of the droplets in the image to obtain fluorescent information of the droplets.
[0088] When excited, the fluorescence inside the multiple microdroplets in the microdroplet container 60 passes through the second optical filter 333, is collected by the upper objective lens 332, and enters the camera 331, which collects a fluorescence image of the multiple microdroplets.
[0089] In one embodiment, to avoid bleaching of the fluorescence due to continuous illumination, a computer synchronizes the activation of the LED light source 341 with the acquisition of the camera 331. When no acquisition is being performed, the LED light source 341 remains closed.
[0090] The dichroic mirror 344 is installed at an angle on the tip of the first optical filter 343 and is used to refract the light emitted from each of the LED light sources 341 into one optical path. The principle of the dichroic mirror 344 is that transparent calcite (Iceland spar) is placed inside it to split the light into two perpendicularly vibrating lights, and the colors of these two lights are observed through the dichroic mirror.
[0091] The compound lens 345 is used to improve the uniformity of the refracted light path. The compound lens 345 is formed by combining a series of small lenses, and when the two-array compound lens matrix is applied to the lighting system, it can obtain high light energy utilization rate and uniform lighting over a large area. The two-array compound lens matrix can realize uniform lighting, improve the uniformity and lighting brightness of the LED light sources of different colors, and effectively calculate the direction and distance between itself and the object being observed, so as to obtain a more accurate fluorescent image. To realize uniform lighting by the compound lens matrix, it is necessary that the two-array compound lens matrix is arranged in parallel, the focal point of each small unit lens in the first row compound lens matrix is aligned with the center of the corresponding small unit lens in the second row compound lens matrix, the optical axes of the two array compound lenses are parallel to each other, a condenser mirror is installed behind the second row compound lens, and an illumination screen is installed on the focal plane of the condenser mirror to form a uniform lighting system.
[0092] The principle of the compound lens matrix to realize uniform illumination is as follows: a light beam parallel to the optical axis passes through a first lens and is focused at the center of a second lens, and the light source is formed as a plurality of light source images by the compound lens of the first array for illumination, and each small lens of the compound lens of the second array images the corresponding small lens of the compound lens of the first array on the illumination surface. The compound lens of the first array divides the entire broad light beam of the light source into a plurality of fine light beams for illumination, and the fine light beams located at symmetrical positions overlap each other in the range of each fine light beam, so that the non-uniformity of the fine light beams is compensated for and the light energy within the entire aperture can be effectively used. The spots emitted from the second array of compound eye lenses are focused on the illumination screen via a focusing mirror, so that each spot on the illumination screen is illuminated by the light rays emitted from each point in the light source, and at the same time, the light beams emitted from each point in the light source also overlap within the same field of view created by the illumination spots, resulting in a single uniform square spot.
[0093] The third controller 310 can control switching between the LED light sources 341 of different colors. The third controller 310 synchronously activates the LED light sources 341 of different colors and the camera 331. The fluorescent image of the microdroplets is mainly generated by the camera 331. The camera 331 can convert an optical image into a digital signal. The camera 331 has a number of aligned capacitors arranged, and is excited by a light beam to convert the image into a digital signal. Each small capacitor can transfer its charge to other adjacent capacitors under the control of an external circuit. The camera 331 collects the fluorescent light of the microdroplets, providing an intuitively visible fluorescent image, and can increase the speed of fluorescent detection and make the detection result more accurate.
[0094] Referring to FIG. 6, in one embodiment, the excitation light source 340 includes five different color LED light sources 341, five of the collimator mirrors 342, five of the first optical filters 343, four of the dichroic mirrors 344, one of the compound lenses 345, and one condenser lens 346. The five different color LED light sources 341 can generate light of different colors and irradiate the microdroplets. By selecting the five different color LED light sources 341, irradiation of different fluorescent colors can be obtained. The five different color LED light sources 341 work in turn. The collimator mirror, the first optical filter 343, and the dichroic mirror 344 are sequentially arranged on the light path emitted from each LED light source. The collimator mirror 342 and the first optical filter 343 are arranged at a perpendicular angle (90°) to the light path. The dichroic mirror 344 is arranged at an angle of 0° to 45° to the light path angle. The compound lens 345 and the condenser lens 346 are sequentially arranged just before the optical path formed by the dichroic mirror 344. The compound lens 345 is arranged at a perpendicular angle (90°) to the optical path and the condenser lens 346.
[0095] The optical path of the focusing lens 346 is obliquely irradiated onto the microdroplets, so that the microdroplets containing the fluorescent substance in the microdroplet container are fluorescently generated. The fluorescence detection assembly 330 collects the fluorescence information of the microdroplets containing the fluorescent substance, and transmits the fluorescence information of the microdroplets containing the fluorescent substance in the form of a fluorescence image to a computer for quantitative analysis.
[0096] In one embodiment, in the excitation light source 340, the numbers of the LED light source 341, the collimator mirror 342, the first optical filter 343, the dichroic mirror 344, the compound lens 345, and the condenser lens 346 are not limited.
[0097] The excitation light source 340 is used to obliquely irradiate the micro-droplet container 60 and irradiate the micro-droplets. The oblique irradiation light path formed by the excitation light source 340 can effectively reduce the background scattering of the excitation light. At the same time, the height of the sidewall of the micro-droplet container 60 can be reduced to help eliminate the shadow generated when the excitation light is irradiated from the side, so that the camera 331 can obtain all the fluorescence information of the micro-droplets, and the sensitivity of the fluorescence signal detection device 30 can be improved.
[0098] In one embodiment, the quantitative analysis device 40 is a computer. The fluorescent information of the microdroplets can be photographed by the fluorescent signal detection device 30. The computer is installed with analysis software, such as matlab, microsoft office, origin, and Microsoft Office visual.c++, which is used to realize quantitative analysis of the acquired fluorescent information of the microdroplets.
[0099] In one embodiment, the controller 50 is connected to the first controller 170, the second controller 210 and the third controller 310, respectively, and is used to control the operation of the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30 and the quantitative analysis device 40.
[0100] The microdroplet generating device 10 micro-disperses the nucleic acid amplification reaction liquid to be detected, forming a plurality of microdroplets. In the process of heating the plurality of microdroplets by the temperature control device 20, the fluorescence signal detecting device 30 captures an image of the change in fluorescence of the plurality of microdroplets in real time. The quantitative analyzing device 40 analyzes the image of the change in fluorescence of the plurality of microdroplets to obtain the Ct values of the plurality of microdroplets, and quantitatively analyzes the concentration of the initial nucleic acid based on the relationship between the Ct value and the initial copy number.
[0101] The digital PCR detector 1 integrates the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30 and the quantitative analysis device 40, so that the operation can be automatically realized through the integrated digital PCR detector 1 by the operator, thereby improving the working efficiency of the digital PCR detector 1.
[0102] The microdroplet generating device 10 microdroplets the nucleic acid amplification reaction liquid to be detected, forming a plurality of microdroplets. Then, the temperature control device 20 performs nucleic acid amplification on the plurality of microdroplets. At the same time, the fluorescent signal detection device 30 is used to capture a fluorescent change image of the plurality of microdroplets in real time. Based on the fluorescent change image of the plurality of microdroplets, a fluorescent change curve of the plurality of microdroplets is obtained. Based on the fluorescent change curve, the Ct value of the plurality of microdroplets is obtained, and the initial DNA concentration is quantitatively analyzed based on the relationship between the Ct value and the initial copy number. Here, the Ct value refers to the number of cycles that have elapsed until the fluorescent signal of each microdroplet reaches a predetermined threshold value.
[0103] The microdroplet generating device 10 generates microdroplets of uniform size, and the temperature control device 20 causes the microdroplets to undergo a nucleic acid amplification reaction, and collects product signals such as fluorescence, ultraviolet absorption, and turbidity. Based on the difference in the structure between the amplified microdroplets and the unamplified microdroplets, the number of droplets in which target sequence amplification has been obtained can be analyzed, and quantitative analysis of nucleic acid molecules can finally be realized. By monitoring the changing fluorescent image of the microdroplets in real time, the detection result is direct, and the problem of false positives and false negatives in the microdroplets can be solved.
[0104] In one embodiment, the microdroplet generating device 10 microdroplets the nucleic acid amplification reaction liquid to be detected to form a plurality of microdroplets. However, the microdroplets generated by the microdroplet generating device 10 are uniform in size. Then, the temperature control device 20 performs nucleic acid amplification on the plurality of microdroplets. At the same time, the fluorescence signal detection device 30 is used to capture images of changes in fluorescence of the plurality of microdroplets in real time. Based on the images of changes in fluorescence of the plurality of microdroplets, a fluorescence change curve is obtained for the plurality of microdroplets. Based on the fluorescence change curve, it is possible to obtain the Ct value of the plurality of microdroplets. Then, the concentration of the initial nucleic acid is quantitatively analyzed based on the relationship between the Ct value and the initial copy number.
[0105] In the Ct value, C indicates the cycle. In real-time fluorescent PCR, the Ct value refers to the number of cycles that elapse until the fluorescent signal in each of the microdroplets reaches a predetermined threshold value.
[0106] When the PCR cycle reaches the cycle number where the Ct value exists, the PCR cycle has just entered the true exponential amplification phase (logarithmic phase), so the minute error has not yet been expanded at this time, and the reproducibility of the Ct value is very good, that is, the Ct value obtained by amplifying the same nucleic acid template at different times, or amplifying in different microdroplet containers at the same time, is constant. If the fluorescence curve corresponding to the microdroplet is an amplification curve, it indicates that the microdroplet contains a target gene component. If the fluorescence curve corresponding to the microdroplet is a straight line, it indicates that the microdroplet does not contain a target gene component. The Ct value is obtained based on the obtained real-time fluorescence curve, and when the Ct value is obtained for each microdroplet, a derivative is derived from the real-time fluorescence curve, and the initial cycle number of the fluorescence curve at which the slope of the real-time fluorescence curve is constant is the required Ct value.
[0107] The detection process by the digital PCR detector 1 mainly includes five steps, namely, preparation of a nucleic acid amplification reaction solution to be detected, microdropletization of the nucleic acid amplification reaction solution to be detected, nucleic acid amplification, collection of fluorescence information, and quantitative analysis. Referring to FIG. 12, in one embodiment, the analysis method by the digital PCR detector includes step S10 of preparing a nucleic acid amplification reaction solution to be detected, step S20 of microdropletizing the nucleic acid amplification reaction solution to be detected to form a plurality of microdroplets, step S30 of performing nucleic acid amplification on the plurality of microdroplets and acquiring fluorescence information on the plurality of microdroplets in real time, and step S40 of quantitatively analyzing the plurality of microdroplets based on the fluorescence information of the plurality of microdroplets. In one embodiment, step S10 includes preparation of a nucleic acid amplification reaction solution to be detected. The nucleic acid amplification reaction solution includes a template of a nucleic acid to be detected, a reaction buffer solution, deoxyribonucleoside triphosphate, a primer, a polymerase, and a product mark substance.
[0108] Among them, the nucleic acid amplification reaction solution may be a nucleic acid amplification reaction solution (also called a DNA amplification reaction solution) using deoxyribonucleic acid (DNA) as a template, a reverse transcription nucleic acid amplification reaction solution (also called an RNA reverse transcription reaction solution) using ribonucleic acid (RNA) as a template, or other nucleic acid amplification reaction solution such as a loop-mediated isothermal amplification (LAMP) reaction solution. Among them, the DNA amplification reaction solution is characterized in that it contains dNTPs, buffer solution, inorganic salt ions, polymerase, primers, a DNA template to be detected, and a fluorescent dye or fluorescent probe, etc., which are necessary for amplifying DNA. The fluorescent dye or fluorescent probe in the reaction solution can indicate the amplification of nucleic acid and may be a fluorescent dye that binds to DNA, such as SYBR Green, or an oligosaccharide nucleotide probe that contains both a fluorescent group and a quenching group, such as a TaqMan fluorescent probe.
[0109] In one embodiment, a set of reagents and solutions is prepared for use only in digital PCR to reduce or avoid potential contamination of the template DNA sample with foreign DNA. All of the equipment and consumables used should be sterilized at high temperature and treated with high temperature drying. The components of the nucleic acid amplification reaction solution for detection are the template DNA to be amplified, specific oligonucleotide primers for amplifying the template, a thermostable DNA polymerase, four kinds of deoxyribonucleotide triphosphate substrates, divalent metal cation Mg 2+ , Taqman probes or fluorescent dyes and PCR buffers, etc.
[0110] In one embodiment, when the nucleic acid amplification reaction liquid to be detected is produced, the nucleic acid amplification reaction liquid to be detected may be marked by a Taqman probe. In one embodiment, when the nucleic acid amplification reaction liquid to be detected is produced, the nucleic acid amplification reaction liquid to be detected is marked by a fluorescent dye of SYBR. In one embodiment, in the step S20, the nucleic acid amplification reaction liquid to be detected is microdropletized to form a plurality of microdroplets, which includes two microdroplet generating methods, a microdroplet generating method by instantaneous accelerated motion and a microdroplet generating method by a periodically changing speed. The microdroplet generating device 10 performs a microdroplet processing on the nucleic acid amplification reaction liquid to be detected, thereby obtaining microdroplets produced in batches, which are used for detection by the digital PCR detector 1. Among them, the driving liquid is a liquid that is incompatible with the nucleic acid amplification reaction liquid to be detected and does not affect each other. The first liquid 190 is the nucleic acid amplification reaction liquid to be detected, and the second liquid 699 is an oil phase mixture.
[0111] When the produced nucleic acid amplification reaction solution passes through the microdroplet generating device, microdroplets can be produced in batch production. In the process of producing a plurality of microdroplets, the plurality of microdroplets are placed in the microdroplet container so as to facilitate detection of the plurality of microdroplets. In one embodiment, the microdroplet generating device 10 can generate a large amount of microdroplets in the second liquid and maintain the plurality of microdroplets not dissolved in each other.
[0112] In one embodiment, step S30 includes step S310 of evenly spreading the multiple microdroplets in the microdroplet container, step S320 of performing nucleic acid amplification on the spread multiple microdroplets, and step S330 of photographing and detecting the multiple microdroplets in real time while the multiple microdroplets are being amplified.
[0113] 13, in one embodiment, the step S310 includes a micro-droplet spreading method, which includes a step S311 of providing a micro-droplet container 60 having an opening 631 and storing a second liquid 699, a step S312 of providing a first liquid 190 having a density greater than that of the second liquid 699 and being incompatible with the second liquid 699, stacking a plurality of micro-droplets generated by the first liquid 190 on a bottom plate 610 of the micro-droplet container, and a step S313 of circulating the plurality of micro-droplets at high and low temperatures until the plurality of micro-droplets are spread on the container bottom plate 610.
[0114] A plurality of microdroplets are generated in the microdroplet container 60, fall onto the container bottom plate 610 of the microdroplet container 60, and are irregularly piled up. When a large amount of microdroplets fall onto the container bottom plate 610, multiple layers of microdroplets are formed on the container bottom plate 610. Moreover, the plurality of microdroplets generated by the microdroplet generating device are difficult to observe because they are gathered at the center of the microdroplet container during the downward descent process.
[0115] Referring to FIG. 14, in step S10, a plurality of microdroplets are dropped into the microdroplet container 60, and when the plurality of microdroplets are piled up on the bottom plate 610 of the microdroplet container, the plurality of microdroplets form a multi-layered microdroplet on the bottom plate 610 of the microdroplet container. In the process of detecting a fluorescent signal, when the plurality of microdroplets are photographed, the multi-layered microdroplets have mutual influences, which affects the photographing and detection of the plurality of microdroplets. Therefore, the microdroplet container 60 storing the plurality of microdroplets is circulated at high and low temperatures. The plurality of microdroplets are circulated at high and low temperatures multiple times until the plurality of microdroplets are spread on the bottom plate 610 of the microdroplet container and the microdroplets are spread in the reaction cell 612 in batch production, so that a large amount of droplets can be observed in parallel on a large scale.
[0116] The temperature control device 20 circulates between high and low temperatures, and the material is laid out based on the principle of thermal expansion and contraction. When the temperature of an object rises, the molecular kinetic energy increases, and the molecular mean free path increases, which is called thermal expansion. Similarly, when the temperature of an object falls, the molecular kinetic energy decreases, and the molecular mean free path decreases, which is called contraction. As the temperature rises with the change in temperature, the viscosity of the sample droplet decreases and the volume shrinks. At the same time, the higher the temperature, the lower the viscosity. When the temperature is about 60°C, the shape of the sample droplet is the softest, and at this time, the shape is roughly hexagonal, while at other temperatures, the shape of the sample droplet is less likely to change, and laying in the droplet container is less likely to be formed.
[0117] In one embodiment, the steps of circulating at high and low temperatures by the temperature control device 20 are as follows. First, the microdroplets are heated to 90°C to 95°C, and heated for 5 to 10 minutes. Then, the microdroplets are annealed and extended for 30 to 60 seconds to lower the temperature to 40°C to 60°C. Finally, circulation is performed multiple times in sequence to lower the temperature to 0°C to 10°C, and the microdroplets are stored.
[0118] In one embodiment, the step of circulating at high and low temperatures by the temperature control device 20 further includes: first, heating the microdroplets so that they rise in temperature, heating them to a temperature of 95°C, and heating them for 10 minutes (heating the microdroplets to 95°C and heating them for 10 minutes is to hot-start the enzymes in the microdroplets); then, when the hot-start of the enzymes is completed for the microdroplets, denaturing the microdroplets for 30 seconds; then, after the microdroplets are denatured, lowering the temperature to 55°C, annealing and extending them for 45 seconds, photographing the microdroplets, and circulating for 45 times; and finally, after circulating for 45 times, lowering the temperature to 4°C and storing the microdroplets for a long period of time.
[0119] The nucleic acid amplification reaction solution to be detected is used to generate a plurality of microdroplets by the microdroplet generating device 10 and perform detection. The plurality of microdroplets produced by the microdroplet generating device 10 are collected at the center of the microdroplet container 60 during the downward descent process, and are therefore difficult to observe. Therefore, it is necessary to spread the plurality of microdroplets in the microdroplet container so as to more accurately obtain information related to the nucleic acid amplification reaction for the plurality of microdroplets. By spreading the plurality of microdroplets in the microdroplet container to form only one layer, mutual influence between multiple microdroplets can be avoided, and the fluorescent signal detecting device 30 can capture and detect more accurate fluorescent information, facilitating quantitative analysis.
[0120] The PCR reaction conditions are temperature, time and number of cycles.
[0121] Regarding the temperature and time arrangement, three temperature points are arranged according to the principle of PCR, namely, denaturation-annealing-extension, in three steps. When the three temperature point method is used for the standard reaction, the double-stranded DNA is denatured at 90-95°C, then rapidly cooled to 40-60°C again, and combined with primer annealing to the target sequence, and then rapidly heated to 70-75°C, where the primer strand is extended along the template by the action of Taq DNA polymerase. On the other hand, for relatively short target genes (when the length is 100-300 bp), the two temperature point method may be used. In addition to the denaturation temperature, the annealing and extension temperatures are integrated into one, and generally, denaturation is performed at 94°C, and annealing and extension are performed at about 65°C (at this temperature, Taq DNA enzyme still has relatively high catalytic activity).
[0122] Regarding the denaturation temperature and time, incomplete unbinding due to low denaturation temperature is the main cause of PCR failure. In general, 93℃-94℃ is sufficient to denature the template DNA, and if it is lower than 93℃, the time needs to be extended. Also, the temperature should not be too high, because it affects the activity of the enzyme in a high temperature environment. In this step, if the template of the target gene or the PCR product is not completely denatured, PCR will fail.
[0123] Regarding annealing temperature and time, the annealing temperature is a relatively important factor that affects the specificity of PCR. After denaturation, the primer and template can be rapidly cooled to a temperature of 40℃ to 60℃ to bind. Since the template DNA is much more complex than the primer, the chance of collision binding between the primer and the template is much higher than the collision between the complementary strands of the template. The annealing temperature and time are determined by the length of the primer, the base composition and its concentration, and the length of the target sequence. For a primer containing 20 nucleotides and with a G+C content of about 50%, it is relatively ideal to select 55℃ as the starting point of the optimal annealing temperature.
[0124] In the acceptable range, if a relatively high annealing temperature is selected, non-specific binding between the primer and the template can be reduced as much as possible, and specificity of the PCR reaction can be improved. In general, when the annealing time is set to 30 to 60 seconds, complete binding between the primer and the template can be achieved.
[0125] Regarding extension temperature and time, the biological activity of Taq DNA polymerase is 150 nucleotides / S / enzyme molecule at 70-80°C, 60 nucleotides / S / enzyme molecule at 70°C, 24 nucleotides / S / enzyme molecule at 55°C, and almost no DNA is synthesized at temperatures above 90°C.
[0126] Therefore, the extension temperature of the PCR reaction is generally selected in the range of 70-75°C, with 72°C being the most commonly used temperature, and too high an extension temperature is not conducive to binding of the primer to the template. The time of the PCR extension reaction may be selected according to the length of the fragment to be amplified. Generally, for DNA fragments of 1 Kb or less, an extension time of 1 minute is sufficient. For target sequences of 3-4 kb, the extension time is 3-4 minutes, and for amplification of only 10 Kb, it needs to be extended to 15 minutes. If the extension time is too long, there will be the appearance of an amplification band with non-specificity. For amplification of a template with a low concentration, the extension time needs to be slightly longer.
[0127] In one embodiment, the step of amplifying nucleic acid in the plurality of microdroplets in step S320 is as follows. First, the microdroplet container 60 is placed on the heating substrate 240 of the temperature control device 20. Then, the plurality of microdroplets are heated so that the temperature rises to 95°C and heated for 10 minutes. The reason for heating the plurality of microdroplets to 95°C and heating for 10 minutes is to allow the enzymes in the plurality of microdroplets to perform a hot start. Next, after the hot start to the enzymes is completed, the plurality of microdroplets are denatured for 30s. After the plurality of microdroplets are denatured, the temperature is lowered again to 55°C, annealed and extended for 45s, and circulated for 45 times. Finally, after circulating for 45 times, the temperature is lowered to 4°C and the plurality of microdroplets are stored for a long time.
[0128] The temperature control device 20 makes the temperature distribution in the micro-droplet container 60 uniform by the flexible circuit board 220 and the thermal conduction enhancing layer 250, and the thermoelectric cooler improves the performance of thermal conduction. When the micro-droplets are amplified in different temperature ranges, the temperature sensor 260 arranged on the surface of the thermal conduction enhancing layer 250 is connected to the second controller 210 to detect the temperature of the micro-droplet container 60 in real time, and feeds back the temperature information to the second controller 210 to control the temperature for heating the micro-droplets, and also realizes rapid switching in only a few seconds. The temperature control device 20 can instantly realize temperature increase and decrease, so that the temperature increase and decrease process is shortened, high and low temperature circulation can be realized, the detection time by the digital PCR detector 1 is shortened, and the detection efficiency is improved.
[0129] In one embodiment, in the step of amplifying nucleic acid into the plurality of microdroplets, the plurality of microdroplets are photographed and detected by the fluorescent signal detection device 30 .
[0130] The fluorescence signal detection device 30 images the fluorescence of the multiple microdroplets, takes a fluorescence image of a fixed number of the multiple microdroplets only once, and automatically identifies the droplet fluorescence in the image based on image processing technology, thereby obtaining fluorescence information of the droplets.
[0131] In one embodiment, the imaging step by the fluorescent signal detection device 30 obtains 45 fluorescent images for each micro-droplet in the micro-droplet container 60 for quantitative analysis.
[0132] In one embodiment, the step of photographing and detecting the microdroplets in real time when amplifying nucleic acid in the microdroplets in step S330 is as follows.
[0133] The microdroplets are heated to a temperature of 95°C and heated for 10 minutes. The microdroplets are heated to 95°C and heated for 10 minutes in order to hot start the enzymes in the microdroplets. Next, when the hot start to the enzymes is completed for the microdroplets, the microdroplets are denatured for 30 seconds. Next, after the microdroplets are denatured, the temperature is lowered to 55°C, annealed and extended for 45 seconds, the microdroplets are photographed, and circulation is performed 45 times. Finally, after circulation is performed 45 times, the temperature is lowered to 4°C and the microdroplets are stored for a long time.
[0134] The optical path of the focusing lens 346 is obliquely irradiated onto the plurality of microdroplets, so that the fluorescent microdroplets contained in the microdroplet container 60 fluoresce. The fluorescence detection assembly 330 collects fluorescence information about the microdroplets containing the fluorescent substance, and transmits the fluorescence information about the microdroplets containing the fluorescent substance to a computer in the form of a fluorescence image for quantitative analysis.
[0135] According to the detection method of the fluorescence imaging, a certain number of the microdroplets are photographed in a fluorescence image only once, and then the fluorescence of the droplets in the image is automatically identified based on the image processing technology to obtain the fluorescence information of the droplets. The imaging range of the detection method of the fluorescence imaging is large, so that the requirements for the detection environment in which the microdroplets are located are relatively low during detection.
[0136] In one embodiment, the sample to be detected for nucleic acid detection is a sample to be detected that contains DNA. The microdroplets of uniform size generated by the microdroplet generating device 10 are subjected to a nucleic acid amplification reaction by a temperature control device 20, and product signals such as fluorescence, ultraviolet absorption, and turbidity are collected. The number of droplets in which target sequence amplification has been obtained is analyzed based on the difference in the configuration between the multiple amplified microdroplets and the non-amplified microdroplets, and quantitative analysis of the nucleic acid molecules can finally be realized. In the process of heating the microdroplets, a fluorescence change image of the multiple microdroplets is photographed in real time, the Ct values of the multiple microdroplets are obtained, and a quantitative analysis of the initial DNA concentration is performed based on the relationship between the Ct value and the initial copy number.
[0137] After the microdroplets containing the targeted DNA are amplified, if their fluorescent signal intensity reaches a certain level, they are indicated as positive, and if the fluorescent signal is almost undetectable in the microdroplets with zero DNA content, they are considered as negative.
[0138] If the initial DNA copy number contained in a microdroplet in digital PCR is x, then according to the theory of mathematical statistics, the probability distribution function P of x = k (k = 0, 1, 2, 3 ...) corresponds to the Poisson distribution probability model, of which λ is the average molecular copy number contained in the microdroplet.
number
[0139] Therefore, the expected value μ and variance σ of the Poisson distribution model 2 According to the equation, the expectation μ is λ and the variance σ2 is known to be λ. Therefore, in digital PCR, since the copy number of the target DNA molecule contained in each microdroplet is λ, quantitative detection of the nucleic acid can be realized by the calculated λ value.
[0140] Regarding the nucleic acid amplification reaction solution to be detected, if its total volume is V (the volume of each microdroplet is v), the concentration c (copy / μL) of the nucleic acid amplification reaction solution to be detected is
number
[0141] Therefore, if the value of λ can be obtained, DNA can be quantitatively detected.
[0142] Among them, the fact that real-time fluorescent quantitative PCR does not require the addition of an internal standard is due to the reproducibility of the Ct value and the linear relationship between the Ct value and the initial DNA concentration. When the PCR cycle reaches the cycle number where the Ct value is located, it has just entered the true exponential amplification phase (logarithmic phase), and at this time, the small errors have not yet been expanded, so the reproducibility of the Ct value is very good, that is, the Ct value obtained by amplifying the same DNA template at different times or amplifying it in different microdroplet containers at the same time is constant.
[0143] When the fluorescence curve corresponding to the microdroplet is an amplification curve, the microdroplet is said to contain a target gene component, and when the fluorescence curve corresponding to the microdroplet is a straight line, the microdroplet is said to not contain a target gene component.
[0144] Based on the acquired real-time fluorescence curve, the Ct value is acquired. When acquiring the Ct value of each microdroplet, a derivative is derived from the real-time fluorescence curve, and the initial number of cycles of the fluorescence curve at which the slope of the real-time fluorescence curve becomes constant is the required Ct value.
[0145] In one embodiment, the microdroplet generating device 10 can generate multiple microdroplets with uniform volume. The size of each of the microdroplets is on the micron level. When the multiple microdroplets have uniform volumes, the multiple microdroplets are quantitatively analyzed based on the fluorescence information of the multiple microdroplets.
[0146] 15, the step S40 includes a digital PCR quantitative detection method. The digital PCR quantitative detection method includes the steps of: acquiring a plurality of real-time fluorescence images for all microdroplets, acquiring a real-time fluorescence curve for the nucleic acid amplified microdroplets based on the plurality of real-time fluorescence images; acquiring all Ct values of the nucleic acid amplified microdroplets based on the real-time fluorescence curve; acquiring all initial nucleic acid copy numbers of the nucleic acid amplified microdroplets based on the relationship between the Ct value and the initial nucleic acid copy number of the nucleic acid amplified microdroplets; acquiring a frequency distribution of the initial nucleic acid copy numbers based on all initial nucleic acid copy numbers of the nucleic acid amplified microdroplets; and calculating a parameter λ of a Poisson distribution based on the frequency distribution of the initial nucleic acid copy numbers in step S4150.
[0147] The digital PCR quantitative detection method solves the problem of false positive or false negative results. The sequencing platform sample has high throughput, so hundreds of samples can be detected simultaneously. In addition, multiple loci can be detected by different types of fluorescence, and the detection speed is fast and the cost of testing is reduced. The use of a digital PCR detector for microdroplet processing allows rare detection fragments to be separated from a large amount of complex background, greatly simplifying the operation, effectively saving preparation time and detection time, and has the advantages of being intuitive, reliable, and stable in reading the results, and the detection sensitivity and accuracy are both accurate, meeting the requirements for quantification, and improving the detection sensitivity and accuracy.
[0148] In one embodiment, step S4110 includes: Step S4111 of acquiring a fluorescence intensity value of each nucleic acid amplified microdroplet based on each real-time fluorescence image; Step S4113 of acquiring a real-time fluorescence curve of each of the nucleic acid amplified microdroplets based on the fluorescence intensity value of each of the nucleic acid amplified microdroplets; and acquiring real-time fluorescence curves of all of the nucleic acid amplified microdroplets based on the fluorescence curves of each of the nucleic acid amplified microdroplets S4115.
[0149] In one embodiment, the step includes collecting fluorescence images of the multiple microdroplets and performing image tracking. When obtaining a real-time fluorescence curve for each microdroplet, it is necessary to obtain the positioning and fluorescence intensity of each microdroplet in each image, respectively. In the digital PCR detector, the imaging system determines what the actual ratio is corresponding to each pixel of the fluorescence image. Based on the fluorescence image, extract the number of pixels corresponding to the diameter of the microdroplet, obtain the micron corresponding to the diameter, and then calculate what the diameter of the microdroplet is.
[0150] In one embodiment, when tracking each microdroplet, NCAST image difference and clustering calculations can be performed based on the photos taken during each temperature cycling process to identify the position of each microdroplet and obtain the fluorescence intensity of the multiple microdroplets.
[0151] In one embodiment, when the distance traveled by a microdroplet in one temperature cycling step is equal to or less than the diameter of one microdroplet, the microdroplet is tracked in the following manner.
[0152] Among them, when tracking each microdroplet, the step of tracking the image of each microdroplet includes first identifying the photos taken for each temperature cycling process and obtaining the center position of each microdroplet, then comparing the center position of each currently identified microdroplet with the center position of each microdroplet in the previous cycling process, and finally, if the distance between the center position of each currently identified microdroplet and the center of the center position of each microdroplet in the previous cycling process is smaller than the diameter of one microdroplet, they are indicated as the same microdroplet.
[0153] In one embodiment, a fluorescence curve of each microdroplet is obtained based on the fluorescence intensity value of each microdroplet in each temperature cycling process. The sum of the fluorescence intensity values of each microdroplet at each point in each temperature cycling process is calculated to obtain the fluorescence intensity value of each microdroplet at a predetermined timing.
[0154] In one embodiment, a method may be used in which a part of the fluorescence intensity value of each microdroplet at a predetermined timing is added so as not to affect the edge portions of adjacent microdroplets. For each temperature cycling process, the fluorescence curve of each microdroplet is obtained by acquiring the change in the state of the multiple microdroplets throughout the entire cycling process based on the fluorescence intensity values of the multiple microdroplets.
[0155] In one embodiment, the microdroplet is cycled 45 times to acquire 45 fluorescence images, and each microdroplet is positioned in the 45 fluorescence images to acquire 45 fluorescence intensity values for each microdroplet to obtain a fluorescence curve for each microdroplet.
[0156] In one embodiment, step S4120 includes: A step S4121 of deriving a derivative of a real-time fluorescence curve of each microdroplet in which nucleic acid has been amplified, and obtaining a slope of the real-time fluorescence curve of each microdroplet in which nucleic acid has been amplified; A step S4123 of acquiring a slope that does not change in value among the slopes of the real-time fluorescence curves of the microdroplets subjected to the nucleic acid amplification based on the slopes of the real-time fluorescence curves of the microdroplets subjected to the nucleic acid amplification; Step S4125: based on the value at which the slope does not change, the corresponding initial cycle number is obtained as the Ct value of each microdroplet that has undergone nucleic acid amplification; and a step S4127 of acquiring the Ct values of all of the nucleic acid amplified microdroplets based on the Ct value of each of the nucleic acid amplified microdroplets.
[0157] In one embodiment, step S4120 includes: Step S4122 of obtaining a threshold fluorescence value of each nucleic acid amplified microdroplet based on the real-time fluorescence curve of each nucleic acid amplified microdroplet; Step S4124: based on the missing value of the fluorescence threshold of each nucleic acid amplified microdroplet, obtain the corresponding round number as the Ct value of each nucleic acid amplified microdroplet; The method further includes a step S4126 of acquiring all Ct values of the nucleic acid amplified microdroplets based on the Ct value of each of the nucleic acid amplified microdroplets.
[0158] In the Ct value, C indicates cycle and t indicates threshold, and the Ct value means the number of cycles that have elapsed until the fluorescent signal in each reaction tube reaches a predetermined threshold value.
[0159] In one embodiment, the first 15 circulated fluorescent signals during PCR reaction are used as the fluorescent background signal, and 10 times the standard deviation of the 3-15 circulated fluorescent signals are used as the fluorescent threshold, i.e., threshold=10×SD cycle 3-15 According to the missing value of the fluorescence threshold, the corresponding number of rounds is obtained as the Ct value.
[0160] In one embodiment, in S4130, a linear relationship exists between the Ct value of each of the microdroplets and the logarithm of the initial DNA copy number of each of the microdroplets.
[0161] In one embodiment, there is a linear relationship between the Ct value of each template (DNA) and the logarithm of the initial copy number of the template (DNA).
number
[0162] The higher the initial copy number, the smaller the Ct value. According to a standard product with a known initial copy number, a standard curve can be made, in which the abscissa represents the logarithm of the initial copy number and the ordinate represents the Ct value. Therefore, if the Ct value of an unknown sample can be obtained, the initial copy number of this sample can be calculated from the standard curve.
number
[0163] Regarding the relationship between the Ct value and the initial DNA concentration, there is a linear relationship between the Ct value of each DNA template and the logarithm of the initial copy number of the DNA template. The higher the initial copy number, the smaller the Ct value.
[0164] In one embodiment, step S4140 includes step S4141 of obtaining the maximum and minimum values of the initial copy numbers of all nucleic acids in the nucleic acid amplified microdroplets based on the initial copy numbers of all nucleic acids in the nucleic acid amplified microdroplets, and step S4143 of selecting the maximum value, the minimum value, the class width and the number of classes to obtain a frequency distribution of the initial copy numbers of nucleic acids.
[0165] The frequency refers to the number of data items located in different intervals, and the sum of the frequencies of the different intervals is equal to the total number of data items in the set.
[0166] In one embodiment, in S4150, the maximum likelihood estimation method is used when calculating the parameter λ of the Poisson distribution.
[0167] In droplet PCR, the initial copy number contained in a single droplet satisfies the Poisson distribution.
number
[0168] In one embodiment, the Ct value determines the number of droplets n having k (k=0, 1, 2, 3, . . .) DNA initial copies. k , can be obtained, and by using the maximum likelihood estimation method,
number
[0169] Wherein, the corresponding frequency value of the initial DNA copy number of the microdroplet is n k In other words, when k=0 DNA initial copy number, the number of the microdroplets represented correspondingly is n0, when k=1 DNA initial copy number, the number of the microdroplets represented correspondingly is n1, when k=2 DNA initial copy number, the number of the microdroplets represented correspondingly is n2, and when k=3 DNA initial copy number, the number of the microdroplets represented correspondingly is n3. In this way, it is inferred similarly. According to this method, it is not necessary to secure the number of dark droplets that are considered negative. In addition, estimating the optimal parameters for the whole using complete frequency distribution data is much more accurate and stable than estimating using a single frequency alone.
[0170] Referring to FIG. 16, in one embodiment, the digital PCR quantitative detection method includes: A step S4210 of acquiring a plurality of real-time fluorescence images for all of the microdroplets, and acquiring a real-time fluorescence curve of the nucleic acid amplified microdroplets based on the plurality of real-time fluorescence images; Step S4220 of acquiring all Ct values of the nucleic acid amplified microdroplets based on the real-time fluorescence curve; A step S4230 of acquiring all the initial nucleic acid copy numbers of the nucleic acid amplified microdroplets based on the relationship between the Ct value and the initial nucleic acid copy number of the nucleic acid amplified microdroplets; A step S4240 of selecting a part of the initial nucleic acid copy numbers based on all the initial nucleic acid copy numbers of the nucleic acid amplified microdroplets; A step S4250 of acquiring a frequency distribution of the initial copy numbers of the part of nucleic acids based on the initial copy numbers of the part of nucleic acids; and Step S4260 of performing point estimation for Poisson distribution based on the frequency distribution of the initial copy numbers of the portion of nucleic acids, and acquiring a parameter λ of the Poisson distribution.
[0171] In one embodiment, a least squares point estimate is made to the Poisson distribution for all of the microdroplets based on an incomplete sampling of their initial DNA concentrations.
[0172] For all the microdroplets, we perform point estimation on the Poisson distribution through incomplete sampling of the initial DNA concentration using the Expectation Maximization Algorithm (EM) and Markov chain Monte Carlo (MCMC) methods. The Markov chain Monte Carlo (MCMC) method is a Bayesian method.
[0173] In one embodiment, the S4260 selects a space [λ] such that the residual sum of squares err of the frequency values of the initial copy numbers of the part of nucleic acids is minimized. min ,λ max ] includes querying λ in
[0174] In one embodiment, when the initial DNA concentration is relatively small, the number of droplets containing 5 or more copies is very small (or can be neglected). When the system is a 20,000 droplet system, it is generally recommended that the DNA concentration of the sample is 6 CPD or less. In the actual test process, when k>4, the division of Ct value becomes small, and it is difficult to distinguish whether the initial copy number of one droplet is 4 or 5 by Ct value, so only incomplete samples of x0, x1, x2, and x3 are used to perform point estimation in Poisson distribution. There are many algorithms for point estimation in Poisson based on incomplete samples, and an algorithm with operability (least square method) is listed and described here.
[0175] In one embodiment, a space [λ min ,λ max ] and set λ to [λ min ,λ max ] space, calculate the sum of squares of the error, and select the appropriate λ so that the sum of squares of the residual is minimized.
number
[0176] In one embodiment, in S4260, the method of performing point estimation on the Poisson distribution further includes the method of moments, the order statistics method, or the maximum likelihood estimation method.
[0177] Among them, the point estimation method further includes the moment method, which estimates parameters corresponding to a population by sample moments.
[0178] First, estimate equations for the population moments (i.e. the expected values of the powers of variables with possible probabilities) associated with the parameters of interest. Then take a sample and estimate the population moments from this sample. Then use the sample moments to substitute for the (unknown) population moments for the parameters of interest and obtain estimates for those parameters.
[0179] The order statistics method is a method of estimating the mathematical expectation of a population using the median of samples. The advantages of the order statistics estimation method are that it is easy to calculate and is difficult to be affected by individual abnormal data. If a certain data in a group of sample values is abnormal (e.g., too small or too large), it may be inferred that this abnormal data was generated randomly in the population or was generated by external interference (e.g., due to mismanagement of workers or errors in entry). If the cause is the latter, it will obviously have an impact when estimating E(x) using the average value of the samples. However, when estimating E(x) using the median of the samples, it is difficult for one (or more) abnormal data to affect the estimated value because the median value is not easily changed.
[0180] The maximum likelihood estimation method (ML), also called maximum likelihood estimation or maximum likelihood method, is a theoretical point estimation method. The basic idea of the maximum likelihood estimation method is that after randomly extracting n sets of sample observation values from a model population, the probability of extracting the n sets of sample observation values from the model for the most reasonable parameter estimate should be maximized, and it is not like the least squares estimation method, in which a model is best applied to the parameter estimates of the sample data.
[0181] In the actual process, the digital PCR quantitative detection method can detect the initial DNA concentration in the multiple microdroplets with high accuracy without relying on a standard curve. In the digital PCR detector, an imaging system is set up to determine what the actual ratio is corresponding to each pixel of the fluorescent image. Based on the fluorescent image, the number of pixels corresponding to the diameter of the microdroplets is extracted, and the microns corresponding to the diameter are obtained, so that the diameter of the microdroplets can be calculated.
[0182] The digital PCR quantitative detection method can dynamically track the multiple microdroplets. In the step of subjecting the multiple microdroplets to temperature cycling, the specific position corresponding to each microdroplet can be determined, and the entire process of amplifying nucleic acid can be monitored. Therefore, the digital PCR quantitative detection method can solve the problem of the multiple microdroplets having false positives. In addition, processing the fluorescence curves of the multiple microdroplets can obtain true absolute quantification without relying on statistical corrections that are performed due to uniformity.
[0183] In addition to eliminating the need for a standard curve, the method also solves the problem of indeterminate quantitative results based on the standard curve, and overcomes the limitations of the end-point detection method of droplet digital PCR, breaking the constraint of estimating parameters for the entire sample to be detected based on only one P(x=0) data. The use of the real-time fluorescent quantitative PCR detection method improves the accuracy of quantitative detection in digital PCR.
[0184] The digital PCR quantitative detection method eliminates the need to ensure the number of negative blank droplets (droplets that do not contain nucleic acid). In addition, using multidimensional frequency distribution data, the accuracy and stability of estimating the optimal parameters for the whole sample is much higher than that of estimating the optimal parameters using only one P(x=0) data.
[0185] Each fluorescence curve represents the change process of a useful piece of information, and is the information (valuable information) added to the droplet sample so that it can be monitored in real time. Using a predetermined algorithm, the mutual influence between adjacent droplets can be eliminated.
[0186] The digital PCR quantitative detection method can achieve reproducibility and high sensitivity through an abstracted mathematical model, and the dynamic range is large, so that monitoring can be achieved with a small amount of droplets. A small amount of data can cover a large amount of information. In addition, the digital PCR quantitative detection method avoids the errors of the Poisson distribution probability model to achieve absolute quantification, making it more intuitive. All data is integrated to eliminate random errors. The fluorescence curve of the droplet sample is obtained, the changes in the fluorescence brightness of the droplet sample are monitored in real time, false positives are eliminated, and the mutual influence between adjacent droplets is eliminated, and then a more accurate data source is provided for the quantitative analysis model.
[0187] Referring to FIG. 17, the Poisson distribution is applied when the initial copy numbers of the partial nucleic acid are 0, 1, 2, and 3, respectively. The abscissa is the average initial copy number (copies per droplet, CPD) contained in each droplet. The ordinate is the standard deviation (Std Dev, STD) of the average initial copy number contained in each droplet. The average initial copy number contained in each droplet is represented by CPD (copies per droplet). It can be seen that the standard deviation of the CPD of the average initial copy number contained in each droplet obtained by the initial copy number of the partial nucleic acid is smaller than the standard deviation of the CPD of the average initial copy number obtained by other algorithms. Therefore, the value of the CPD for the average initial copy number contained in each droplet obtained by this algorithm is more accurate. The results of simulating 20,000 droplets only 1,000 times are shown. If only a single-point estimation method is used, only a limited concentration range is covered, and the accuracy of the estimation also deteriorates rapidly as the concentration of the sample increases. However, when using the incomplete Poisson distribution fitting algorithm (N=0, 1, 2, 3), the estimation accuracy does not change obviously with the increase in the concentration of the sample, and it is also possible to double the concentration of the nucleic acid amplification reaction solution to be detected. When the number of droplets is relatively small, the incomplete Poisson distribution fitting algorithm (partial sampling Poisson distribution fitting algorithm) still has good accuracy.
[0188] As can be seen from the simulation results, when the digital PCR quantitative detection method is used, the system using 200 droplets for testing has better accuracy than the conventional single-point estimation algorithm (uCount algorithm). When the droplet numbers are close, the stability, accuracy, and dynamic range of the Poisson fitting algorithm are also much better than those of the conventional single-point estimation algorithm. To achieve the same detection accuracy, the number of droplets required to use the Poisson fitting algorithm is two orders of magnitude lower than that required by the conventional single-point estimation algorithm. Therefore, the digital PCR detector 1 has high detection accuracy and large detection range, and can detect multiple different types of nucleic acids with only a small number of droplets, improving the usage efficiency.
[0189] In one embodiment, the plurality of uniform microdroplets generated by the microdroplet generating device 10 may not have a uniform volume when the volume of the microdroplets is changed if the microdroplets have a particular volume. The microdroplet generating device 10 may also generate a plurality of microdroplets with different volumes for use in clinical detection.
[0190] Whether it is micropore type or droplet type digital PCR technology, the volume of the reaction cell is often kept to a high degree of uniformity, and it may be considered as a single volume digital PCR technology. The quantification limit of single volume digital PCR is mainly determined by the volume and number of reaction cells, and the lower limit of detection is related to the total volume of the sample. Single volume digital PCR technology cannot adjust its resolution and dynamic range independently. In addition, although serial dilution of the sample to be detected can expand its dynamic range, it cannot improve the sensitivity of detection. In addition, the serial dilution method increases the consumption of reagents, increases the risk of cross contamination, and complicates the operation.
[0191] Multivolume digital PCR (MVdPCR) avoids the drawbacks of serial dilutions and allows researchers to independently adjust the dynamic range and resolution.
[0192] The micro-droplet container of multi-volume digital PCR contains a series of reaction cells with different volumes, and the small volume reaction cells can perform quantification for high concentration samples, while the large volume reaction cells have sufficient volume to achieve high sensitivity detection. Multi-volume digital PCR does not require a large number of reaction cells, but can reach the dynamic range of single volume digital PCR. Therefore, the micro-droplet container can effectively reduce the consumption of reagents while completing the analysis of many samples.
[0193] In the digital PCR detector, the imaging system is set up to determine what is the actual ratio corresponding to each pixel of the fluorescent image. Based on the fluorescent image, the number of pixels corresponding to the diameter of the microdroplet is extracted, and the micron corresponding to the diameter is obtained, so that the diameter of the microdroplet can be calculated.
[0194] In one embodiment, the sample solution is a nucleic acid amplification reaction solution used in a quantitative analysis method for a digital PCR detector.
[0195] Referring to FIG. 18, the different volumetric digital PCR quantitative analysis methods presented in the above cases are as follows: The total volume of the droplets v1, v2, ... v m where v1, v2, ... v m The numbers of the corresponding microdroplets are n1, n2, ..., n m Let the volumes v1, v2, ... v m The number of negative microdroplets with amplified nucleic acid in the corresponding microdroplets is sequentially expressed as b1, b2, ..., b m Step S4310: The relevant parameters v1, v2, ... v for all the microdroplets are m , n1, n2, …, n m , b1, b2, …, b m Step S4320 of constructing a joint binomial distribution function f(c) for the concentration c of the nucleic acid amplification reaction solution based on A step S4330 of obtaining a value of c when an extreme point is taken in the joint binomial distribution function f(c) based on the joint binomial distribution function f(c); Step S4340 of converting the joint binomial distribution function f(c) into a joint binomial distribution function F(Λ) for ln(c) to obtain a standard deviation and a confidence interval for ln(c); The method includes a step S4350 of acquiring the standard deviation and confidence interval of the concentration c of the nucleic acid amplification reaction solution based on the standard deviation and confidence interval for ln(c).
[0196] After the microdroplets containing the target DNA are amplified, if their fluorescent signal intensity reaches a certain level, they are indicated as positive, whereas for microdroplets with zero DNA content, the fluorescent signal is almost undetectable and they are considered as negative.
[0197] If the initial DNA copy number contained in a microdroplet in digital PCR is x, then according to the theory of mathematical statistics, the probability distribution function P of x = k (k = 0, 1, 2, 3 ...) corresponds to the Poisson probability model, of which λ is the average molecular copy number contained in the microdroplet.
number
[0198] If the total volume of the nucleic acid amplification reaction solution to be detected is V (the volume of each microdroplet is v), the concentration c (copies / μL) of the nucleic acid amplification reaction solution to be detected is
number
[0199] Among them, the fact that real-time fluorescent quantitative PCR does not require the addition of an internal standard is due to the reproducibility of the Ct value and the linear relationship between the Ct value and the initial DNA concentration. When the PCR cycle reaches the cycle number where the Ct value is located, it has just entered the true exponential amplification phase (logarithmic phase), and at this time, the small errors have not yet been expanded, so the reproducibility of the Ct value is very good, that is, the Ct value obtained by amplifying the same DNA template at different times or amplifying it in different microdroplet containers at the same time is constant.
[0200] When the fluorescence curve corresponding to the microdroplet is an amplification curve, the microdroplet is said to contain a target gene component, and when the fluorescence curve corresponding to the microdroplet is a straight line, the microdroplet is said to not contain a target gene component.
[0201] Based on the acquired real-time fluorescence curve, the Ct value is acquired. When acquiring the Ct value of each microdroplet, a derivative is derived from the real-time fluorescence curve, and the initial number of cycles of the fluorescence curve at which the slope of the real-time fluorescence curve becomes constant is the required Ct value.
[0202] In one embodiment, step S4310 includes: A sample solution containing the target nucleic acid is dispensed into droplets of different volumes v1, v2, ...v m where the microdroplets have volumes v1, v2, ... v m The numbers of the corresponding microdroplets are n1, n2, ..., n m Step S4311: A step S4313 of amplifying nucleic acid for all of the microdroplets, detecting the same by photographing, and acquiring fluorescent images for all of the microdroplets; Based on all the fluorescence images of the microdroplets, all the volumes v1, v2, ... v m and the corresponding nucleic acid amplified negative microdroplet quantities b1, b2, ..., b m and a step S4315 of acquiring the
[0203] In one embodiment, step S4310 includes: A step S4312 of forming a plurality of microdroplets by atomizing a sample solution containing the target nucleic acid; A step S4314 of amplifying nucleic acid in the plurality of microdroplets, detecting the nucleic acid by photographing, and acquiring fluorescent images of all of the microdroplets in which the nucleic acid has been amplified; Obtaining all volumes of the nucleic acid amplified microdroplets based on the fluorescent images, where the volumes are respectively v1, v2, ... v m Let the volumes v1, v2, ... v m The number of the amplified microdroplets is then sequentially determined as n1, n2, ..., n m Let the volumes v1, v2, ... v m The number of negative microdroplets amplified with the nucleic acid corresponding to the amplified microdroplets is expressed as b1, b2, ..., b m The method further includes a step S4316 of:
[0204] In one embodiment, the step includes collecting fluorescence images of the microdroplets and performing image tracking. When obtaining the real-time fluorescence curve of each microdroplet, it is necessary to position each microdroplet in each image and obtain the fluorescence intensity of each microdroplet. In the digital PCR detector, the imaging system determines what the actual ratio is corresponding to each pixel of the fluorescence image. Based on the fluorescence image, extract the number of pixels corresponding to the diameter of the microdroplet, obtain the micron corresponding to the diameter, and then calculate what the diameter of the microdroplet is.
[0205] In one embodiment, when tracking each microdroplet, NCAST image difference and clustering calculations can be performed based on the photos taken during each temperature cycling process to identify the position of each microdroplet and obtain the fluorescence intensity of the multiple microdroplets.
[0206] In one embodiment, the fluorescence curve of each microdroplet is obtained based on the fluorescence intensity value of each microdroplet in each temperature cycling process. Each fluorescence curve shows the curve change process of one useful piece of information, and is information added to the droplet sample so as to be monitored in real time, and the mutual influence between adjacent droplets can be eliminated by a predetermined algorithm. The fluorescence intensity value of each point of each microdroplet is calculated for each temperature cycling process, and the sum is obtained as the fluorescence intensity value of each microdroplet at a predetermined timing.
[0207] In one embodiment, a method may be used in which a part of the fluorescence intensity value of each microdroplet at a predetermined timing is added so that the edge portions of adjacent microdroplets are not affected by each other. In each temperature cycling process, the circumstances in which the multiple microdroplets all change during the cycling process are obtained based on the fluorescence intensity values of the multiple microdroplets, and a fluorescence curve of each microdroplet is obtained. In one embodiment, the microdroplets are circulated 45 times to obtain 45 fluorescence images. Each microdroplet in the 45 fluorescence images is positioned to obtain 45 fluorescence intensity values of each microdroplet, and a fluorescence curve of each microdroplet is obtained.
[0208] In one embodiment, in S4320, a joint binomial distribution function f(c) for a concentration c of a nucleic acid amplification reaction solution to be detected is constructed as follows:
number
[0209] In single-volume digital PCR, if the volume of each microdroplet is v and the nucleic acid concentration of the nucleic acid amplification reaction solution to be detected is c, the average amount of DNA contained in each microdroplet is vc. If the number of molecules contained in each microdroplet is k, the probability distribution P of k can be estimated using the Poisson distribution probability model as follows:
number
[0210] For k=0, i.e., for negative microdroplets that do not contain target DNA molecules, the above equation can be rewritten as:
number
[0211] For single volume digital PCR analysis, the probability of negative microdroplets can be inferred by the total number of microdroplets n and the negative microdroplets b. Therefore,
number
[0212] For a particular test result, the quantity b of negative microdroplets and the total number n are known. Thus, constructing a binomial equation gives:
number
number
[0213] In one embodiment, step S4330 includes: A step S4331 of deriving a derivative of the joint binomial distribution function f(c) to obtain a derivative of the joint binomial distribution function f(c); and step S4332 of setting the derivative of the joint binomial distribution function f(c) to 0 and acquiring the value of the nucleic acid amplification reaction solution concentration c when the joint binomial distribution function f(c) takes an extreme point.
[0214] Usually, when the derivative of the function is 0, the function value is taken as a maximum or minimum value. Since the binomial distribution contains only one maximum value, the solution when the derivative of the function is 0 is the most possible concentration value. When the joint binomial distribution function f(c) is taken as the maximum value, the corresponding most possible number of c is obtained.
[0215] In one embodiment, the joint binomial distribution function F(Λ) for the ln(c) in step S4340 is
number
[0216] Since the P function is more symmetrical for ln(c) than for c, the standard deviation σ of ln(c) is more statistically meaningful. By enforcing the condition that the concentration is positive, it has a relatively good accuracy when analyzing samples with low concentrations. To simplify the calculation, it is necessary to switch the corresponding parameters when calculating ln(c) and the corresponding standard deviation σ.
[0217] In one embodiment, step S4340 includes: Step S4341 of taking the logarithm of the function F(Λ) to obtain a function L(Λ); A step S4342 of deriving a first derivative of the function L(Λ) and setting the first derivative of the function L(Λ) to zero; A step S4343 of acquiring a standard deviation σ corresponding to ln(c); and obtaining a confidence interval for ln(c) based on the standard deviation σ corresponding to ln(c) at step S4344.
[0218] Taking the logarithm of the function F(Λ) and converting it as follows:
number
[0219] When the first derivative of L(Λ) is derived,
number
[0220] ln(θ i ) to -v i Instead of t i Let us denote the number of positive microdroplets in the i-th volume by b i =n i -t i So the equation for step 4 becomes
number
[0221]
number
[0222] In one embodiment, in S4343, the standard deviation σ is obtained based on the Fisher information I(Λ) of ln(c).
[0223] In one embodiment, in step S4343, the Fisher information I(Λ) of ln(c) is
number
[0224] For the standard deviation σ, the Fisher information I(X) of ln(c) is obtained by combining them. The corresponding Fisher information is given by the following formula, in which E[] denotes the expected value of the corresponding parameter.
number
[0225] In one embodiment, the standard deviation σ and confidence interval corresponding to the ln(c) are respectively
number
[0226]
number
[0227] From the above formula, the standard deviation σ and confidence interval corresponding to ln(c) can be obtained.
number
[0228] Based on the obtained ln(c) and the corresponding standard deviation σ and confidence interval, the nucleic acid concentration c of the nucleic acid amplification reaction solution to be detected can be obtained. From the standard normal distribution table, the corresponding value is obtained, and the confidence interval of ln(c) is obtained. Furthermore, since the nucleic acid concentration of the nucleic acid amplification reaction solution to be detected is c, the initial DNA copy number contained in the nucleic acid amplification reaction solution to be detected can be obtained.
[0229] Among them, the confidence interval is the inference space of a population parameter that is constructed by the statistics of a sample. In statistics, the confidence interval (CI) of a sample of one probability is a spatial inference for a certain population parameter of this sample. The confidence interval indicates the degree to which the true value of this parameter lies around the measurement result with a certain probability. The confidence interval indicates the degree of confidence in the measured value of the parameter being measured, i.e., the necessary "one probability" mentioned above.
[0230] The quantitative results of digital PCR must usually be presented in combination with a confidence interval and a confidence horizon. In digital PCR, the confidence interval indicates the degree to which the true concentration of the sample is located in the space around the measurement result λ with a certain probability, and this probability is called the confidence level. The two ends of the confidence interval are called the confidence limits.
[0231] Compared with single-volume digital PCR, the dynamic detection range of five orders of magnitude can be achieved with less than 200 microdroplets, and its performance is as good as that of single-volume digital PCR with 12,000 microdroplets, thus reducing the cost of the equipment and the cost of consumables. In addition, the special situation that the microdroplets have a uniform volume can be corrected so that the detection accuracy of the digital PCR detector 1 can be improved.
[0232] The digital PCR quantitative detection method solves the problem of false positive or false negative results. The sequencing platform sample has high throughput, so hundreds of samples can be detected simultaneously. In addition, multiple loci can be detected by different types of fluorescence, and the detection speed is fast and the cost of testing is reduced. The use of a digital PCR detector for microdroplet processing allows rare detection fragments to be separated from a large amount of complex background, greatly simplifying the operation steps, effectively saving preparation time and detection time, and the results can be read intuitively, reliably, and stably. The detection sensitivity and accuracy are both accurate, meeting the quantitative requirements, and improving the detection sensitivity and accuracy.
[0233] In the actual process, the different volume digital PCR quantitative analysis method can detect the initial DNA concentration in the multiple microdroplets with high accuracy without relying on a standard curve. The digital PCR detector 1 determines what the actual ratio corresponding to each pixel of the fluorescent image is in the imaging system. Based on the fluorescent image, the number of pixels corresponding to the diameter of the microdroplets is extracted, and the microns corresponding to the diameter are obtained, so that the diameter of the microdroplets can be calculated.
[0234] The digital PCR quantitative detection method can dynamically track the multiple microdroplets. In the step of subjecting the multiple microdroplets to temperature cycling, the specific position corresponding to each microdroplet can be determined, and the entire process of amplifying nucleic acid can be monitored. Therefore, the digital PCR quantitative detection method can solve the problem of the multiple microdroplets having false positives. In addition, processing the fluorescence curves of the multiple microdroplets can obtain true absolute quantification without relying on statistical corrections that are performed due to uniformity.
[0235] In addition to being able to escape the reliance on the standard curve, it also solves the problem that the quantitative results are not definite due to the standard curve, and it also solves the limitations of the end-point detection method in droplet digital PCR, and it also breaks the restriction of estimating parameters for the entire sample to be detected using only one data of P(x=0). The real-time fluorescent quantitative PCR detection method improves the accuracy of digital PCR quantitative detection.
[0236] The digital PCR quantitative detection method can achieve reproducibility and high sensitivity through the abstract mathematical model, and the dynamic range is large, so that monitoring can be achieved with a small amount of droplets. A small amount of data can cover a large amount of information. In addition, the digital PCR quantitative detection method avoids the errors of the Poisson distribution probability model to achieve absolute quantification, which is more intuitive. All data is integrated to eliminate random errors. The fluorescence curve of the droplet sample is obtained, the changes in the fluorescence brightness of the droplet sample are monitored in real time, false positives are eliminated, and the mutual influence between adjacent droplets is eliminated, and then a more accurate data source is provided for the quantitative analysis model.
[0237] The sample DNA to be detected is used as a template, and a detection primer and its probe corresponding to the sample DNA to be detected are added. The Taqman fluorescent probe is used in the real-time fluorescent quantitative PCR detection method.
[0238] A reagent kit for quantitative detection of nucleic acid of human cytomegalovirus is provided, which includes primers and probes for real-time fluorescent quantitative detection of human cytomegalovirus DNA.
[0239] The positive quality control (non-standard concentration) with a concentration of 10^6 copies / mL in the reagent kit is diluted proportionally to obtain concentrations of 10^6 copies / mL, 10^5 copies / mL, 10^4 copies / mL, and 0.5x10^4 copies / mL. Five sample concentrations of 2x10^6 copies / mL, 10^6 copies / mL, 10^5 copies / mL, 10^4 copies / mL, and 0.5x10^4 copies / mL are also prepared. Among them, the ratio of the reagents for the sample to be detected is 1ul of sample (2ul of sample added to 2x10^6 copies / mL), 1ul of DNA polymerase, and 20ul of buffer, totaling 22ul.
[0240] Samples with the above sample concentrations of 2 x 10^6 copies / mL, 10^6 copies / mL, 10^5 copies / mL, 10^4 copies / mL and 0.5 x 10^4 copies / mL were detected using the digital PCR detector, QX200 digital PCR detector and qPCR digital PCR detector provided in the present application, respectively, and a comparison table was obtained between the detection values of the initial copy numbers of the five nucleic acid amplification reaction solutions by each device and the correlation coefficients of the true values, as shown in Table 1.
[0241] [Table 1]
[0242] The correlation coefficient R is a statistical index showing the strength of correlation between parameters, and measures the linear relationship between two parameters. From Table 1, it can be seen that the correlation coefficient between the detected value and the true value of the initial copy number of the five nucleic acid amplification reaction solutions detected by the digital PCR detector provided by the present application is the largest and closest to 1. Therefore, the digital PCR detector 1 provided by the present application has higher detection accuracy and higher precision.
[0243] The digital PCR detector 1 integrates the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30 and the quantitative analysis device 40, and the integrated digital PCR detector 1 controlled by the controller 50 enables the operator to automatically operate the detector, improving work efficiency, speeding up the reaction, and providing good reproducibility, high sensitivity, strong specificity, and clear results.
[0244] The conventional digital PCR detection method has problems of being labor intensive, time consuming, and low in efficiency, but the present invention provides a simple and highly efficient digital PCR detection method.
[0245] Referring to FIG. 19, the digital PCR detection method provided by the present application includes: Step S10 of preparing a nucleic acid amplification reaction solution to be detected; A step S20 of forming a matrix of microdroplets by forming the nucleic acid amplification reaction solution to be detected into microdroplets; a step S30 of subjecting the matrix of microdroplets to a polymerase chain reaction and obtaining a fluorescence curve for each microdroplet and a dissolution curve for each microdroplet in the matrix of microdroplets; and a step S40 of analyzing the matrix of microdroplets based on a fluorescence curve of each microdroplet and a dissolution curve of each microdroplet in the matrix of microdroplets to obtain information on the nucleic acid to be detected.
[0246] When preparing the reaction solution for nucleic acid amplification to be detected, the use of saturated fluorescent dyes can classify different types of mutations, provide high resolution and sensitivity, and reduce the cost of detection by digital PCR detectors. Moreover, the digital PCR detection method performs a polymerase chain reaction (PCR) on the matrix of microdroplets using a highly integrated digital PCR detector, and after the PCR of the matrix of microdroplets is amplified, the PCR product is analyzed by a melting curve. In the process of performing a polymerase chain reaction on the matrix of microdroplets, a fluorescence curve of each of the microdroplets is obtained. After the PCR amplification of the matrix of microdroplets is completed, the melting curve of each of the microdroplets in the circulation process is obtained while circulating again at high and low temperatures. According to the digital PCR detection method, by obtaining a fluorescence curve and a melting curve for the matrix of microdroplets, it is possible to seamlessly perform both real-time monitoring of PCR amplification throughout the entire process and analysis of the melting curve of the PCR product. Furthermore, based on the fluorescence curve and dissolution curve of the microdroplet matrix, genotyping and classification can be realized based on the dissolution curves of different shapes, and qualitative and quantitative analysis of the microdroplet matrix can be realized, thereby making digital PCR detection more comprehensive, simple and efficient.
[0247] In one embodiment, in step S10, the nucleic acid amplification reaction solution contains a nucleic acid template to be detected, a reaction buffer solution, deoxyribonucleoside triphosphates, primers, polymerase, and a product marker substance, etc. The thermostable DNA polymerase may be FastStart Taq DNA polymerase, Ex Taq, Z-Taq, AccuPrime Taq DNA polymerase, HS Taq DNA polymerase, etc.
[0248] Among them, the nucleic acid amplification reaction solution may be a nucleic acid amplification reaction solution (also called a DNA amplification reaction solution) using deoxyribonucleic acid (DNA) as a template, a reverse transcription nucleic acid amplification reaction solution (also called an RNA reverse transcription reaction solution) using complementary deoxyribonucleic acid (cDNA), i.e., ribonucleic acid (RNA) as a template, or other nucleic acid amplification reaction solutions such as a loop-mediated isothermal amplification (LAMP) reaction solution, among which the DNA amplification reaction solution is characterized in that it contains dNTPs, buffer solution, inorganic salt ions, polymerase, primers, a DNA template to be detected, dye, etc., which are necessary for amplifying DNA. The dye in the reaction solution may be a fluorescent dye that can indicate nucleic acid amplification and is bound to DNA, such as SYBR Green.
[0249] In one embodiment, a set of reagents and solutions are prepared for use only in digital PCR to reduce or avoid potential contamination of the template DNA sample with exogenous DNA. All equipment and consumables used should be sterilized at high temperature and dried at high temperature.
[0250] In one embodiment, when the nucleic acid amplification reaction solution to be detected is prepared, the nucleic acid amplification reaction solution to be detected is marked with SYBR Green fluorescent dye. Since SYBR Green fluorescent dye can bind to all double-stranded DNA, there is no need to select a template, and it is inexpensive and applicable to detecting a wide variety of products. Analysis by melting curve is generally used when SYBR Green is used as a fluorescent dye. This is because SYBR Green dye is a non-specific dye, and if there is amplification, the dye binds to double-stranded DNA, so the fluorescence is greatly enhanced. The purpose of modifying the fluorescent signal and creating a temperature diagram to form a melting curve is to observe whether the fragment that emits fluorescence due to amplification is the target gene for detection required during digital PCR detection. If the created melting curve has only a single peak, the pip position is the annealing temperature, and if it corresponds to a narrow peak, the product is a product of PCR amplification specificity. On the other hand, if the peak position is incorrect or corresponds to a wide peak, the product does not have specificity, or the corresponding product is not designed. In addition, if a small peak exists beyond the peak of the melting curve, it may be a primer dimer, so it is necessary to redesign the primer, etc. A high-resolution melting curve indicates that there has been a change in the nucleotide if there is a slight change in temperature or the shape of the curve. By repeatedly analyzing the melting curve of the matrix for a large number of microdroplets, typing into a nucleic acid sequence can be automatically realized based on a matching program of intensive curve analysis.
[0251] 20, in one embodiment, in step S20, the nucleic acid amplification reaction solution to be detected is made into droplets to form a matrix of droplets, the matrix of droplets including a large number of droplets.
[0252] In one embodiment, a digital PCR detector 1 is provided, which includes a microdroplet generating device 10, a temperature control device 20, a fluorescent signal detecting device 30, a quantitative analysis device 40, and a controller 50.
[0253] The microdroplet generating device 10 is used to make the nucleic acid amplification reaction liquid into microdroplets, form a matrix of the microdroplets, and form a matrix of the microdroplets in a microdroplet container, thereby simultaneously detecting multiple types of target sequences. The temperature control device 20 is used to amplify nucleic acid by temperature cycling. The fluorescent signal detection device 30 is disposed opposite to the temperature control device 20, and is used to collect matrix signals from the microdroplets in which nucleic acid has been amplified. The quantitative analysis device 40 is connected to the fluorescent signal detection device 30 via a data line, and is used to transmit matrix fluorescent information of the microdroplets for quantitative analysis. The controller 50 is connected to the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30, and the quantitative analysis device 40, respectively, and is used to control the microdroplet generating device 10, the temperature control device 20, the fluorescent signal detection device 30, and the quantitative analysis device 40.
[0254] When the digital PCR detector is in operation, the microdroplet generating device 10 can make the nucleic acid amplification reaction liquid to be detected into microdroplets and form the microdroplet matrix. The microdroplet matrix includes a large number of microdroplets. The temperature control device 20 performs nucleic acid amplification on the microdroplet matrix. The fluorescent signal detection device 30 collects the fluorescence change image of the microdroplet matrix in real time. The temperature control device 20 causes the microdroplet matrix to undergo a nucleic acid amplification reaction, and the fluorescent signal detection device 30 collects product signals of the microdroplet matrix subjected to the nucleic acid amplification reaction, such as signals of fluorescence, ultraviolet absorption, turbidity, etc. Due to the difference in the configuration between the multiple amplified microdroplets and the unamplified microdroplets, the number of droplets in which target sequence amplification has been obtained can be analyzed, and quantitative analysis of nucleic acid molecules can finally be realized. By monitoring the change in the signal of the matrix of the microdroplets in real time, the detection result can be made direct, and the problem of false positives and false negatives of the microdroplet matrix can be solved.
[0255] The microdroplet matrix is generated in the microdroplet container by the microdroplet generating device 10, and falls to the bottom of the microdroplet container and piles up irregularly. The microdroplet matrix produced by the microdroplet generating device 10 is concentrated at the center of the microdroplet container during the downward falling process. At this time, it is necessary to lay a plurality of the microdroplet matrices on the bottom of the microdroplet container before collecting the signal of the microdroplet matrix.
[0256] In one embodiment, before collecting signals of the matrix of the microdroplets, the temperature control device 20 performs high and low temperature to spread the matrix of the microdroplets on the bottom of the microdroplet container. First, the temperature of the matrix of the microdroplets is increased. Next, the temperature of the matrix of the microdroplets is decreased. Again, the matrix of the microdroplets is circulated at high and low temperatures until the matrix of the microdroplets is spread on the bottom plate of the microdroplet container. Finally, the matrix of the microdroplets is spread in the microdroplet container, and PCR amplification is performed on the spread matrix of the microdroplets, and detection is performed by photography.
[0257] In one embodiment, the microdroplet generating device 10 can generate multiple microdroplets of uniform volume. The size of each of the microdroplets is on the order of microns. When the multiple microdroplets have uniform volumes, the multiple microdroplets can be quantitatively analyzed based on the fluorescence information of the multiple microdroplets.
[0258] In one embodiment, step S30 includes: Step S310 of configuring temperature parameters, time parameters and cycle times of the polymerase chain reaction; a step S320 of polymerase chain reaction of the matrix of microdroplets based on the temperature parameters and the time parameters, sequentially cycling the matrix the number of times, and acquiring a fluorescence curve for each of the microdroplets for each cycling step; and step S330 of lowering the temperature of the matrix of microdroplets amplified by polymerase chain reaction and then raising the temperature at regular intervals to obtain a melting curve of each of the microdroplets.
[0259] PCR consists of three basic reaction steps: denaturation, annealing, and extension. The denaturation of the template DNA means that the template DNA is heated to 90-95°C for a certain period of time, and then the double strand of the template DNA or the double strand DNA formed through PCR amplification is dissociated into a single strand so that it binds with the primer and prepares for the next reaction. The annealing of the template DNA and primer means that the template DNA is heated to denature into a single strand, and then the temperature is lowered to 50-60°C so that the primer and the complementary sequence of the template DNA single strand bind. The extension of the primer means that the DNA template and primer combined product is synthesized by the action of DNA polymerase at 70-75°C using dNTP as a reaction material and the target sequence as a template, based on the principle of base sequence pairing and semi-conservative replication, to create a semi-conservative replication strand that is complementary to a new template DNA strand. By cycling through the three steps of denaturation, annealing and extension, many "semi-conservatively replicated strands" can be obtained, and these new strands can be used as templates for the next cycle. One cycle takes 2-4 minutes, so the target gene to be amplified can be amplified millions of times in 2-3 hours.
[0260] Among them, the annealing temperature is a relatively important factor that affects the specificity of PCR. If the temperature after denaturation is rapidly cooled to 40℃-60℃, the primer and template can be bound. Since the template DNA is much more complex than the primer, the chances of the primer colliding with the template and binding are much higher than those of the template complementary strand. The annealing temperature and time are determined by the length, base composition and concentration of the primer, and ultimately the length of the target sequence.
[0261] In step S310, the matrix of microdroplets is cycled through three steps of denaturation, annealing and extension about 30 to 50 times in the presence of primers, a DNA sample to be detected and a thermostable DNA polymerase, thereby performing PCR. The number of cycles is generally set to cycle through the three steps of denaturation, annealing and extension 30 to 50 times. The temperature parameter is generally set to 40°C to 95°C, and the time parameter may be determined according to a specific process.
[0262] In one embodiment, step S320 includes: a step S321 of polymerase chain reaction of the matrix of the microdroplets based on the temperature parameters and the time parameters, and acquiring a fluorescent image of the matrix of the microdroplets; A step S322 of sequentially cycling the number of times and acquiring all of the fluorescent images of the matrix for the microdroplets in the polymerase chain reaction process; A step S323 of acquiring fluorescence information of each of the microdroplets for each circulation step based on all of the fluorescence images of the matrix of the microdroplets; and step S324 of acquiring a fluorescence curve of each of the microdroplets based on the fluorescence information of each of the microdroplets for each circulation step, and acquiring a fluorescence curve of the matrix of the microdroplets.
[0263] In step S321, First, the matrix of the microdroplets is heated to 95° C. for 4 minutes so that the enzyme in the matrix of the microdroplets is hot-started, and the matrix of the microdroplets is denatured for 1 minute after the enzyme in the matrix of the microdroplets is hot-started; Next, after the matrix of the microdroplets is denatured, the temperature is lowered to 55° C. and annealed for 1 minute so that the primer and the DNA template are bound to form a partial double strand, and then the matrix of the microdroplets is photographed by the fluorescent signal detection device 30 to obtain a fluorescent image of the matrix of the microdroplets in the first circulation. and then heating the matrix of microdroplets to 70° C. and elongating for 7 minutes. Finally, the above three steps of denaturation-annealing-extension are cycled 45 times in sequence according to the number of cycles, and when 45 cycles are completed, the temperature is lowered to 4°C and the multiple microliquids are stored.
[0264] In one embodiment, the temperature control device 20 heats and cools the matrix of microdroplets, arranging the circulation number to be 45, and then for each microdroplet, 45 fluorescence images can be obtained in 45 circulation steps. Each microdroplet is circulated 45 times to obtain 45 fluorescence images. Each microdroplet is positioned in the 45 fluorescence images, and 45 fluorescence intensity values are obtained for each microdroplet to obtain a fluorescence curve for each microdroplet.
[0265] In one embodiment, step S323 includes first obtaining a fluorescence intensity value of each of the PCR-amplified microdroplets based on each fluorescence image, then obtaining a fluorescence curve of each of the PCR-amplified microdroplets based on the fluorescence intensity value of each of the PCR-amplified microdroplets, and finally obtaining all of the fluorescence curves of the PCR-amplified microdroplets, i.e., the fluorescence curve of the microdroplet matrix, based on the fluorescence curve of each of the PCR-amplified microdroplets.
[0266] Referring to Fig. 21, in one embodiment, a fluorescent image of the matrix of microdroplets is collected and image tracking is performed. When obtaining the fluorescent curve of each matrix of microdroplets, it is necessary to locate each of the microdroplets in each image and obtain the fluorescent intensity of each of the microdroplets. In the digital PCR detector, the imaging system is determined as to what is the actual ratio corresponding to each pixel of the fluorescent image. Based on the fluorescent image, the number of pixels corresponding to the diameter of the microdroplets is extracted, and the microns corresponding to the diameter are obtained, so that it can be calculated as to what is the diameter of the microdroplets.
[0267] In one embodiment, when tracking each of the microdroplets, NCAST image difference and clustering calculations may be performed based on the images collected at each temperature cycling step to identify the position of each of the microdroplets and obtain the fluorescence intensity of the matrix of the microdroplets.
[0268] In one embodiment, when the distance traveled by a microdroplet in one temperature cycling step is equal to or less than the diameter of one microdroplet, the microdroplet is tracked in the following manner. Wherein, when tracking each of the micro-droplets, the step of tracking the image of each of the micro-droplets includes: First, the photographs taken at each temperature cycling step are identified, and the center position of each microdroplet is obtained; Next, comparing the currently identified center positions of each microdroplet with the center positions of each microdroplet in the previous circulation step; Finally, if the distance between the center position of each currently identified microdroplet and the center of the center position of each microdroplet during the previous circulation step is less than one microdroplet diameter, they are indicated as the same microdroplet.
[0269] 22, in one embodiment, a fluorescence curve of each of the microdroplets is obtained based on the fluorescence intensity value of each of the microdroplets in each temperature cycling step. The sum of the fluorescence intensity values of each part of each of the microdroplets is calculated for each temperature cycling step, and the sum is obtained as the fluorescence intensity value of each microdroplet at a predetermined timing.
[0270] In one embodiment, a method may be used in which the fluorescence intensity values of each microdroplet at a predetermined timing are added together so as not to affect the edge portions of adjacent microdroplets. For each temperature cycling step, the circumstances under which all of the multiple microdroplets change to the cycling step are obtained based on the fluorescence intensity values of the multiple microdroplets, and the fluorescence curve of each microdroplet is obtained.
[0271] In one embodiment, step S330 includes: Step S33: lowering the temperature of the matrix of microdroplets amplified by the polymerase chain reaction to 40° C. or less; Step S332: increasing the temperature of the microdroplet matrix, which has been cooled to 40° C. or less, at a certain temperature interval and acquiring a fluorescent image of the microdroplet matrix corresponding to the temperature interval; a step S333 of acquiring fluorescence information of each of the microdroplets corresponding to the temperature intervals based on a fluorescence image of the matrix of the microdroplets corresponding to the temperature intervals; and S334: obtaining a dissolution curve for each of the microdroplets based on the fluorescence information of each of the microdroplets corresponding to the temperature interval, and obtaining a dissolution curve for the matrix of the microdroplets.
[0272] After the PCR amplification reaction is completed, the temperature is continuously increased and the fluorescent signal is monitored at each step to generate a melting curve. Different DNA has different temperature melting curves, so that the fluorescent dye is restored to a free state by the denaturation of double-stranded DNA during the reaction, and the fluorescent signal decreases. Then, a graph is created showing the change in the fluorescent signal with the change in temperature. The amplified product dye method requires the formation of a melting curve. This is because the specificity of the dye method is poor, so the melting curve can be used to confirm whether the amplified product is the target product. There is a characteristic peak at the melting temperature, and this characteristic peak can be used to separate the specific product from other products, such as primer dimers or non-specific products.
[0273] In step S332, after the PCR amplification, the melting curve of the PCR product is analyzed, and PCR amplification and the analysis of the melting curve of the PCR product are seamlessly performed. In step S332, the temperature is lowered to 40° C. or less by the temperature control device 20, and the temperature is raised to 95° C. in 0.1° C. intervals, and the fluorescence signal detection device 30 takes an image once each time the temperature is raised to 95° C. by 0.1° C. for each interval. After the image is taken, the temperature of the microdroplet matrix is lowered to 4° C., and the microdroplet matrix is stored.
[0274] In one embodiment, the method of processing the fluorescence images when obtaining the fluorescence curve for each of the microdroplets is the same as the method of processing the fluorescence images when obtaining the dissolution curve for each of the microdroplets.
[0275] In step S333, based on the fluorescent images collected at 0.1°C intervals, the fluorescent intensity corresponding to each of the microdroplets is obtained, and a curve relating to temperature and fluorescent intensity is drawn to obtain a peak diagram including a peak at the first derivative.
[0276] A dissociation curve is a curve that indicates the degree to which the double helix structure of DNA decomposes with increasing temperature. Analysis of the dissociation curve allows the identification of different reaction products, including non-specific products. The temperature at which the entire double helix structure of DNA is half degraded is called the dissociation temperature (Tm), and different sequences of DNA have different Tm values. In other words, the dissociation curve of a DNA can be said to be a fingerprint of a DNA, and corresponds to a specific DNA. Based on the dissociation curve diagram, the temperature at which the peak is located indicates the Tm value (dissociation temperature) of the double-stranded DNA molecule. Based on the Tm value of the amplified product, its genotype can be determined. The Tm of a DNA fragment is determined by its length, G+C composition, sequence, strand complementarity, concentration and buffer region components (e.g., salts, dyes and PCR enhancers).
[0277] Each melting curve indicates the case where the product is single in each of the microdroplets, and if a melting curve has a single peak and is located in a certain reasonable temperature range (generally 80 to 90°C), it is considered normal. On the other hand, if the melting curve has a double peak, it may correspond to non-specific amplification. Then, it can be determined whether the product is the target gene or is single.
[0278] Upon analysis of the high-resolution melting curves of each of the microdroplet matrices, single nucleotide polymorphisms and scanning mutations can be detected.
[0279] In one embodiment, during the digital PCR detection process, the fluorescent signal detection device 30 collects images of the matrix of microdroplets.
[0280] The micro-droplet container is irradiated with light from above at an oblique angle. The fluorescent signal detection device 30 periodically performs two-dimensional scanning on the matrix of micro-droplets and collects images in real time. The internal fluorescence of the matrix of micro-droplets in the micro-droplet container is excited and collected by the objective lens of the fluorescent signal detection device 30 and enters a camera, which collects a fluorescent image of the matrix of micro-droplets.
[0281] The fluorescent signal detection device 30 images the matrix fluorescence of the microdroplets, and captures a certain number of fluorescent images of the microdroplets only once, and then automatically identifies the droplet fluorescence in the image based on image processing technology to obtain the fluorescent information of the droplets.
[0282] The fluorescent signal detection device collects fluorescent information from the matrix of the microdroplets containing fluorescent substances through a fluorescent sensing assembly, and the detected fluorescent information is transmitted to a computer in the form of a fluorescent image for quantitative analysis.
[0283] In one embodiment, step S40 includes: Step S410: obtaining an initial copy number of nucleic acid in the matrix of microdroplets based on a fluorescence curve of the matrix of microdroplets; and step S420 of acquiring nucleic acid information of the matrix of the microdroplets based on a dissolution curve of the matrix of the microdroplets.
[0284] In one embodiment, step S410 includes: Step S411, obtaining the fluorescence curve and corresponding Ct value of each of the microdroplets based on the fluorescence curve of the matrix of the microdroplets; By clustering the Ct values of the fluorescence curves of the respective microdroplets, the Ct values are successively clustered in descending order as x1, x2, ..., x n A step S412 of acquiring a classification of the Said x1, x2,..., x n Based on the classification, the numbers y1, y2, ..., y of the microdroplets corresponding to each classification are n Step S413 of acquiring The numbers of the microdroplets corresponding to each category y1, y2, ..., y n Based on the x1, x2, ..., x n The numbers of the microdroplets y1, y2, ..., y n Step S414 of acquiring a frequency distribution of and calculating an initial copy number of nucleic acid in the matrix of microdroplets based on the frequency distribution S415.
[0285] When the PCR cycle reaches the cycle number where the Ct value exists, the PCR cycle has just entered the true exponential amplification phase (logarithmic phase), so the minute errors have not yet been magnified at this time, and the reproducibility of the Ct value is very good, that is, the Ct value obtained by amplifying the same nucleic acid template at different times, or amplifying in different microdroplet containers at the same time, is constant. If the fluorescence curve corresponding to the microdroplet is an amplification curve, it indicates that the microdroplet contains a target gene component. If the fluorescence curve corresponding to the microdroplet is a straight line, it indicates that the microdroplet does not contain a target gene component.
[0286] Based on the acquired real-time fluorescence curve, a Ct value is obtained. When a Ct value is acquired for each microdroplet, a derivative is derived from the real-time fluorescence curve. The initial number of cycles of the fluorescence curve at which the slope of the real-time fluorescence curve is constant is the required Ct value.
[0287] In one embodiment, in the step S411, first, a derivative is derived for the fluorescence curve of each PCR-amplified microdroplet to obtain the slope of the fluorescence curve of each PCR-amplified microdroplet. Next, a value that does not change is obtained from the slope of the fluorescence curve of each PCR-amplified microdroplet by the slope of the fluorescence curve of each PCR-amplified microdroplet. Furthermore, next, the corresponding initial cycle number is obtained as the Ct value of each PCR-amplified microdroplet by the value that does not change. Finally, all Ct values of the PCR-amplified microdroplets are obtained by the Ct value of each PCR-amplified microdroplet.
[0288] In one embodiment, in step S411, first, the missing value of the fluorescence threshold of each PCR-amplified microdroplet is obtained by the fluorescence curve of each PCR-amplified microdroplet. Next, the missing value of the fluorescence threshold of each PCR-amplified microdroplet is obtained as the Ct value t of each PCR-amplified microdroplet according to the missing value. Furthermore, next, all the Ct values of the PCR-amplified microdroplets are obtained by the Ct values of each PCR-amplified microdroplet.
[0289] In the Ct value, C indicates cycle and t indicates threshold, and the Ct value means the number of cycles that have elapsed until the fluorescent signal in each reaction tube reaches a predetermined threshold value.
[0290] In one embodiment, the first 15 cycled fluorescent signals during PCR reaction are taken as the fluorescent background signal, and 10 times the standard deviation (SD) of the 3-15 cycled fluorescent signals are taken as the fluorescence threshold, i.e., threshold = 10 × SD cycle 3-15According to the missing value of the fluorescence threshold, the corresponding number of rounds is obtained as the Ct value. The relationship between the Ct value and the initial DNA concentration is that the higher the initial copy number, the smaller the Ct value.
[0291] In step S412, clustering is performed based on the Ct value of the fluorescence curve of each of the microdroplets, and the microdroplets are sorted in descending order of size, x2, ..., x n The classification of the x1 type is obtained. Among them, the classification of the dark droplets in the microdroplet matrix is x1, that is, the classification of the droplets that do not contain the initial copy number of nucleic acid in the microdroplet matrix is x1. Since the Ct value is smaller as the initial copy number of nucleic acid is larger, the Ct value corresponding to the dark droplets (negative droplets) is infinite at this time, that is, the Ct value corresponding to the x1 type is also infinite. By analogy, the initial copy number of nucleic acid corresponding to the x2 type is 1, the initial copy number of nucleic acid corresponding to the x3 type is 2, the initial copy number of nucleic acid corresponding to the x4 type is 3, and the initial copy number of nucleic acid corresponding to the x5 type is 4.
[0292] In one embodiment, in step S415, when the number y1 of the microdroplets classified into the x1 category is greater than or equal to the feature value m, a Poisson distribution is fitted based on the frequency distribution to obtain a parameter λ of the Poisson distribution, and the initial copy number of nucleic acid in the matrix of the microdroplets is obtained.
[0293] Wherein, the range of the characteristic value m is located at 0.5%-10% of the total number of the microdroplets in the matrix of the microdroplets.
[0294] In one embodiment, the characteristic value m may be 5% of the total number of microdroplets.
[0295] When the number y1 of the microdroplets classified into the x1 category is equal to or greater than the characteristic value m, the number y1 of dark droplets in the matrix of microdroplets is equal to or greater than the characteristic value m. In this case, the number of dark droplets in the matrix of microdroplets plays a certain role in calculating the initial copy number of nucleic acid in the matrix of microdroplets as a whole, so that the numbers y1, y2, ..., y n The frequency distribution is fitted with a Poisson distribution to obtain the parameter λ of the corresponding Poisson distribution.
[0296] In digital PCR, if the initial DNA copy number contained in a microdroplet is x, then based on mathematical statistics theory, the probability distribution function P of x = k (k = 0, 1, 2, 3 ...) satisfies the Poisson probability model, of which λ is the average molecular copy number contained in the microdroplet.
number
[0297] Therefore, the expected value μ and variance σ in the Poisson distribution model 2 Therefore, the expected value μ is λ and the variance is σ 2 Therefore, since the number of copies of the target DNA molecule contained in each microdroplet in digital PCR is λ, it can be seen that the λ value can be calculated to realize quantitative detection of nucleic acid.
[0298] In droplet PCR, the initial copy number contained in a droplet satisfies the Poisson distribution.
number
[0299] The initial copy number of nucleic acid in the matrix of microdroplets is then λ multiplied by the number of the microdroplets in the matrix of microdroplets.
[0300] Regarding the nucleic acid amplification reaction solution to be detected, if its total volume is V (the volume of each microdroplet is v), the concentration c (copy / μL) of the nucleic acid amplification reaction solution to be detected is
number
[0301] In one embodiment, in step S415, when the number y1 of the micro-droplets in the category x1 is smaller than the feature value m, Said x2,..., x n The number of microdroplets corresponding to each of the classes y2, ..., y n Based on the frequency distribution of a part of the above, the classification of x2 and the corresponding initial copy number of the nucleic acid are sequentially fitted with a Poisson distribution, and the corresponding parameter λ of each Poisson distribution is j Step S4151 to obtain (j=0, 1, 2....); The residual sum of squares of the frequency values, err, is minimized, and λ optima To obtain l optimally, we set a space [λ min , λ max ] to λ j In step S4152, The optimal λ optima and step S4153 of calculating the initial copy number of nucleic acid in the matrix of the microdroplets based on l.
[0302] When the number y1 of the microdroplets in the x1 category is smaller than the feature value m, the number of dark droplets in the matrix of microdroplets is not useful for calculating the total initial copy number of nucleic acid in the matrix of microdroplets and may be ignored.
[0303] For a 20,000 droplet system, it is generally recommended that the DNA concentration of the sample be 6 CPD or less.
[0304] In the actual test process, when k>4, the Ct value division becomes small, and it is difficult to distinguish whether the initial copy number of one droplet is 4 or 5 based on the Ct value. n We perform incomplete sampling by classification and fit the data to a Poisson distribution.
[0305] In one embodiment, a space [λ min , λ max ] and set [λ min , λ max ] space and find the optimal λ optimal is selected to minimize the sum of squared residuals.
[0306] In one embodiment, when obtaining the parameter λ of the Poisson distribution, the maximum likelihood estimation method is used to estimate the parameter λ.
[0307] In one embodiment, the method for inferring the parameter λ may be the method of moments, the order statistics method, or the maximum likelihood estimation method.
[0308] This method does not require a specific number of dark droplets to be considered negative, and is much more accurate and stable than guessing using a single frequency alone.
[0309] In step S4153, the initial copy number of nucleic acid in the matrix of the microdroplets is determined by the optimal λ optimal multiplied by the number of said microdroplets in said matrix of microdroplets.
[0310] In one embodiment, with an incomplete sample, the least squares method is used to obtain a point estimate of the Poisson distribution parameter λ.
[0311] In practical steps, the digital PCR quantitative detection method can detect the initial DNA concentration in the multiple microdroplets with high accuracy without relying on a standard curve.
[0312] In addition, the digital PCR quantitative detection method can solve the problem of false positives in the multiple microdroplets, and by processing the fluorescence curves of the multiple microdroplets, true absolute quantification can be obtained without relying on statistical corrections due to hypothetical uniformity.
[0313] In addition to eliminating the need for a standard curve, the method also resolves the problem of indeterminate quantitative results based on the standard curve, and overcomes the limitations of the end-point detection method of droplet digital PCR, breaking the constraint of estimating parameters for the entire sample to be detected based on only one P(x=0) data. The use of the real-time fluorescent quantitative PCR detection method improves the accuracy of quantitative detection in digital PCR.
[0314] The digital PCR quantitative detection method eliminates the need to ensure the number of blank droplets that are considered negative. In addition, when multi-dimensional frequency distribution data is used, the accuracy and stability of estimating the optimal parameters for the whole sample is much higher than that of estimating the optimal parameters using only one P(x=0) data.
[0315] Each fluorescence curve represents the change process of a curve of useful information, which is the information added to the droplet sample so as to be monitored in real time, and the mutual influence between adjacent droplets can be eliminated through a predetermined algorithm.
[0316] The digital PCR quantitative detection method can achieve reproducibility and high sensitivity through the abstract mathematical model, and the dynamic range is large, so that monitoring can be achieved with a small amount of droplets. A small amount of data can cover a large amount of information. In addition, the digital PCR quantitative detection method avoids the error of the Poisson distribution probability model to achieve absolute quantification, which is more intuitive. All data is integrated to eliminate random errors. The fluorescence curve of the droplet sample is obtained, the change in the fluorescence brightness of the droplet sample is monitored in real time, false positives are eliminated, and the mutual influence between adjacent droplets is eliminated, and then a more accurate data source is provided for the quantitative analysis model.
[0317] Referring to FIG. 23, the Poisson distribution is applied when the initial copy numbers of the partial nucleic acid are 0, 1, 2, and 3, respectively. The abscissa is the average initial copy number (copies per droplet, CPD) contained in each droplet. The ordinate is the standard deviation (Std Dev, STD) of the average initial copy number contained in each droplet. The average initial copy number contained in each droplet is represented by CPD (copies per droplet). It can be seen that the standard deviation of CPD for the average initial copy number contained in each droplet obtained by the initial copy number of the partial nucleic acid is smaller than the standard deviation of CPD for the average initial copy number obtained by other algorithms. Therefore, the value of CPD for the average initial copy number contained in each of the microdroplets obtained by the digital PCR detection method is more accurate. The result of simulating 20,000 droplets only 1,000 times is shown. If only a single-point estimation method is used, only a limited concentration range is covered, and the estimation accuracy also rapidly deteriorates as the concentration of the sample increases. However, when using the fitting algorithm with the incomplete Poisson distribution, the estimation accuracy does not change obviously with the increase in the sample concentration, and it is possible to double the concentration of the nucleic acid amplification reaction solution to be detected. When the number of droplets is relatively small, the fitting algorithm with the incomplete Poisson distribution (partial sampling Poisson distribution fitting algorithm) still has good accuracy.
[0318] The digital PCR quantitative detection method solves the problem of false positive or false negative results. The sequencing platform sample has high throughput, so hundreds of samples can be detected simultaneously. In addition, multiple loci can be detected by different types of fluorescence, and the detection speed is fast and the cost of testing is reduced. The microdroplet processing using the digital PCR detector can separate rare detection fragments from a large amount of complex background, greatly simplifying the operation and effectively saving preparation time and detection time, and has the advantages of being intuitive, reliable, and stable in reading the results, and the detection sensitivity and accuracy are both accurate, meeting the quantitative requirements, and improving the detection sensitivity and accuracy.
[0319] In one embodiment, step S420 includes step S421 of acquiring a melting temperature corresponding to the melting curve of each of the microdroplets based on the melting curve of the matrix of the microdroplets, and step S422 of classifying the microdroplets of the matrix of the microdroplets based on the melting temperature, acquiring nucleic acid information of the matrix of the microdroplets, and acquiring nucleic acid information of the nucleic acid to be detected.
[0320] Different sequences of DNA have different Tm values. In other words, the melting curve of one DNA can be said to be a fingerprint of one DNA, and corresponds to one specific DNA. Based on the melting curve diagram, the temperature at which the peak is located indicates the Tm value (melting temperature) of the double-stranded DNA molecule. Based on the Tm value of the amplified product, its genotype can be determined. By classifying similar melting curves and genotyping or classifying melting curves with different shapes and comparing them with the melting curve of the target gene, it is possible to non-specifically eliminate false positives and eliminate sequences different from the target gene.
[0321] In one embodiment, algorithms such as decision trees, Bayesian, artificial neural networks, K-nearest neighbors, support vector machines and association rule based classification, Bagging and Boosting may be used to classify the matrix of microdroplets according to their dissolution curves.
[0322] In one embodiment, the digital PCR detection method further includes a step S50 of obtaining a high-resolution melting curve of the matrix of microdroplets, classifying the microdroplets of the matrix of microdroplets, and obtaining nucleic acid information, such as genotyping or mutation detection, on the matrix of microdroplets.
[0323] From the dissolution curve, it is possible to obtain the specificity of the nucleic acid amplification of the microdroplet matrix and the presence or absence of a phenomenon called primer dimer in the nucleic acid amplification step.
[0324] The microdroplet matrix is used to obtain a high-resolution melting curve of the microdroplet matrix by detecting the change in the fluorescent signal value in real time during the process of dsDNA melting. The high-resolution melting curve is a new technology of genetic analysis in which different forms of melting curves are formed due to the different melting temperatures of mononucleotides. It has extremely high sensitivity, can detect differences in a single base, is low cost, has high throughput, is fast, has accurate results, is not limited by the detection locus, and can realize true "closed tube" operation. In cases such as mutation scanning, single nucleotide polymorphism analysis, methylation research, genotyping, and sequence matching, HRM analysis technology plays an important role. The thermal stability of double-stranded nucleotides is affected by their length and base composition, and changes in the sequence bring about changes in the unwinding behavior of dsDNA during the process of temperature increase. The fluorescent dye used only binds to dsDNA, so that the change in the fluorescent signal value can be detected in real time during the dsDNA melting process using real-time PCR technology, and the differences present in the PCR products can be intuitively represented in the form of different melting curve shapes. Furthermore, genotyping or classification of the test group can be realized according to the different melting curve shapes through specialized analysis software.
[0325] In one embodiment, in the step S20, a micro-droplet generating method with instantaneous acceleration motion or a micro-droplet generating method with periodically changing velocity may be used when forming the matrix of micro-droplets.
[0326] In one embodiment, in step S10, a saturation dye is used in the nucleic acid amplification reaction solution to be detected to analyze the product of the polymerase chain reaction.
[0327] In one embodiment, high resolution melting analysis (HRM) may be used to qualitatively classify and analyze a plurality of the microdroplets, and PCR reaction products may be analyzed using saturation dyes without the need for sequence-specific probes.
[0328] In one embodiment, there are three basic principles for primer design. First, the primer and template sequences must be closely complementary. Second, the formation of stable dimers or barrette structures between primers must be avoided. In addition, the primer must not cause DNA polymerization (i.e., mispolymerization) at non-target loci of the template. Specifically, in order to realize these three basic principles, many factors must be considered, such as the length of the primer, the length of the product, the sequence Tm value, the internal stability of the double strand formed by the primer and template, the energy value for forming primer dimers and barrette structures, the generation efficiency at the locus where mispolymerization occurred, and the GC content of the primer and product. In addition, for special detection, the primer may be modified, for example, by increasing the locus of the restriction endonuclease and inducing mutations.
[0329] The Tm value of the template sequence corresponding to the primer is about 72°C, which is the optimum annealing condition. For example, the formula for calculating the Tm value is Tm=4(G+C)+2(A+T), and there are many methods, such as the k-nearest neighbor method, used in the Oligo software.
[0330] Referring to FIG. 24, in one embodiment, a melting curve of the microdroplet matrix obtained by the digital PCR detection method is created, in which the negative first derivative of the fluorescent signal changes with temperature, and the temperature at which the peak is located indicates the Tm value (melting point temperature) of the double-stranded DNA molecule. The genotype can be determined only from the Tm value of the amplified product. Therefore, it can be seen that there are two melting temperatures, Tm1 and Tm2. The melting temperatures Tm1 and Tm2 correspond to two different types of DNA, respectively, and therefore the target DNA in the microdroplet matrix can be classified.
[0331] To solve the problem of the conventional PCR detection technology that the amount of work becomes huge and time-consuming because detection is repeated multiple times, the present invention provides nucleic acid detection microspheres, a manufacturing method, a reagent kit, and a high-throughput nucleic acid detection method for use in high-throughput nucleic acid detection analysis that can achieve high throughput, high sensitivity, and short detection time.
[0332] 25-27, the present application provides a nucleic acid detection microsphere 700 for detecting and analyzing nucleic acid with high throughput. The nucleic acid detection microsphere 700 includes a nucleolus 730 and a coating layer 710. The nucleolus 730 has fluorescent code information. The coating layer 710 coats the nucleolus 730, and the coating layer 710 includes a substrate 711 and a primer 712 dispersed on the substrate 711, and the primer 712 uniquely corresponds to the nucleolus 730.
[0333] Wherein, the coating layer 710 covers the nucleolus 730 to form the nucleic acid detection microsphere 700. The substrate 711 is a hydrophilic polymer gel formed in hydrophobic oil, which has no fluidity and is difficult to change shape and volume. The hydrophilic polymer gel is in a gel state at room temperature and dissolves at a temperature higher than room temperature, and does not affect the diffusion and activity of enzymes, reaction solutions, etc. At the same time, the primer 712 dispersed in the substrate 711 qualitatively analyzes and identifies the target detection nucleic acid. The nucleolus 730 is a heat-resistant material and has fluorescent code information. The fluorescent code information is represented by the fluorescent code signal of the nucleolus 730, so that the fluorescent code signal realizes a special mark function. Moreover, each nucleolus 730 corresponds uniquely to the primer 712, so that the nucleic acid detection microsphere 700 is marked by the nucleolus 730 and tracked for detection.
[0334] When PCR detection is performed, a nucleic acid detection solution is obtained by mixing a plurality of types of the nucleic acid detection microspheres 700 with the nucleic acid amplification reaction solution to be detected. The nucleic acid detection solution is made into droplets to form a plurality of microdroplets, and PCR reaction is performed on the microdroplets. In the PCR reaction process, the double-stranded DNA is denatured at 90°C to 95°C, and then rapidly cooled to 50°C to 60°C again, the primers anneal and bind to the target sequence, and the temperature is rapidly raised to 70°C to 75°C, and the primer chains are extended along the template by the action of Taq DNA polymerase, amplifying the nucleic acid in an appropriate temperature range. In the process of controlling the PCR temperature on multiple microdroplets, the coating layer 710 dissolves and decomposes, releasing the primers 712 contained in the coating layer 710 into the corresponding microdroplets, which react with the target nucleic acid molecules contained in the microdroplets, and finally locating, tracking and identifying the nucleoli 730, and the target nucleic acid molecules are identified through the primers 712 corresponding to the nucleoli 730, thereby realizing PCR high-throughput detection.
[0335] In practical application, multiple kinds of the nucleic acid detection microspheres 700 can be produced in batches. Multiple kinds of the nucleic acid detection microspheres 700 can be mixed into the nucleic acid amplification reaction solution to be detected according to a certain ratio according to the actual needs of detecting the target nucleic acid to obtain a nucleic acid detection solution for detecting the target nucleic acid, which can detect multiple kinds of target nucleic acid molecules only once, eliminating the need for repeated detection, resulting in less work, shorter detection time, and higher sensitivity.
[0336] 28-29, in one embodiment, the coating layer 710 further comprises a probe 713 , the probe 713 and the primer 712 are dispersed on the substrate 711 and uniquely correspond to the nucleolus 730 .
[0337] Among them, the probe 713 may be a fluorescent probe that indicates the amplification of nucleic acid, for example, an oligosaccharide nucleotide probe that simultaneously contains a fluorescent group and a quenching group, such as a TaqMan fluorescent probe. The probe 713 is dispersed in the substrate 711 and is used to qualitatively analyze and identify the target detection nucleic acid molecule. In the process of controlling a plurality of microdroplets at a PCR temperature, the coating layer 710 dissolves and decomposes, releasing the primer 712 and the probe 713 contained in the coating layer 710 into the corresponding microdroplets to react with the target detection nucleic acid molecule contained in the microdroplets, and finally realizing the positioning, tracking and identification of the nucleolus 730. In addition, the primer 712 and the probe 713 corresponding to the nucleolus 730 are used to find the target nucleic acid molecule, thereby realizing high-throughput PCR detection.
[0338] In one embodiment, the primers 712 may be arranged as different types of primers. When detecting in batch processing, multiple types of the primers 712 may be arranged as different types of primers, so that different types of target nucleic acid molecules can be detected. In addition, a certain type of the primers 712 corresponds to a certain type of the nucleolus 730, in other words, each of the primers 712 has a corresponding representative number of the nucleolus 730, so that they can be identified by detecting the nucleolus 730.
[0339] In one embodiment, for example, 100 nucleic acid detection microspheres 700, the 100 nucleic acid detection microspheres 700 correspond to 100 different primers 712, that is, the 100 nucleic acid detection microspheres 700 correspond to 100 different nucleoli 730. That is, the 100 different primers 712 correspond to 100 different nucleoli 730. In the process of increasing the temperature of PCR for a plurality of microdroplets containing the 100 nucleic acid detection microspheres 700, the coating layer 710 of each nucleic acid detection microsphere 700 dissolves and decomposes, releasing the primer 712 contained in the coating layer 710 into the corresponding microdroplet, and performing PCR amplification. At this time, for one of the nucleoli 730 contained in a part of the microdroplets, the primer 712 contained in the microdroplet is found by the nucleolus 730, and the target nucleic acid molecule in the microdroplet is found by the primer 712, thereby realizing PCR detection.
[0340] In one embodiment, the substrate is an agarose gel. Agarose gel is a gel produced using agarose as a support medium, and the melting point of agarose is 62°C to 65°C. Once melted, the liquid state is maintained at 37°C for several hours, and solidifies into a gel at 30°C. In the process of controlling the temperature of PCR for a plurality of microdroplets, the coating layer 710 melts and decomposes to release the primers 712 and the probes 713 contained in the coating layer 710 into the corresponding microdroplets, and the primers 712 and the target nucleic acid molecules contained in the microdroplets are subjected to a PCR reaction, and the fluorescent dye or the probes 713 indicate whether the nucleic acid has been amplified.
[0341] In one embodiment, the nucleolus 730 is a solid sphere containing a fluorescent dye.
[0342] The nucleolus 730 is made of a heat-resistant material, such as polyimide, polytetrafluoroethylene, polyphenylene sulfide, or polyamide. Alternatively, the nucleolus 730 can have a fluorescent dye to emit a fluorescent signal. The nucleolus 730 can be coded with different types of fluorescent dyes and the intensity of the fluorescence to obtain a large number of different types of the nucleolus 730, and the nucleolus 730 can have a fluorescent code signal, thereby realizing coding of a plurality of the nucleic acid detecting microspheres 700.
[0343] In one embodiment, the present application uses two different kinds of fluorescent dyes, and each fluorescent dye has 10 different levels of fluorescent signal intensity, thereby obtaining 10×10=100 different marks of the nucleolus 730, and if the nucleolus 730 has fluorescent code information, obtaining 10×10=100 different marks of the nucleic acid detection microspheres 700. Wherein, each of the nucleic acid detection microspheres 700 corresponds to one of the nucleolus 730, each of the nucleolus 730 corresponds to the primer 712, and each of the nucleolus 730 corresponds to the probe 713. By using a plurality of the nucleic acid detection microspheres 700, a plurality of different kinds of target nucleic acid molecules can be PCR detected only once, and there is no need to perform multiple detections repeatedly, which has the advantages of small workload, short detection time, high throughput and high sensitivity.
[0344] In one embodiment, the nucleus 730 has a diameter of 10 microns to 100 microns, and the coating layer has a thickness of 10 microns to 100 microns.
[0345] The nucleic acid detection microsphere 700 may generally have a diameter of 20 microns to 150 microns. In this way, sufficient microdroplets can be collected when collecting images. Among them, the nucleolus 730 may have a diameter of 10 microns to 100 microns. The coating layer may have a thickness of 10 microns to 100 microns. The nucleic acid detection microsphere 700 is not good if it is too large or too small. If it is too small, it is difficult to identify, and if it is too large, it often blocks the outlet end of the microdroplet generating device when generating multiple microdroplets, preventing the generation of multiple microdroplets. By arranging the diameter of the nucleic acid detection microsphere 700, in addition to being able to be identified by the fluorescent signal detection device 30 when generating multiple microdroplets again, it can cover as many microdroplets as possible so as to conveniently collect images, and does not prevent the generation of multiple microdroplets at the outlet end of the microdroplet generating device.
[0346] In one embodiment, the method for producing the nucleic acid detection microspheres includes: A step S110 of providing a plurality of nucleoli 730 and a primer solution; Step S120: providing a gel powder, adding the gel powder to double distilled water to obtain a gel powder solution, and heating the gel powder solution until it becomes clear to obtain a coating layer preparation solution; Step S130: mixing the plurality of nucleoli 730, the primer solution, and the coating layer preparation solution at a gel dissolving temperature to obtain a preparation solution of nucleic acid detecting microspheres; a step S140 of forming droplets of the nucleic acid detecting microspheres by atomizing the solution for manufacturing the nucleic acid detecting microspheres at the gel dissolution temperature; and a step S150 of cooling the droplets of the plurality of nucleic acid detecting microspheres and acquiring the plurality of nucleic acid detecting microspheres 700 by flow cytometry.
[0347] In step S110, the nucleoli 730 are solid spheres containing the same type of fluorescent dye, and the nucleic acid detection microspheres 700 are manufactured, where the nucleic acid detection microspheres 700 are uniquely associated with the nucleoli 730, and the primers 712 are uniquely associated with the nucleoli 730.
[0348] The primer solution also contains the primer 712. When the dried powder primer 712 is diluted with sterilized ultrapure water, the primer concentration is diluted to 100 μM, in other words, to 100 μmol / L. Then, 100 ul of the primer solution with a concentration of 100 μM is placed in 900 ul of the coating layer manufacturing solution so that the primer concentration is 10 μM (μmol / L).
[0349] In step S120, the gel powder may be a material capable of producing a gel, such as powdered agar or diethylene glycol diacrylate. The coating layer preparation liquid may be a powdered agar solution, which is prepared by providing 1.5% to 4.5% powdered agar and 10 ml of double distilled water in a mass ratio, adding the powdered agar to the double distilled water, and dissolving the powdered agar at high temperature until it becomes clear, to obtain the coating layer preparation liquid. The coating layer preparation liquid is a powdered agar solution.
[0350] In step S130, the primers 712 contained in the primer solution are the same type of primers, and the nucleoli 730 are the same type of fluorescent nucleoli. The melting temperature of the gel is the temperature at which the gel is converted into a liquid solution. The melting point of the agarose is 62°C to 65°C, and it solidifies and becomes a gel at 30°C. Then, the primers 712 and the nucleoli 730 are added to the coating layer manufacturing solution (the coating layer manufacturing solution is a powdered agar solution) in a high temperature environment of 62°C to 65°C to obtain the manufacturing solution of the nucleic acid detecting microspheres.
[0351] In one embodiment, when the primer 712 and the nucleolus 730 are added to the agarose solution in step S130, the concentration of the nucleolus 730 is generally selected depending on the size of the nucleic acid detection microspheres 700 to be generated.
[0352] Referring to FIG. 30-31, in step S140, a microfluidic control chip, a microfluidic generator, or a microdroplet generating device is used to form a plurality of droplets of the nucleic acid detecting microspheres in hydrophobic oil in a high temperature environment.
[0353] Referring to FIG. 30, in one embodiment, step S140 includes: providing a liquid ejection pipette tip having an outlet end and storing a preparation solution for the nucleic acid detection microspheres; and providing an open-ended container storing a hydrophobic oil; a step S142 of inserting an outlet end of the liquid ejection pipette tip under the surface of the hydrophobic oil at the gel dissolving temperature; and step S143, in which the outlet end of the liquid ejection pipette tip undergoes instantaneous accelerated movement below the surface of the hydrophobic oil or moves at a periodically changing speed to eject the manufacturing solution of the nucleic acid detection microspheres from the outlet end of the liquid ejection pipette tip and form droplets of the plurality of nucleic acid detection microspheres below the surface of the hydrophobic oil.
[0354] The present application provides a microdroplet generating device including a liquid ejection pipette tip, a fluid drive mechanism, and a motion control mechanism. The liquid ejection pipette tip has an outlet end and an inlet end, and the fluid drive mechanism drives the liquid ejection pipette tip to suck a manufacturing solution for nucleic acid detection microspheres into the liquid ejection pipette tip through the inlet end, and inserts the outlet end of the liquid ejection pipette tip into a container storing an oily liquid so that the outlet end of the liquid ejection pipette tip is inserted below the surface of the oily liquid. The motion control mechanism performs instantaneous accelerated motion below the surface of the oily liquid or motion at a periodically changing speed, thereby discharging the manufacturing solution for nucleic acid detection microspheres from the outlet end of the liquid ejection pipette tip, and forming droplets of the nucleic acid detection microspheres below the surface of the oily liquid. Among them, the oily liquid and the preparation solution of the nucleic acid detecting microspheres are two liquids that are incompatible with each other or have an interface reaction, and the oily liquid may be mineral oil (including tetradecane, etc.), vegetable oil, silicone oil, perfluoroalkane oil, etc.
[0355] In step S150, the droplets of the nucleic acid detection microspheres are cooled to room temperature of about 30° C., whereby the nucleic acid detection microspheres solidify and become gel, and the nucleic acid detection microspheres 700 are selected by flow cytometry. The flow cytometry irradiates the droplets of the nucleic acid detection microspheres in a high-speed flowing state with a high-energy laser. The droplets of the nucleic acid detection microspheres contain zero, one or more nucleoli 730, and the nucleoli 730 are solid spheres containing fluorescent dye, so the intensities of the scattered light and emitted fluorescence are detected and screening is performed to obtain the nucleic acid detection microspheres 700 containing only one nucleolus 730.
[0356] At this time, the cooled nucleic acid detecting microspheres 700 become gel-like and are easily stored and transported in a room temperature environment, and are transported in batches for use in PCR detection.
[0357] In one embodiment, the method for producing the nucleic acid detection microspheres includes: providing a primer solution, a probe solution, and a plurality of nucleoli 730; Step S220: providing a gel powder, adding the gel powder to double distilled water to obtain a gel powder solution, and heating the gel powder solution until it becomes clear to obtain a coating layer preparation solution; Step S230: mixing the plurality of nucleoli 730, the primer solution, and the probe solution with the coating layer preparation solution at a gel dissolving temperature to obtain a preparation solution of nucleic acid detecting microspheres; a step S240 of atomizing the solution for producing the nucleic acid detecting microspheres at the gel dissolution temperature to form a plurality of droplets of the nucleic acid detecting microspheres; and S250 cooling the droplets of the plurality of nucleic acid detection microspheres and selecting the plurality of nucleic acid detection microspheres by flow cytometry.
[0358] In step S210, the probe solution contains the probe 713 for detecting whether the nucleic acid is amplified, and may be an oligosaccharide nucleotide probe that simultaneously contains a fluorescent group and a quenching group, such as TaqMan fluorescent probe. In the process of controlling the temperature of PCR by a plurality of microdroplets, the coating layer 710 dissolves and decomposes, and the primer 712 and the probe 713 contained in the coating layer 710 are released into the corresponding microdroplets, and react with the target detection nucleic acid molecule contained in the microdroplets, and finally, the nucleolus 730 is located, tracked and identified, and the target nucleic acid molecule is found by the primer 712 and the probe 713 corresponding to the nucleolus 730, so that PCR high-throughput detection can be realized.
[0359] Among them, the nucleoli 730 are solid spheres containing the same type of fluorescent dye, and the nucleic acid detection microspheres 700 are manufactured, where the nucleic acid detection microspheres 700 are uniquely corresponding to the nucleoli 730, the primers 712 are uniquely corresponding to the nucleoli 730, and the probes 713 are uniquely corresponding to the primers 712.
[0360] In step S220, the manufacturing method of the manufacturing solution for the coating layer may be the same as the manufacturing method in step S120.
[0361] In step S240, the manufacturing method for forming the droplets of the plurality of nucleic acid detecting microspheres may be the same as the method in step S140.
[0362] In step S250, the method of obtaining the plurality of nucleic acid detecting microspheres 700 may be the same as that in step S150.
[0363] In one embodiment, in step S250, the nucleic acid detecting microsphere may be a nucleic acid detecting microsphere containing one of the nucleoli.
[0364] In one embodiment, in step S220, the gel powder may be agar or polyethylene glycol diacrylate.
[0365] In one embodiment, the reagent kit is used for high-throughput nucleic acid detection analysis, the reagent kit includes the nucleic acid detection microspheres and the nucleic acid reaction solution according to any of the above embodiments.
[0366] The nucleic acid reaction solution contains enzymes, dNTPs, fluorescent dyes, ions, etc., which are necessary for PCR amplification. For example, if the nucleic acid detection microspheres 700 contain the probes 713, the nucleic acid reaction solution does not need to contain fluorescent dyes.
[0367] The reagent kit is used to store and transport many different kinds of the nucleic acid detecting microspheres 700. Among them, the nucleic acid detecting microspheres 700 may be preserved in glycerin.
[0368] In one embodiment, a set of reagents and solutions are prepared for use only in digital PCR to reduce or avoid potential contamination of the template DNA sample with exogenous DNA. All equipment and consumables used should be sterilized at high temperature and dried at high temperature.
[0369] Referring to FIG. 32, in one embodiment, the high-throughput nucleic acid detection method includes: Step S310 includes providing a nucleic acid amplification reaction solution and a variety of different kinds of nucleic acid detection microspheres 700, the nucleic acid detection microspheres 700 including nucleoli 730 and a coating layer 710, the nucleoli 730 having code information, the coating layer 710 coating the nucleoli 730, the coating layer 710 including a substrate 711 and a primer 712 dispersed in the substrate 711, the primer 712 uniquely corresponding to the nucleoli 730, and the nucleoli 730 being solid spheres containing a fluorescent dye; Step S320 of mixing the various kinds of nucleic acid detection microspheres 700 with the nucleic acid amplification reaction solution to obtain a nucleic acid detection solution; A step S330 of forming the nucleic acid detection liquid into droplets to form a plurality of droplets 800; A step S340 of amplifying nucleic acid in the plurality of microdroplets 800 and obtaining the amplified plurality of microdroplets 800; Step S350: based on the amplified microdroplets 800, detecting the nucleolus 730 in each of the microdroplets 800, screening the microdroplets 800 that contain only one nucleolus 730, and obtaining a first effective microdroplet 810; The method includes a step S360 of detecting the fluorescent signal of the nucleolus 730 in the first effective microdroplet 810 based on the first effective microdroplet 810, obtaining the primer 712 corresponding to the nucleolus 730, reading the reported fluorescent signal of the nucleic acid amplification reaction, and obtaining whether the corresponding target nucleic acid molecule is present in the first effective microdroplet 810.
[0370] In step S310, the nucleic acid amplification reaction solution is a nucleic acid amplification reaction solution using deoxyribonucleic acid as a template, a reverse transcription nucleic acid amplification reaction solution using ribonucleic acid as a template, or a loop-mediated isothermal amplification reaction solution. The nucleic acid amplification reaction solution contains a fluorescent dye. The nucleic acid amplification reaction solution contains a nucleic acid template, a reaction buffer, deoxyguanosine triphosphate, a polymerase, and a divalent metal cation, and if the probe 713 is not present on the coating layer 710, the reaction buffer contains a fluorescent dye.
[0371] Among them, the nucleic acid amplification reaction solution may be a nucleic acid amplification reaction solution (also called a DNA amplification reaction solution) using deoxyribonucleic acid (DNA) as a template, a reverse transcription nucleic acid amplification reaction solution (also called an RNA reverse transcription reaction solution) using ribonucleic acid (RNA) as a template, or other nucleic acid amplification reaction solution such as a loop-mediated isothermal amplification (LAMP) reaction solution. Among them, the DNA amplification reaction solution is characterized in that it contains dNTPs, buffer solutions, inorganic salt ions, polymerase, primers, a DNA template to be detected, and a fluorescent dye or fluorescent probe, etc., which are necessary for amplifying DNA.
[0372] In the PCR reaction system, when SYBR Green fluorescent dye is added in a free state, it generates weak fluorescence, but once it is combined with double-stranded DNA, the fluorescence is greatly enhanced to generate a fluorescent signal, and it is possible to ensure that the increase in the fluorescent signal and the increase in the PCR product are completely synchronized. At this time, the fluorescent signal generated by SYBR Green fluorescent dye can be detected to obtain a report fluorescent signal of the nucleic acid amplification reaction, and it can be determined whether the first effective microdroplet 810 contains the corresponding target nucleic acid molecule.
[0373] The sizes, shapes, and primers 712 of the nucleic acid detecting microspheres 700 of the various different types of nucleic acid detecting microspheres 700 may be the same or different. The nucleic acid detecting microspheres 700 may include different types of primers 712 for detecting different types of the target nucleic acid molecules.
[0374] In step S320, when the nucleic acid detection solution is formed by mixing the various kinds of nucleic acid detection microspheres 700 and the nucleic acid amplification reaction mixture, the concentration of the nucleic acid detection microspheres 700 in the nucleic acid detection solution may be adjusted so that the number of coatings is maximized when the multiple microdroplets 800 are generated and the distribution of the microspheres corresponds to the model of Poisson distribution theory. In this case, the probability of one nucleolus 730 contained in each microdroplet 800 is expressed as p(x=1)=λe -λ , p'(x=1)=e -λ -λe -λ = 0, and in this case, when λ = 1, that is, when one nucleolus 730 contained in each microdroplet 800 is averaged, the probability of coverage by one nucleolus 730 is maximized. In this case, the probability of one nucleolus 730 contained in each microdroplet 800 is p(x = 1) = e -1 =0.368.
[0375] Referring to FIG. 1, in one embodiment, the nucleic acid high-throughput detector provided by the present application includes a microdroplet generating device, a temperature control device, a fluorescent signal detection device, an analysis device, and a controller. The microdroplet generating device is used to microdropletize the nucleic acid detection liquid to form the plurality of microdroplets 800. The temperature control device is connected to the microdroplet generating device via a rail, and is used to transfer the plurality of microdroplets to the temperature control device and realize nucleic acid amplification by temperature cycling using the temperature control device. The fluorescent signal detection device detects the fluorescence of the plurality of microdroplets with nucleic acid amplification until the amplification of the plurality of microdroplets is completed. The controller is connected to the microdroplet generating device, the temperature control device, and the fluorescent signal detection device, respectively, and is used to control the microdroplet generating device, the temperature control device, and the fluorescent signal detection device.
[0376] Among them, the microdroplet generating device includes a liquid ejection pipette tip, a fluid driving mechanism, and a motion control mechanism. The liquid ejection pipette tip has an outlet end and an inlet end, and the fluid driving mechanism drives the liquid ejection pipette tip to suck the nucleic acid detection liquid into the liquid ejection pipette tip by the inlet end, and inserts the outlet end of the liquid ejection pipette tip into a container storing an oily liquid so that the outlet end of the liquid ejection pipette tip enters below the surface of the oily liquid. At the same time, the motion control mechanism discharges the nucleic acid detection liquid from the outlet end of the liquid ejection pipette tip by a motion that instantaneously accelerates below the surface of the oily liquid or a motion that periodically changes speed, thereby forming the multiple microdroplets 800 below the surface of the oily liquid. Among them, the oily liquid and the nucleic acid detection liquid are two liquids that are incompatible with each other or have an interface reaction, and the oily liquid may be mineral oil (including tetradecane, etc.), vegetable oil, silicone oil, perfluoroalkane oil, etc.
[0377] 33-34, in one embodiment, a microfluidic control chip, a microfluidic generator, a microdroplet generating device, or the like may be used in the step S330 to microdropletize the nucleic acid detection liquid and form a plurality of microdroplets 800. In addition, the method of producing the plurality of microdroplets 800 is not limited to the above device, and other devices for producing the plurality of microdroplets 800 may be used.
[0378] Each of the microdroplets 800 contains zero, one or a plurality of the nucleic acid detection microspheres 700, and each of the microdroplets 800 contains the nucleic acid amplification reaction solution for amplifying nucleic acid.
[0379] In one embodiment, the multiple microdroplets 800 formed by microdropletizing the nucleic acid detection liquid in step S330 may have the same size or may have different sizes.
[0380] In one embodiment, a microfluidic control chip may be used when forming the nucleic acid detection liquid into fine droplets in step S330.
[0381] When the nucleic acid detection liquid is microdropletized, each microdroplet 800 may contain zero, one or more of the nucleic acid detection microspheres 700. When the temperature for amplifying nucleic acid in the microdroplets 800 is higher than the melting point of the agarose, the coating layer 710 melts to release the primers 712, and the primers 712 and the nucleic acid molecules in the microdroplets 800 are simultaneously amplified by PCR, and at this time, the type of the primers 712 can be identified by identifying the corresponding nucleoli 730 in the microdroplets 800, and the target nucleic acid molecule can be identified.
[0382] In one embodiment, in step S350, the first effective microdroplet 810 includes one of the nucleoli 730. Zero or more of the microdroplets 800 are regarded as invalid microdroplets. The first effective microdroplet 810 includes a fluorescent dye and the primer 712. In the process of performing PCR amplification on the primer 712 and the nucleic acid molecule in the first effective microdroplet 810, when the fluorescent dye is combined with double-stranded DNA and the fluorescence is greatly enhanced, it emits a relatively strong fluorescent signal, and the first effective microdroplet 810 has a relatively strong fluorescent signal, so that the nucleoli 730 and the primer 712 can obtain the type of the corresponding target nucleic acid molecule in the first effective microdroplet 810.
[0383] In one embodiment, step S360 includes: Step S361, providing a fluorescent signal detection device including a code fluorescent channel and a fluorescent dye detection channel, and identifying the fluorescent signal of the nucleolus 730 in the effective microdroplet based on the code fluorescent channel; Step S362 of acquiring the primer 712 corresponding to the nucleolus 730 based on the fluorescent signal of the nucleolus 730; and step S363 of detecting a reported fluorescent signal resulting from a nucleic acid amplification reaction in the first effective microdroplet 810 based on the fluorescent dye detection channel, and obtaining whether a corresponding target nucleic acid molecule is present in the first effective microdroplet 810.
[0384] The nucleoli 730 are solid spheres containing fluorescent dyes, and different types of fluorescent dyes and the intensity of the fluorescence may be used to mark the nucleoli 730. The fluorescence of each type corresponds to a certain type of the nucleoli 730, and each type of the nucleoli 730 corresponds to a certain type of the primers 712, which means that each type has a corresponding representative number in the primers 712, i.e., the nucleoli 730.
[0385] In step S360, the presence or absence of the target nucleic acid molecule is detected according to the presence or absence of the reported fluorescence signal, thereby achieving qualitative detection. In the screening process, the first effective microdroplets 810 having the same type of the nucleolus 730 can be divided into the same group. In addition, in the nucleolus 730 of this category, the ratio of the number of microdroplets that do not have the reported fluorescence signal in the first effective microdroplets 810 to the total number of microdroplets of this category is obtained according to the presence or absence of the reported fluorescence, and the concentration of the target nucleic acid molecule corresponding to the same type of the nucleolus 730 is calculated and obtained according to Poisson distribution.
[0386] Referring to FIG. 35, in one embodiment, the high-throughput nucleic acid detection method includes: Step S410: providing a nucleic acid amplification reaction solution and a variety of different kinds of nucleic acid detection microspheres 700, wherein the nucleic acid detection microspheres 700 include nucleoli 730 and a coating layer 710, the nucleoli 730 have code information, the coating layer 710 coats the nucleoli 730, the coating layer 710 includes a substrate 711, and a primer 712 and a probe 713 dispersed on the substrate 711, the primer 712 and the probe 713 are uniquely corresponding to the nucleoli 730, and the nucleoli 730 are solid spheres having fluorescent code information; Step S420 of mixing the various kinds of nucleic acid detection microspheres 700 with the nucleic acid amplification reaction solution to obtain a nucleic acid detection solution; A step S430 of forming the nucleic acid detection liquid into droplets to form a plurality of droplets 800; A step S440 of amplifying nucleic acid in the plurality of microdroplets 800 and obtaining the amplified plurality of microdroplets 800; Step S450: detecting the nucleolus 730 in each of the microdroplets 800 based on the amplified microdroplets 800, screening the microdroplets 800 that contain only one nucleolus 730, and obtaining a second effective microdroplet 820; and a step S460 of detecting the fluorescent signal of the nucleolus 730 in the second effective microdroplet 820 based on the second effective microdroplet 820, acquiring the primer 712 and the probe 713 corresponding to the nucleolus 730, reading the reported fluorescent signal resulting from the nucleic acid amplification reaction, and acquiring whether the corresponding target nucleic acid molecule is present in the second effective microdroplet 820.
[0387] When the nucleic acid detection liquid is microdropletized, each microdroplet 800 may contain zero, one or more of the nucleic acid detection microspheres 700. When the temperature for amplifying nucleic acid in the microdroplets 800 is higher than the melting point of the agarose, the coating layer 710 melts to release the primers 712, and the primers 712 and the nucleic acid molecules in the microdroplets 800 are simultaneously amplified by PCR, and at this time, the type of the primers 712 can be identified by identifying the corresponding nucleoli 730 in the microdroplets 800, and the target nucleic acid molecule can be identified.
[0388] In step S450, the second effective microdroplet 820 includes one of the nucleoli 730. The microdroplet 800 including zero or more than one of the nucleoli 730 is regarded as an invalid microdroplet. The second effective microdroplet 820 further includes the probe 713 and the primer 712. When the second effective microdroplet 820 includes the probe 713, the second effective microdroplet 820 does not need to include a fluorescent dye, and in this case, the probe 713 functions as a fluorescent mark. When the probe 713 binds to double-stranded DNA during the process of performing PCR amplification on the primer 712 and the nucleic acid molecule in the second effective microdroplet 820, the second effective microdroplet 820 including the corresponding target nucleic acid molecule can be identified.
[0389] In the process of performing PCR amplification on the primer 712 and the nucleic acid molecule in the second effective microdroplet 820, after the probe 713 binds to the double-stranded DNA, it is possible to determine whether the second effective microdroplet 820 contains the corresponding target nucleic acid molecule by identifying the probe 713. Then, the type of the corresponding target nucleic acid molecule in the first effective microdroplet 810 can be obtained by the nucleolus 730 and the primer 712.
[0390] In one embodiment, the method of forming the nucleic acid detection liquid into droplets in step S430 is the same as that in step S330.
[0391] Referring to FIG. 6, in one embodiment, the present application provides a fluorescent signal detection device 30. The fluorescent signal detection device 30 includes an excitation light source 340, a fluorescent detection assembly 330, and a third controller 310. The excitation light source 340 is disposed above a detection region of the microdroplets 800, and irradiates the detection region of the microdroplets 800 at an oblique angle to form an oblique irradiation light path. The fluorescent detection assembly 330 is disposed directly above the detection region of the microdroplets 800, and is used to collect fluorescent images of the microdroplets 800. The third controller 310 is connected to the excitation light source 340 and the fluorescent detection assembly 330, respectively, and is used to control the excitation light source 340 and the fluorescent detection assembly 330. The fluorescent signal detection device 30 can perform multiple fluorescent channel imaging and bright-field and dark-field imaging of the microdroplets. Among them, multiple fluorescence channel imaging is used to detect the reaction signals of microdroplets, and bright-field and dark-field imaging is used to detect the size information of the microdroplets formed and monitor the state of the droplets during the reaction process.
[0392] The excitation light source 340 includes LED light sources 341 of different colors, a collimator mirror 342, a first optical filter 343, a dichroic mirror 344, a compound lens 345, and a condenser lens 346. The LED light sources 341 of different colors can generate light of different colors and irradiate the microdroplets 800. By selecting the LED light sources 341 of different colors, different fluorescent colors can be irradiated and the LED light sources 341 of different colors can work alternately. The collimator mirror 342, the first optical filter 343, and the dichroic mirror 344 are arranged in sequence immediately before the optical path of each LED light source radiation. The collimator mirror 342 and the first optical filter 343 are arranged at a perpendicular angle to the optical path (arranged at an angle of 90°). The dichroic mirror 344 is arranged at an angle of 0° to 45° to the optical path. In one optical path formed by the dichroic mirror 344, the compound lens 345 and the condenser lens 346 are sequentially arranged just before it. The compound lens 345 and the condenser lens 346 are arranged at a perpendicular angle (90° angle) to the optical path. The internal fluorescence of the microdroplets 800 is excited and condensed by the objective lens 332 above through the second optical filter 333, and enters the camera 331, and the camera 331 collects fluorescent images of the microdroplets.
[0393] The optical path emitted by the excitation light source 340 is obliquely irradiated onto the microdroplets 800, thereby causing the fluorescent material contained in the microdroplets 800 to fluoresce. The fluorescence detection assembly 330 collects fluorescence information about the microdroplets containing the fluorescent material, and transmits the fluorescence information about the microdroplets containing the fluorescent material in the form of a fluorescence image to an analysis device (computer) for analysis.
[0394] The second controller 310 is used to switch between different optical filters to configure different fluorescence detection channels, including a code fluorescence channel, a fluorescent dye detection channel, a fluorescent probe detection channel, a microdroplet identification channel and multiple candidate channels.
[0395] Wherein, when the microdroplets 800 are generated, ROX reference dye is added to the nucleic acid detection solution. The ROX reference dye does not participate in the PCR reaction, and can identify information such as the specific position, outline and number of the microdroplets 800. The microdroplet identification channel is used to identify the fluorescence of the ROX reference dye and accurately position each of the microdroplets 800. The coding fluorescent channel can identify the fluorescent signal and the fluorescent signal intensity of the nucleolus 730, and obtain the first effective microdroplet 810 containing one of the nucleolus 730. The fluorescent dye detection channel or the fluorescent probe detection channel identifies the report fluorescent signal of the nucleic acid amplification reaction in the first effective microdroplet 810, and judges whether PCR amplification has been performed on the primer 712 or the primer 712 and the probe 713 and the target nucleic acid molecule based on the report fluorescent signal.
[0396] In step S460, the presence or absence of target nucleic acid molecules can be detected according to the presence or absence of reported fluorescent signals, and qualitative detection can be realized. In the screening process, the second effective microdroplets 820 containing the same type of nucleolus 730 can be divided into a group. At the same time, the presence or absence of reported fluorescent signals can be detected, and the ratio of the number of microdroplets with no reported fluorescent signals to the total number of microdroplets of this category can be obtained for the second effective microdroplets 820 in the nucleolus 730 of this category, and the concentration of the target nucleic acid molecules corresponding to the same type of nucleolus 730 can be calculated according to Poisson distribution.
[0397] The coded fluorescent channel detects the fluorescent signal of the nucleolus 730 in the plurality of microdroplets 800, and the first effective microdroplet 810 can be screened from the plurality of microdroplets 800. The first effective microdroplet 810 contains one of the nucleolus 730. The fluorescent dye detection channel detects the first effective microdroplet 810, reads the reported fluorescent signal of the nucleic acid amplification reaction, and judges whether the first effective microdroplet 810 contains the corresponding target nucleic acid molecule. If the first effective microdroplet 810 contains the target nucleic acid molecule, the type of the corresponding target nucleic acid molecule can be determined by the primer 712 corresponding to the nucleolus 730 in the first effective microdroplet 810.
[0398] Similarly, the second effective microdroplet 810 can be screened from the multiple microdroplets 800 by detecting the fluorescent signal of the nucleolus 730 in the multiple microdroplets 800 using the coded fluorescent channel. Among them, the second effective microdroplet 820 contains one of the nucleolus 730. Then, the fluorescent probe detection channel detects the second effective microdroplet 820, reads the reported fluorescent signal of the nucleic acid amplification reaction, and judges whether the corresponding target nucleic acid molecule is contained in the second effective microdroplet 820. If the second effective microdroplet 820 contains the corresponding target nucleic acid molecule, the type of the corresponding target nucleic acid molecule can be determined by the corresponding primer 712 or probe 713 of the nucleolus 730 in the second effective microdroplet 820.
[0399] In one embodiment, the fluorescent signal detection device includes a plurality of the coded fluorescent channels for identifying the nucleoli 730 of many different fluorescent marks. Specifically, the first coded fluorescent channel is arranged as fluorescent A, and 10 gradient densities are arranged, the second coded fluorescent channel is arranged as fluorescent B, and 10 gradient densities are arranged in the same manner, so that the fluorescent signal detection device can identify the nucleoli 730 of 10×10=100 different fluorescent channels and intensity marks, in other words, the nucleoli 730 of 100 different fluorescent marks can mark 100 different kinds of the primers 712 or the primers 712 and the probes 713. By analogy, a large number of different kinds of the nucleoli 730 can be obtained, and thus a large number of different kinds of the nucleic acid detection microspheres 700 can be marked.
[0400] The nucleic acid detection microspheres 700 are composed of the nucleolus 730, the primer 712, the probe 713 and the coating layer 710. The various kinds of the nucleic acid detection microspheres 700 are randomly distributed in the nucleic acid amplification reaction solution, and the nucleic acid detection solution is mixed to obtain the nucleic acid detection solution, and the nucleic acid detection solution is again made into microdroplets to generate the multiple microdroplets 800. When the temperature is increased to 60°C or higher, the coating layer 710 dissolves, releasing the primer 712 and the probe 713 into the microdroplets 800, forming a complete nucleic acid amplification reaction system, and the nucleolus 730 remains in the microdroplets 800, which is a fluorescent symbol representing the microdroplets 800. After the amplification is completed, if the microdroplets 800 contain target nucleic acid molecules, the fluorescent dye or the probe 713 will bind to the double-stranded DNA during the amplification process, and the fluorescent signal will be enhanced, and the generation of the fluorescent signal will be reported.
[0401] Next, by detecting the nucleolus 730 having the fluorescent code information in a plurality of the microdroplets 800, the microdroplets 800 having the nucleolus 730 having only one fluorescent code information are screened as effective microdroplets, and then proceed to analysis. Based on the obtained effective microdroplets (effective microdroplets are the first effective microdroplets 810 or the second effective microdroplets 820 in the above embodiment), the fluorescent signal of the nucleolus 730 in the effective microdroplets is detected, and the classification of the primer 712 and the probe 713 is also obtained. Next, the reported fluorescent signal of the nucleic acid amplification reaction in the effective microdroplets is obtained, and based on the reported fluorescent signal, it is determined whether the effective microdroplets contain the corresponding target nucleic acid molecules. Therefore, according to the nucleic acid detection microspheres 700, the manufacturing method, the reagent kit, and the high-throughput nucleic acid detection method, by adding multiple types of the nucleic acid detection microspheres 700 only once, the presence or absence of multiple target nucleic acid molecules can be detected at one time, and the concentration of each detection target nucleic acid can be obtained based on the Poisson distribution.
[0402] Therefore, by mixing a large amount of different types of the nucleic acid detection microspheres 700 with the nucleic acid amplification reaction solution to be detected to detect the target nucleic acid, multiple types of target nucleic acids can be detected in one go, eliminating the need to repeat the detection multiple times, reducing the amount of work, saving time, and increasing sensitivity.
[0403] The technical features of the above embodiments may be combined in any manner, and for the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, it is considered that they fall within the scope of the present specification.
[0404] It should be understood that the above examples only show some embodiments of the present application in detail and specifically, but do not limit the scope of protection of the present application. Those skilled in the art should understand that, without departing from the creative concept of the present application, some modifications and improvements can be made, all of which should fall within the scope of protection of the present application. Therefore, the scope of protection of the present application is based on the content described in the claims.
[0405] Finally, in this specification, the numbers of the members, such as "first", "second", etc., are used only to distinguish the objects of description, and have no order or technical meaning. In addition, "connection" and "coupling" in this application include both direct connection and indirect connection (coupling) unless otherwise specified. In the description of this application, the orientation or positional relationship indicated by terms such as "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", etc., is merely for facilitating and simplifying the description of this application based on the orientation or positional relationship shown in the drawings, and does not indicate or suggest that the mentioned devices or parts necessarily have a certain orientation and are constructed and operated in a certain orientation, and therefore should not be understood as limiting the present invention.
[0406] In this specification, unless otherwise expressly specified and limited, a first feature being "above" or "below" a second feature may mean that the first feature is in direct contact with the second feature, or that the first feature is in indirect contact with the second feature via an intermediate medium. Also, a first feature being "above," "upper," and "upper side" of a second feature means that the first feature is directly above or diagonally above the second feature, or simply that the horizontal height of the first feature is higher than that of the second feature. A first feature being "below," "lower," and "lower side" of a second feature means that the first feature is directly below or diagonally below the second feature, or simply that the horizontal height of the first feature is lower than that of the second feature.
[0407] In this specification, technical terms relating to relationships, such as "first," "second," etc., are used only to distinguish one thing or operation from another, and do not necessarily require or imply any actual relationship or sequence between those things or operations. Moreover, technical terms such as "comprises," "includes," or any other variations thereof refer to a non-exclusive inclusion meaning, such that a process, method, article, or equipment consisting of a series of elements includes not only those elements but also other elements not expressly listed, as well as elements inherent in the process, method, article, or equipment. Unless further limited, an element defined by a sentence "comprises a ..." does not exclude other similar elements present in the process, method, article, or equipment that includes the element.
[0408] In each embodiment of the present specification, the description will be step-by-step, and the differences from other embodiments will be focused on, and reference may be made between the embodiments with respect to the same or similar parts.
[0409] Those skilled in the art can implement or realize the present application with the above description of the disclosed embodiments. Various modifications to these embodiments will be apparent to those skilled in the art. The general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present application. Thus, the present application is not limited to the embodiments disclosed herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. Step S10 of preparing a nucleic acid amplification reaction solution to be detected; A step S20 of forming a matrix of microdroplets by forming the nucleic acid amplification reaction solution to be detected into microdroplets; A step S30 of subjecting the matrix of microdroplets to a polymerase chain reaction and obtaining a fluorescence curve of each microdroplet in the matrix of microdroplets during the polymerase chain reaction and a melting curve of each microdroplet; and a step S40 of analyzing the matrix of microdroplets based on a fluorescence curve during a polymerase chain reaction of each microdroplet in the matrix of microdroplets and a melting curve of each microdroplet, thereby obtaining information on the nucleic acid to be detected; In step S40, and obtaining an initial copy number of nucleic acid in the matrix of microdroplets based on a fluorescence curve of the matrix of microdroplets S410; In step S410, obtaining a Ct value corresponding to the fluorescence curve of each of the microdroplets based on the fluorescence curve of the matrix of the microdroplets; Step S412: sorting the microdroplets in descending order by clustering based on the Ct value of the fluorescence curve of each of the microdroplets to obtain a classification of x 1 , x 2 , . . . , x n ; Step S413: acquiring the numbers y 1 , y 2 , ..., y n of the microdroplets corresponding to each classification based on the classification of x 1 , x 2 , ..., x n ; A step S414 of acquiring a frequency distribution of the numbers y1, y2, ..., yn of the micro-droplets corresponding to each classification of x1, x2, ..., xn based on the numbers y1, y2, ..., yn of the micro-droplets corresponding to each classification; and calculating an initial copy number of nucleic acid in the matrix of microdroplets based on the frequency distribution (S415).
2. In step S30, Step S310 of configuring temperature parameters, time parameters, and number of cycles for the polymerase chain reaction; S320: sequentially subjecting the matrix of microdroplets to a polymerase chain reaction for the number of cycles based on the temperature parameters and the time parameters, and acquiring a fluorescence curve for each of the microdroplets for each cycle; The digital PCR detection method according to claim 1, further comprising a step S330 of lowering the temperature of the matrix of microdroplets amplified by the polymerase chain reaction and raising the temperature at regular temperature intervals to obtain a melting curve of each of the microdroplets.
3. In step S320, a step S321 of polymerase chain reaction of the matrix of microdroplets based on the temperature parameters and the time parameters, and acquiring a fluorescent image of the matrix of microdroplets; Sequentially cycling through the number of cycles and acquiring all of the fluorescent images of the matrix of microdroplets in a polymerase chain reaction step S322; A step S323 of acquiring fluorescence information of each of the microdroplets for each circulation step based on all of the fluorescence images of the matrix of the microdroplets; The digital PCR detection method according to claim 2, further comprising a step S324 of acquiring a fluorescence curve of each of the microdroplets based on the fluorescence information of each of the microdroplets for each circulation step, and acquiring a fluorescence curve of the matrix of the microdroplets.
4. In step S330, A step S331 of lowering the temperature of the matrix of microdroplets amplified by the polymerase chain reaction to 40° C. or less; A step S332 of increasing the temperature of the matrix of microdroplets, the temperature of which has been decreased to 40° C. or less, at a certain temperature interval and acquiring a fluorescent image of the matrix of microdroplets corresponding to the temperature interval; A step S333 of acquiring fluorescence information of each of the microdroplets corresponding to the temperature intervals based on a fluorescence image of the matrix of the microdroplets corresponding to the temperature intervals; Step S334: obtaining a melting curve of each of the microdroplets based on the fluorescence information of each of the microdroplets corresponding to the temperature interval, and obtaining a melting curve of the matrix of the microdroplets; The digital PCR detection method according to claim 2, comprising:
5. Step S40 further includes: The digital PCR detection method according to claim 1, further comprising a step S420 of acquiring nucleic acid information of the matrix of the microdroplets based on a melting curve of the matrix of the microdroplets.
6. In step S415, 1 The number y of the microdroplets of each category 1 The digital PCR detection method of claim 1, characterized in that when is greater than or equal to the feature value m, a Poisson distribution is fitted based on the frequency distribution to obtain a parameter λ of the Poisson distribution, and the initial copy number of nucleic acid in the matrix of the microdroplets is obtained.
7. In step S415, when the number y1 of the micro-droplets in the category x1 is smaller than the feature value m, The x 2 , …, x n The number y of microdroplets corresponding to each classification 2 , …, y n Based on a frequency distribution of a part of the x 2 The classification and the corresponding initial copy number of the nucleic acid are fitted with a Poisson distribution, and the corresponding parameter λ of each Poisson distribution is j Step S4151 of acquiring (j=0, 1, 2....); [0031] The optimal λ optimaland a step S4153 of calculating the initial copy number of nucleic acid in the matrix of the microdroplets based on the above.
8. In step S420, Step S421: obtaining the melting curve and corresponding melting temperature of each of the microdroplets based on the melting curve of the matrix of the microdroplets; The digital PCR detection method of claim 5, further comprising a step S422 of classifying the matrix of microdroplets based on the melting temperature, acquiring nucleic acid information of the matrix of microdroplets, and acquiring nucleic acid information of the nucleic acid to be detected.
9. The digital PCR detection method of claim 1, further comprising step S50 of obtaining a high-resolution melting curve of the matrix of microdroplets, classifying the matrix of microdroplets, and obtaining nucleic acid information for genotyping and / or mutation detection on the matrix of microdroplets.
10. A digital PCR detector for carrying out the digital PCR detection method according to any one of claims 1 to 9, comprising: a microdroplet generating device arranged to convert the nucleic acid amplification reaction solution into microdroplets and form a plurality of microdroplets; a temperature control device connected to the microdroplet generating device via a rail and configured to transfer the plurality of microdroplets to the temperature control device and realize nucleic acid amplification by temperature cycling; a fluorescent signal detection device disposed opposite the temperature control device, arranged to capture and detect the multiple nucleic acid amplified microdroplets, imaging the microdroplets with multiple fluorescent channels and imaging them in bright field and dark field, the imaging with the multiple fluorescent channels being arranged to detect reaction signals of the microdroplets, and the imaging with bright field and dark field being arranged to detect size information of the microdroplets and monitor the state of the droplets in the reaction process; a quantitative analysis device connected to the fluorescence signal detection device via a data line and arranged to transmit and quantitatively analyze the fluorescence information of the plurality of microdroplets; a controller connected to the microdroplet generating device, the temperature control device, the fluorescent signal detection device and the quantitative analysis device, respectively, and configured to control the microdroplet generating device, the temperature control device, the fluorescent signal detection device and the quantitative analysis device.
11. The microdroplet generating device includes: a liquid dispensing pipette tip having an outlet end and an inlet end for storing a first liquid; a fluid drive mechanism connected to an inlet end of the liquid ejection pipette tip for discharging a first liquid stored inside the liquid ejection pipette tip from an outlet end of the liquid ejection pipette tip; a motion control mechanism for controlling the outlet end of the liquid-ejecting pipette tip to move in a counter-movement manner with respect to a second liquid along a predetermined trajectory, at a predetermined speed, or at a predetermined acceleration, so that the first liquid discharged from the outlet end of the liquid-ejecting pipette tip overcomes surface tension and adhesive force to form minute droplets; The digital PCR detector of claim 10, further comprising: a first controller connected to the fluid drive mechanism and the motion control mechanism, respectively, for controlling operation of the fluid drive mechanism and the motion control mechanism.
12. The temperature control device includes: A flexible circuit board; a heating substrate spaced apart from the flexible circuit board; a plurality of semiconductor thermocouples; the heating substrate includes an opposing first surface and a second surface; The digital PCR detector of claim 10, wherein the plurality of semiconductor thermocouples are disposed between the flexible circuit board and the first surface, and the plurality of semiconductor thermocouples are connected to each other in series, in parallel, or in series-parallel.
13. The fluorescent signal detection device comprises: an excitation light source disposed above a detection region of a micro-droplet container and obliquely irradiating the detection region of the micro-droplet container to form an oblique illumination light path; a fluorescent detection assembly disposed directly over a detection area of the micro-droplet container for collecting fluorescent images and bright-field and dark-field images of the plurality of micro-droplets; and a third controller connected to the excitation light source and the fluorescence detection assembly, respectively, for controlling the excitation light source and the fluorescence detection assembly.
14. The excitation light source is A plurality of LED light sources of different colors, each of which is provided at each tip with a collimator mirror and a first optical filter in sequence; a dichroic mirror that is tilted and disposed at a tip of the first optical filter, and that refracts the light emitted from each of the LED light sources into one optical path; a compound lens for improving uniformity of the refracted optical path; The digital PCR detector according to claim 13, further comprising a condenser lens disposed at the tip of the compound lens for condensing and forming an illumination spot.
Citation Information
Patent Citations
Integral rigid runner droplet digital PCR system and method
CN106520524A
Digital PCR concentration calculation method
CN107622185A
